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Abstract 
 
Introduction: Distress has become so problematic in oncology that it has been 
recognized as the “sixth vital sign” implying that distress monitoring should occur 
as routinely as the monitoring of one’s temperature or blood pressure. The 
research reported herein investigated the impact of head and neck cancer on 
levels of distress, commonly reported problems, and perceptions of quality of life 
in individuals with head and neck cancer and their caregivers. 
Method: Two distinct studies were conducted; the first explored the patient 
experience of distress and quality of life while the second assessed the caregiver 
experience of these same constructs. A prospective, longitudinal research design 
was employed for the patient study while a cross-sectional design was utilized for 
the caregiver study. Measurement instruments included: (1) a demographic 
survey; (2) the Distress Thermometer and Problem Checklist; (3) the EORTC 
Quality of Life questionnaire (EORTC-QLQ-C30), and (4) the EORTC Head and 
Neck module (EORTC-QLQ-H&N35), to evaluate quality of life in individuals with 
head and neck cancer; and (5) the Caregiver Quality of Life-Cancer Scale 
(CQOLC) to assess quality of life in caregivers.  
Results: Data indicate that elevated distress can exist at any point along the 
continuum of care in both individuals with head and neck cancer and their 
caregivers. Relative to the patient population, distress was most prevalent at 
diagnosis and length of time following diagnosis had a large effect on perceived 
distress. Meanwhile 45% of caregiver participants reported clinically significant 
distress; both caregiver sex and the treatment status (i.e., awaiting treatment, 
  iii 
undergoing treatment, completed treatment) of the individual for whom they were 
providing care influenced perceptions of distress in caregivers. Relative to quality 
of life, participants in both studies reported elevated burden in three primary 
domains: role fulfillment, physical functioning, and psychological well-being. 
Conclusion: Data suggest that perceptions of distress are individualized and 
heterogeneous in nature. Thus, routine distress screening represents a critical 
first step in the identification of elevated distress in both those with head and 
neck cancer and their caregivers. Through early identification and effective 
management of distress, comprehensiveness of care may be enhanced and 
long-term outcomes may be optimized.  
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Epigraph 
 
 
 
 
 
 
 
 
 
 
“We must embrace pain and burn it as fuel for our journey” 
 
Kenji Miyazawa 
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Chapter 1 
Introduction and Review of Literature 
 
Cancer is a disease of multiple types, sites, and etiologies. Statistics 
indicate that it is the leading cause of death in economically developed countries 
and the second leading cause of death in developing nations (WHO, 2008). This 
prevalence translated to approximately 12.7 million diagnoses of cancer and 7.6 
million cancer-related deaths in 2008 (Jemal et al., 2011). Unfortunately, the 
cause for concern related to cancer extends beyond the pervasiveness of the 
disease to also include the myriad consequences that stem from it. Due to the 
current forms of treatment available (e.g., chemotherapy, radiotherapy, surgery, 
and multimodality protocols), there are often significant consequences related to 
the functioning and quality of life of individuals with cancer (Semple, Sullivan, 
Dunwoody, & Kernohan, 2004) in addition to that of their caregivers.  
Irrespective of anatomical site, all individuals with cancer experience some 
level of distress related to their diagnosis and treatment (NCCN, 2013). 
Unfortunately, this problem is amplified in those with head and neck cancer, a 
population who exhibits the highest rates of anxiety, depression, and suicide 
compared with other cancer sites (Kendal, 2006; Misono, Weiss, Fann, Redman, 
& Yueh, 2008). While the specific reasons underlying the disproportionate rate of 
suicide and depression in individuals with head and neck cancer are unknown, 
researchers have speculated that the cause may be attributable to the 
devastating effect of the disease and its treatment on the quality of life of 
individuals with head and neck cancer (Misono et al., 2008). The impact of the 
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disease and its treatment on one’s appearance and essential functions such as 
breathing, swallowing and speech were also cited as possible factors contributing 
to the elevated rates of depression and suicide in individuals with head and neck 
cancer (Misono et al., 2008). In addition to the concerns of the person with head 
and neck cancer, it is apparent that the diagnosis of cancer and its 
accompanying sequelae (e.g., treatment- and disease-related consequences 
such as impaired breathing, speech, and swallowing) create a crisis for family 
members and significant others (Blood, Simpson, Dineen, Kauffman, & 
Raimondi, 1994); these individuals are expected to grieve – or rather, respond to 
the loss (Lev & McCorkle, 1998) – while simultaneously supporting the health 
and psychosocial well-being of the individual with cancer. Given this level of 
burden, it is not surprising that partners of those with head and neck cancer 
report higher levels of anxiety than those with the disease (Vickery, Latchford, 
Hewison, Bellew, & Feber, 2003). Consequently, it is apparent that elevated 
distress has the potential to impact not only individuals with head and neck 
cancer, but also their loved ones and caregivers.  
Since the relationship between individuals with cancer and their caregivers 
appears to be interrelated, with both partners experiencing negative 
consequences when one is distressed (Northouse, Templin, & Mood, 2001; 
Segrin, Badger, Dorros, Meek, & Lopez, 2007), efforts to develop an improved 
understanding of the factors that contribute to elevated distress in both those with 
head and neck cancer and their caregivers may have important implications for 
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improving health-related outcomes in both caregivers and those with head and 
neck cancer. 
Head and Neck Cancer 
Head and neck cancer refers to an extensive array of diverse tumour 
types that arise from various anatomic sites located within the head and neck 
region (Pai & Westra, 2009; Walden & Aygun, 2013). These sites include, but are 
not limited to: craniofacial bones, skin, soft tissues, mucosal membranes, and 
salivary glands (Pai & Westra, 2009). More than 90% of head and neck cancer 
diagnoses may be histologically classified as squamous cell carcinomas; most of 
these tumours originate in the mucosal surfaces of the head and neck such as 
the nasopharynx, oropharynx, hypopharynx, larynx, and oral cavity (Marur & 
Forastiere, 2008; Ragin, Modugno, & Gollin, 2007; Walden & Aygun, 2013). 
Other less common forms of malignant neoplasms include adenocarcinomas, 
lymphomas, melanomas and sarcomas (Semple et al., 2004). 
Head and neck cancer may present as a localized disease without lymph 
node involvement or it may present as regionally advanced disease with a 
primary tumour and/or lymph node involvement, indicating the increased 
potential for distant metastases (Marur & Forastiere, 2008; Vokes, 2012). 
Treatment may consist of surgical excision, radiotherapy, chemotherapy or a 
combination of these approaches (Semple et al., 2004; Vokes, 2012). 
Irrespective of treatment modality, individuals diagnosed with head and neck 
cancer face a distinct set of treatment-related challenges related to oral 
communication, emotional expression, social interaction, and/or physical 
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function. The manner in which one learns to adapt or cope with these distressing 
changes may significantly influence his or her perceived quality of life and level of 
distress. Collectively, one’s ability to cope with distressing changes related to the 
disease and/or its treatment may impact both short- and long-term health related 
outcomes (Elani & Allison, 2011; Horney et al., 2011).  
Incidence of head and neck cancer and mortality. In the past 20 years, 
the overall incidence of head and neck cancer has declined in Canada, the 
United States, and Western Europe (Johnson-Obaseki, McDonald, Corsten, & 
Rourke, 2012; Siegel, Ward, Brawley, & Jemal, 2011). Despite this decline, 
international incidence rates of head and neck cancer reached an estimated 
633,000 new cases in 2008 (Ferlay et al., 2010). Within Canada, findings reveal 
an increased incidence in oropharyngeal cancer in both men and women but a 
decreased incidence in all other head and neck sites for both sexes (Johnson-
Obaseki et al., 2012). Relative to mortality, international data indicate that an 
estimated 355,000 individuals succumbed to their disease in 2008 (Ferlay et al., 
2010). Recent Canadian data suggest that there has been no statistically 
significant improvement in survival among women for any head and neck cancer 
site, however, slight improvements in survival were reported among men for all 
head and neck cancer sites, with oropharyngeal sites representing the most 
improved rate of survival (Johnson-Obaseki et al., 2012). The reasons for the 
varying incidence and mortality rates associated with oropharyngeal cancer 
versus other head and neck sites may be explained through an examination of 
etiological factors. 
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Etiology. The etiology of head and neck cancer stems from a variety of 
risk factors that contribute to the disease both independently and collectively. 
Namely, diet, oral hygiene, genetic predisposition, preexisting medical conditions, 
infectious agents, and exposure to a variety of carcinogens may all contribute to 
the development of head and neck cancer (Pai & Westra, 2009; Vokes, 2012; 
Wynder & Bross, 1957; Wynder, Bross, & Feldman, 1961). Of these potential 
carcinogens, tobacco usage is a well established risk factor for the development 
of head and neck cancer (Pai & Westra, 2009; Vokes, 2012; Wynder & Bross, 
1957; Wynder et al., 1961). In fact, Rodriguez and colleagues (2004) determined 
that heavy smokers under the age of 46 have a 20-fold increased risk of 
developing oral or pharyngeal cancer compared to individuals who do not smoke. 
Not surprisingly, the risk associated with smoking tobacco products is directly 
correlated with the duration and amount of smoking (Pai & Westra, 2009; 
Rodriguez et al., 2004). Similar to lung cancer, environmental exposure to 
tobacco smoke also has been shown to increase the risk of head and neck 
cancer, even among those with no smoking history (Zhang et al., 2000). In 
addition, smokeless tobacco products have been cited as an etiologic agent for 
oral cancers (Cogliano et al., 2004; Cullen et al., 1986; Zhou et al., 2012). 
Additionally, heavy alcohol consumption is also recognized as an 
independent risk factor for head and neck cancer (Hashibe et al., 2007; Sturgis & 
Cinciripini, 2007). Heavy alcohol consumption has been estimated to increase 
the risk of developing oral cancer by five-fold (Rodriguez et al., 2004). Though 
both alcohol and tobacco are independent risk factors for head and neck cancer, 
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when the two agents are combined the risk of developing oral or pharyngeal 
cancer has been reported to increase by nearly 50-fold (Rodriguez et al., 2004). 
In fact, it has been reported that as many as 75% of all head and neck cancers 
are attributable to the synergistic influence of this carcinogenic combination 
(Hashibe et al., 2007). Although alcohol itself does not act as a direct carcinogen, 
its metabolite, acetaldehyde, interferes with DNA synthesis and repair 
mechanisms causing irreparable damage (Brooks & Theruvathu, 2005). Since 
alcohol is a chemical solvent, it is thought to amplify the carcinogenic effects of 
tobacco by prolonging and enhancing the mucous membrane exposure to the 
carcinogens found within tobacco (Pai & Westra, 2009). In effect, alcohol may 
increase the susceptibility of the body to the harmful carcinogens found in 
tobacco.  
Although alcohol consumption and tobacco exposure are well-established 
risk factors, recently, there has been an epidemiologic shift towards human 
papillomavirus (HPV)-related head and neck cancers (Li et al., 2012; Marur, 
D'Souza, Westra, & Forastiere, 2010; Marur & Forastiere, 2008). Syrjanen, 
Pyrhonen, and Syrjanen (1983) first suggested the role of HPV in head and neck 
carcinogenesis (Campisi & Giovannelli, 2009). Since then, epidemiological 
research has shown that the risk of developing HPV-induced head and neck 
cancer is increased by sexual behaviours associated with the transmission of 
high-risk HPV types (Forte, Niu, Lockwood, & Bryant, 2012; Walden & Aygun, 
2013) specifically HPV-16, -18, and -31 (Marur et al., 2010; Marur & Forastiere, 
2008; Pai & Westra, 2009). In effect, HPV is emerging as a preeminent and 
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significant risk factor for oropharyngeal cancer and appears to be altering the 
demographics of head and neck cancer toward those who are younger and 
without a history of tobacco use or heavy alcohol consumption (Walden & Aygun, 
2013).  
In addition to tobacco, alcohol and HPV, there are several additional risk 
factors for head and neck cancer that include, but are not limited to: poor oral 
hygiene (Pai & Westra, 2009), diets deficient in vitamin A (Marur & Forastiere, 
2008) or with low fruit and vegetable intake (Pai & Westra, 2009; Vokes, 2012), 
infectious agents such as the Epstein-Barr virus (Vokes, 2012), a family history of 
disease (Pai & Westra, 2009), marijuana smoke (Vokes, 2012), and occupational 
exposures – particularly in nickel refining, textiles, leatherworking, woodworking, 
metalworking, and any areas with exposure to asbestos, chromium, radiation or 
mustard gas (Marur & Forastiere, 2008; Vokes, 2012). All of these factors, either 
individually or collectively, may contribute to the development of head and neck 
cancer and the associated consequences and complications of the disease and 
its treatment. While the presence of a single etiologic factor may pose significant 
risk for the development of head and neck cancer, the possibility of coexisting 
factors must be considered in the treatment and assessment of health status and 
outcomes in individuals with head and neck cancer. 
Impact of disease. The diagnosis of head and neck cancer carries with it 
a unique set of challenges that potentially exceed those associated with other 
sites of cancer (Howren, Christensen, Karnell, & Funk, 2012; Semple, 2001). 
This assertion is related to the fact that head and neck cancer treatment can be 
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quite complex with potentially debilitating consequences. In essence, debilitating 
side effects related to the disease and its treatment are present in all of those 
diagnosed with head and neck cancer; however for some, the consequences 
stemming from these side effects are more disabling than others. For instance, 
side effects may include difficulties related to essential functions such as 
breathing, eating, swallowing and speech production, in addition to a loss of 
smell and taste, decreased sensation, sticky saliva, excessive dry mouth, pain, 
swelling, and facial disfigurement (Doyle, 1994; Payakachat, Ounpraseuth, & 
Suen, 2012). Further, some institutions require those individuals receiving 
chemoradiation treatment to undergo prophylactic extraction of all dentition in an 
effort to prevent future dental and mandibular problems (Hunter & Jolly, 2013). 
Understandably, this process can be quite traumatic in and of itself. Moreover, 
these myriad side effects stemming from the complex treatment regimens 
required for the management of head and neck cancer often serve to impair daily 
functioning and one’s ability to work. 
Treatment regimens for head and neck cancer have the potential to create 
a debilitating and lasting impact on an individual’s functional status, which may 
consequently limit their ability to work both during and after treatment (Penner, 
2009). Research examining work-related disability in those with head and neck 
cancer revealed that 52% of individuals who were employed at the time of 
diagnosis were unable to return to work following the completion of treatment 
(Taylor et al., 2004). Likewise, other researchers have reported a similar inability 
of individuals with head and neck cancer to return to their previous employment 
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for extended periods of time, if at all (Shone & Yardley, 1991; Taylor et al., 2004; 
Verdonck-de Leeuw, Van Bleek, Leemans, & de Bree, 2010). Even if those with 
head and neck cancer are able to return to work following treatment, many have 
reported having to change their jobs because of poor health and/or physical 
discomfort related to treatment consequences (Liu, 2008). When compared with 
other types of cancer, individuals with head and neck cancer have reported the 
highest risk of quitting their jobs following treatment for their cancer (Short, 
Vasey, & Tunceli, 2005). This change in employment status may have significant 
implications on the financial and psychosocial well-being of these individuals 
(Taylor et al., 2004). 
In addition to the impact on one’s employment status, further concerns 
may arise related to one’s independence and ability to participate in social 
activities. To elaborate, research has shown that individuals treated for head and 
neck cancer often either decrease the frequency of their driving or stop driving 
altogether during and after treatment because of treatment-related impairments 
(e.g., shoulder dysfunction following neck dissection) (Yuen, Gillespie, Day, 
Morgan, & Burik, 2007). Consequently, daily routines and tasks such as running 
errands or driving to and from work (if applicable) are disrupted, as those who 
have been treated for head and neck cancer must increasingly rely on others 
(e.g., caregivers) for transportation (Yuen et al., 2007). This reliance on others to 
perform tasks which once symbolized independence (e.g., driving) may result in 
feelings of dependence and decreased self-worth in those with head and neck 
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cancer. As a result of these myriad concerns, individuals may experience 
substantial problems within the context of social and family settings. 
Often, these concerns are exacerbated by the very visible side effects of 
head and neck cancer and its treatment including the potential for physical 
disfigurement and scarring (Björklund, Sarvimäki, & Berg, 2010; Doyle, 1994). 
Society tends to place more importance on the head and neck region than any 
other area of the body (Semple et al., 2004). The emphasis on facial aesthetics 
and cosmesis may be particularly difficult for those with head and neck cancer 
because the visible signs of head and neck cancer and its treatment often cannot 
easily be concealed (Semple et al., 2004). Consequences such as these often 
prevent those with head and neck cancer the privacy afforded by less visible 
forms of illness. As a result, those treated for head and neck cancer may 
experience unwelcomed intrusions such as those associated with insensitive 
comments or staring (Björklund et al., 2010). These experiences may result in 
feelings of stigmatization and consequently cause additional psychological 
distress. Feelings of stigmatization may result in multiple levels of social penalty 
and consequently contribute to additional psychological and social distress for 
individuals with head and neck cancer (Doyle, 2005; Fife & Wright, 2000; Lebel 
et al., 2013). Factors such as these have led researchers to describe head and 
neck cancer as the most emotionally traumatic form of cancer (Björklund et al., 
2010; Koster & Bergsma, 1990).  
Given that research has demonstrated a relationship between the 
emotional experiences of individuals with cancer and their caregivers (Northouse 
  
11 
et al., 2001) – in essence suggesting that when one individual is distressed (e.g., 
person with head and neck cancer), that the other individual may also be 
distressed (e.g., caregiver) – there appears to be a potential to experience 
emotional trauma as a result of either having head and neck cancer or caring for 
someone with the disease. Essentially, the emotional trauma caused by head 
and neck cancer and its treatment may directly influence the emotional state of 
caregivers (Hagedoorn, Sanderman, Bolks, Tuinstra, & Coyne, 2008). 
Importantly, researchers have begun to acknowledge that head and neck cancer 
not only has enormous consequences for the individual with the disease, but also 
for their loved ones and caregivers, as the entire family dynamic may be 
disrupted by the disease and its accompanying consequences (Björklund et al., 
2010). Thus, it would seem important to understand and acknowledge the 
concerns of both the individual with head and neck cancer and their caregivers 
since improvements in our understanding of the caregiver experience may 
promote the identification of meaningful ways to support caregivers. 
Caregivers 
The definition and use of the term “caregiver” has been discussed in the 
literature for several years (Hunt, 2003). Caregivers have been described as 
unpaid individuals who participate in the experiences and activities involved in 
the provision of assistance to a loved one who is unable to provide for 
themselves (Pearlin, 1994). Recently, authors have suggested that a caregiver is 
‘who the person says it is’ (Hodges & Humphris, 2009; Kissane & Bloch, 2002; 
Stenberg, Ruland, & Miaskowski, 2010), implying that the caregiver may consist 
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of a blood relative, neighbour, friend, or other individual. Regardless of how the 
term caregiver is defined or who fulfills the role, providing care for another 
individual who has been diagnosed with cancer is an experience, shared closely 
with the recipient of care, which may affect numerous aspects of the caregiver’s 
life. 
It has been well established that family members of individuals with cancer 
are affected by the illness throughout the trajectory of the disease (Stenberg et 
al., 2010). For instance, the consequences of the disease continue to impact 
family members well into the survivorship stage for those who survive the illness 
and into the end of life care for those who do not (McCorkle & Pasacreta, 2001; 
Stenberg et al., 2010). Family members often provide the primary source of 
emotional and social support for individuals with cancer. They also serve a key 
role in how effectively an individual with cancer is able to manage the impact of 
their illness and its treatment (Zwahlen, Hagenbuch, Jenewein, Carley, & Buchi, 
2011). Considering that hospital stays have decreased in length (Cohen, Stock, 
Andersen, & Everts, 1997; Yueh et al., 2003), individuals with cancer are 
increasingly left to manage their illness and its side effects at home. As a result, 
the burden of responsibility for family members has increased; this in turn has 
made the role of family-based caregiving ever more vital (Stenberg et al., 2010). 
This shift towards family-based caregiving often requires a reorganization of 
personal roles and responsibilities on the part of the caregiver in order to address 
the needs of the individual with cancer and also ensure that the family is still able 
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to function effectively and perform essential tasks (e.g., raising children, paying 
bills, etc.). 
The role of caregivers. Most often, the spouse or significant other of the 
individual with cancer fulfills the role of primary caregiver (Mellon, Northouse, & 
Weiss, 2006). Despite the fact that these loved ones often receive minimal or no 
preparation, they are frequently tasked with many care-related responsibilities 
such as the provision of physical care, medication administration, transportation, 
emotional support, household management, and assistance with activities of 
daily living (Northouse & McCorkle, 2010). The demand for these tasks to be 
undertaken is often within a very short period of time following the diagnosis of 
their loved one’s cancer. While family caregivers have historically provided 
significant contributions to the care of their loved ones, the level of technical, 
physical, and psychological support currently required of caregivers has reached 
unparalleled levels in recent years (Given, Given, & Kozachik, 2001). This shift in 
burden of care towards caregivers results from healthcare system changes which 
have transferred the delivery of cancer care from an in-patient, hospital-based 
setting to ambulatory and home-based settings much sooner following treatment 
than in previous years (Cohen et al., 1997; Given et al., 2001; Yueh et al., 2003). 
This shift in care settings has translated to an increased level of caregiver 
involvement in the daily care of the individual with cancer (Given et al., 2001). 
Thus, since individuals are providing care for those with cancer much sooner 
following treatment (e.g., surgery), they must also deal with a more acute set of 
potential issues (e.g., wound care, infection, swallowing problems). 
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 In addition to the disease- and treatment-related factors that caregivers 
are responsible for (e.g., disease and treatment monitoring, symptom 
management, medication administration, transportation to appointments), they 
must also ensure that the responsibilities usually fulfilled by the individual with 
cancer (e.g., errands, payment of bills, care for minor children, preparation of 
meals) are addressed. Ensuring the fulfillment of responsibilities may be 
particularly burdensome when the person with cancer is a spouse or family 
member and the household tasks that were formerly shared between two 
individuals must now be accounted for by the caregiver alone. While this effort to 
preserve the normal level of family functioning is commendable, it can create 
feelings of role overload for the caregiver (Northouse & McCorkle, 2010). As the 
number of illness-related demands increase, caregivers experience numerous 
physical, psychological and social consequences that potentially may exceed 
those experienced by the individual with cancer (Mellon et al., 2006). Moreover, 
research has demonstrated that as the level of demand on caregivers increases, 
they are placed at an elevated risk for the development of depression (Braun, 
Mikulincer, Rydall, Walsh, & Rodin, 2007). This elevated risk poses a problem 
not only for the caregiver’s well-being, but also may impact their ability to provide 
complex care to another when their own physical and mental health is 
compromised. Thus, in order to ensure optimal caregiving, efforts to understand 
and ameliorate the negative consequences of caregiving would appear to be a 
reasonable area of consideration. 
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The consequences of caregiving. A recent review of the effects of 
caring for an individual with cancer conducted by Stenberg and colleagues 
(2010) identified more than 200 problems and burdens associated with being a 
caregiver. This large range of concerns included issues related to one’s physical 
health, psychological state, social activities, and practical responsibilities. While 
the range of physical health concerns was indeed quite extensive, the most 
commonly reported physical problems according to Stenberg et al. (2010) 
consisted of pain, fatigue, sleep disturbances, loss of physical strength, loss of 
appetite, and weight loss; symptoms which would appear to mirror those of 
depression (Miller & Massie, 2009). These problems seem understandable given 
that caregivers are often required to adjust their lifestyle (e.g., restricting leisure 
activity and contact with friends and family) in order to accommodate the 
increasing needs of the individual with cancer (Stenberg et al., 2010). These 
lifestyle amendments often mean that during a time when the restorative benefits 
of relaxation and social support are most needed, that caregivers actually have 
the least amount of time and resources available for their own self-care (Bevans 
& Sternberg, 2012).  
Further complicating the situation, caregivers have been shown to 
prioritize the needs of the individual with cancer over their own (Williams, 2007), 
thus, leaving minimal time for maintaining activity and exercise, good nutrition, 
and regular healthcare check-ups. Consequently, caregivers experience 
increased health-related concerns such as fatigue and sleep disturbances, which 
are exacerbated as symptom burden increases and functioning decreases in the 
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individual with cancer (Palos et al., 2011). Symptom burden is a concept that is 
comprised of both the severity of symptoms and the individual’s subjective 
perception of the impact of the symptoms on their daily life and level of 
functioning (Cleeland, 2007). As a result, one could infer that as the level of 
symptom burden increases in individuals with head and neck cancer, so too does 
the level of burden in caregivers. 
In addition to physical consequences reported by caregivers, they have 
also reported a diverse range of positive and negative psychological responses 
to their experience as a caregiver. Specifically, caregivers have described a 
spectrum of emotions ranging from positive affect such as hopefulness and 
compassion for others, to negative emotions such as, bitterness, resentment, 
fear, anger, depression, and anticipatory grief (Williams & Bakitas, 2012). 
Regarding the ability to fulfill the responsibilities of providing care, some 
caregivers have noted positive feelings of accomplishment, while others report 
feeling overwhelmed (Williams & Bakitas, 2012). Upon reflection of the 
caregiving experience, some individuals have found caregiving to be positive for 
their self-esteem (Kim, Schulz, & Carver, 2007), while others have found that 
managing tasks and emotions in the context of caring for a loved one was 
immensely difficult (Williams & Bakitas, 2012). Given the broad spectrum of 
emotional responses to the experience of caregiving, it is apparent that the act of 
providing care to a loved one with cancer, is a complex experience that is 
marked by both positive and negative affect. 
The provision of care for an individual with cancer is often a challenging, 
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disruptive, and time-consuming activity (Williams & Bakitas, 2012). Given the 
level of burden facing caregivers, it is not surprising that multiple studies report 
higher levels of anxiety and depression in caregivers than the patients 
themselves (Mellon et al., 2006; Vickery et al., 2003). This finding is of central 
importance to understanding the experience of distress in caregivers because it 
acknowledges the psychological impact of the diagnosis and treatment of the 
individual with cancer on the caregiver. The experience of illness and treatment 
is clearly different for caregivers. They are often faced with the very real prospect 
of losing their partner or loved one. Such a possibility may produce feelings of 
grief and helplessness because they are unable to take a direct role in combating 
the cancer (Vickery et al., 2003).  
Relative to social consequences, caregivers have frequently reported 
problems with employment, education, isolation, financial well-being, and the 
ability to fulfill roles (Stenberg et al., 2010). When a loved one is diagnosed with 
cancer, understandably, there are changes in the roles, expectations, 
responsibilities and relationship dynamics of the family as individuals adjust to 
the reality of such a diagnosis and impact of the disease (Northouse, Williams, 
Given, & McCorkle, 2012). Accordingly, the level of burden on caregivers often 
increases. This increased burden may be particularly evident in caregivers who 
must balance their caregiving responsibilities with the provision of care for 
children and/or ailing parents. These individuals may feel overwhelmed with the 
demands on their time and energy as they try to balance their responsibilities to 
their loved ones with their own personal and employment-related obligations 
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(Coristine, Crooks, Grunfeld, Stonebridge, & Christie, 2003). Further, caregivers 
without flexible jobs or employers who can accommodate such needs have often 
been required to use sick leave and vacation time in order to fulfill their new and 
potentially rapidly expanding obligations, which may subsequently create an 
additional level of economic strain (Stenberg et al., 2010). Thus, it is apparent 
that the social consequences of being a caregiver extend beyond the realm of 
one’s daily social participation in enjoyable activities, to also include the potential 
limitation of one’s future occupational and economic stability. 
With regard to the financial burden of caregiving, an American study of the 
time costs associated with informal caregiving for cancer survivors found that on 
average, caregivers provided 8.3 hours of care per day for 13.7 months (Yabroff 
& Kim, 2009). When the economic burden of caregiving was evaluated relative to 
the value of the caregiver’s time providing care, the value of lost employment, 
and out-of-pocket expenditures (e.g., transportation, parking, home 
modifications, cancer care supplies, etc.), the financial costs were considerable, 
ranging from $31,442 to $91,670, depending on the specific type of cancer (Van 
Houtven, Ramsey, Hornbrook, Atienza, & van Ryn, 2010). These estimates of 
time costs and out-of-pocket expenditures highlight the substantial financial 
burden that often may be experienced by caregivers.  
In addition to the financial stressors noted previously, caregivers have 
reported feelings of isolation (Northouse et al., 2012; Williams & Bakitas, 2012). 
Not only does the work of caregiving disrupt their opportunity to engage socially 
with others (Stetz & Brown, 2004), but the caregiver’s personal needs are often 
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neglected as their focus remains on the needs of the individual with cancer 
(Schubart, Kinzie, & Farace, 2008). Feelings of isolation and loneliness were 
particularly significant in caregivers without access to family or friends (Schubart 
et al., 2008). The inherent difficulty in serving as a caregiver to a loved one with 
cancer lies in both the overwhelming nature of the role and the fact that despite 
one’s best effort, that the individual with cancer may still suffer and possibly 
succumb to their illness. Thus the fear of losing a loved one may in and of itself 
induce tremendous feelings of anticipatory grief in the caregiver. 
Caregivers are often expected to grieve, while simultaneously supporting 
the physical, psychological, social and practical needs of their loved one. They 
must also work to maintain their regular family and employment-related 
responsibilities, while balancing their own fears, anxieties and concerns for the 
well-being of their loved one. In light of the essential role of caregivers and the 
numerous personal and care-related demands they face, it would seem important 
to work to understand their experiences and identify meaningful ways to assist 
them. Research seeking to understand the experience of caregivers has 
suggested that the provision of care for an individual with cancer may constitute 
a distressing life experience (Longacre et al., 2012; Roing, Hirsch, & Holstrom, 
2008). Since the presence of elevated distress in caregivers has been identified 
as a factor that may compromise both the physical health and psychological well-
being of both caregivers and individuals with cancer (Hagedoorn et al., 2008; 
Northouse et al., 2001), investigations into the factors which can influence 
distress may inform our understanding of the caregiver experience. Improved 
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knowledge regarding the factors that contribute to and/or exacerbate distress 
may help to identify meaningful ways to both detect and possibly alleviate 
distress in these individuals. 
Distress 
Psychosocial distress has been identified as a significant and ongoing 
problem among individuals diagnosed with cancer. Distress has become so 
prevalent that the National Comprehensive Cancer Network (NCCN) has 
established a Distress Management Panel to address the issue. The NCCN 
(2013) has defined distress as: 
…a multi-determined unpleasant emotional experience of a psychological 
(cognitive, behavioral, emotional), social, and/or spiritual nature that may 
interfere with the ability to cope effectively with cancer, its physical 
symptoms and its treatment. Distress extends along a continuum, ranging 
from common normal feelings of vulnerability, sadness and fears, to 
problems that can become disabling, such as depression, anxiety, panic, 
social isolation, and spiritual crisis (p.6).  
As highlighted by the presence of a “continuum” of distress, there is an 
inherent distinction to be made between the pathologic experience of distress 
(e.g., clinical depression, anxiety disorders, etc.) and one’s natural response to a 
catastrophic life event; be that the threat to one’s own life, or to the life of a loved 
one. Transitory negative feelings are a normal part of the cancer experience and 
are to be expected as individuals react to an unanticipated threat, potential and 
actual losses, and to the potential side effects of unpleasant and/or painful 
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treatments (Haman, 2008). Cancer and its treatment often create feelings of 
uncertainty, anticipated changes to personal roles and functioning, and practical 
concerns related to medical care and financial well-being. As individuals and 
caregivers attempt to manage these concerns, they are likely to experience 
emotions such as sadness, anger and fear. The majority of individuals will 
experience brief episodes of sadness or anxiety, insomnia, loss of interest in 
activities, thoughts of helplessness and hopelessness, or worries about potential 
catastrophe (e.g., loss of life) (Haman, 2008). 
While most individuals will eventually adapt to the changes brought on by 
the cancer experience (Vickery et al., 2003), a subset of individuals will 
experience distress to the extent that adaptive coping is impaired severely 
enough or long enough to be considered disruptive (Haman, 2008). A few days 
characterized by tearfulness and decreased interest in regular activities may be 
viewed as a component of adaptive coping to the changes and losses that are 
inherent in the experience for both the patient and caregiver (Haman, 2008). 
However, if the symptoms persist for extended periods of time – some sources 
suggest more than one week (Haman, 2008) while others advocate for at least 
two weeks or more (American Psychological Association [APA], 2000) – 
problems may arise with social support networks, one’s physical well-being, and 
influence even treatment compliance and survival in individuals with cancer 
(Haman, 2008). Notably, certain symptoms such as suicidal ideation with 
accompanying plan and intent require immediate intervention, even if the 
symptoms only last for short periods of time. Generally, it has been suggested 
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that if distress persists for greater than a week, leads to noncompliance with 
treatment recommendations (McDonough, Boyd, Varvares, & Maves, 1996), or 
puts the individual (or others) in danger, intervention is required (Haman, 2008). 
Ideally, problematic distress in both those with cancer and their caregivers should 
be identified and addressed in order to avoid negative outcomes such as, fatigue, 
weight loss, decreased medical compliance, and increased hospital stays 
(DiMatteo, Lepper, & Croghan, 2000) in those with cancer, and compromised 
psychological functioning, and changes to the immune system that limit glucose 
control and increase cardiovascular vulnerability (Rohleder, Marin, Ma, & Miller, 
2009) in caregivers. 
Distress in individuals with cancer. Normal emotions such as sadness, 
worry, and fear occur in every person, and are undoubtedly exacerbated with a 
diagnosis of any serious disease such as cancer. Clinical psychiatric disorders 
such as depression and anxiety do not develop overnight; rather, they are the 
cumulative outcome along the continuum of mental health that extends beyond 
normal emotional responses and psychological reactions (Mohan & Pandey, 
2002). Research has established that across the trajectory of illness – from initial 
diagnosis through treatment, termination of treatment, survivorship, or recurrence 
and palliation – psychosocial distress is evident in approximately 25% to 45% of 
those with cancer (Carlson, 2003; Carlson et al., 2004; Singer et al., 2012; 
Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001). Moreover, 
large-scale studies conducted at the Tom Baker Cancer Centre in Alberta, 
Canada (Carlson et al., 2004) and the Johns Hopkins Kimmel Cancer Centre in 
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Baltimore, Maryland (Zabora et al., 2001) of a representative sample of 
individuals screened for psychosocial distress detected high levels of fatigue (in 
nearly 50% of patients), depression (24%), anxiety (24%), and pain (26%), in 
addition to financial hardship and other challenges. Distress is a common 
sequela of cancer as a disease and thus requires careful consideration in the 
context of understanding the individual’s response to the diagnosis of malignant 
disease. 
From a therapeutic perspective, untreated depression has been shown to 
affect medical compliance, appetite, wound healing, and contribute to increases 
in length of hospital stays (DiMatteo et al., 2000; Jenkins, Carmody, & Rush, 
1998; McDonough et al., 1996). Furthermore, the impact of depression on 
functions such as sleep, motivation and energy level are also well documented 
(Roscoe et al., 2007). By intensifying fatigue and weight loss, depression has the 
potential to amplify treatment-related side effects for individuals with cancer, 
contributing to a vicious cycle that may not only worsen depression and overall 
rates of distress, but also negatively influence disease control through decreased 
medical compliance (DiMatteo et al., 2000).  
Relative to the impact of depression on medical compliance, research has 
demonstrated that depressed individuals with cancer take more breaks in 
treatment and thus require a greater length of time in order to complete the 
prescribed treatment protocol (Archer, Hutchison, & Korszun, 2008). These 
findings have critical implications for individuals with head and neck cancer given 
that the success of radiation therapy – one of the key forms of treatment for head 
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and neck cancer – is dependent in part on the completion of therapy as close as 
possible to the prescribed time (Lydiatt, Moran, & Burke, 2009). In consideration 
of these factors, the chances of survival are likely to be lessened in those 
individuals who experience depression, when compared to those who are not 
depressed (Archer et al., 2008). Thus, given the numerous challenges facing an 
individual with cancer, support from caregivers is essential in order to facilitate 
successful coping, adjustment, and sometimes even survival (Foster et al., 
2005). As a result, understanding the factors that contribute to elevated distress 
would appear to be an important component to ensuring the optimal well-being of 
both those with cancer and their caregivers.  
Distress in caregivers. While cancer has been shown to impact the 
quality of life of caregivers in myriad ways, researchers have recently suggested 
that the psychological well-being of caregivers is the area most significantly 
impacted during the initial stages of the caregiving experience (Northouse, 
Katapodi, Schafenacker, & Weiss, 2012). When the level of demand for care that 
is placed on caregivers exceeds their available resources (e.g., psychological 
wherewithal, personal coping mechanisms, social support, etc.), caregivers 
report feeling overwhelmed and distressed (Drabe, Wittmann, Zwahlen, Büchi, & 
Jenewein, 2012). Distress in caregivers is problematic for two key reasons; first 
for the problems that it poses to caregivers personally, and second for the 
consequent impact on the individuals with cancer. Both the personal 
consequences of distress for caregivers and the resultant impact on those with 
cancer are discussed hereunder. 
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 Relative to the personal toll of distress on caregivers, research indicates 
that between 20% to 40% of caregivers experience high levels of distress or 
depression (Edwards & Clarke, 2004; Longacre et al., 2012). However these 
incidence rates increased when the individual with cancer demonstrated poor 
physical functioning, high symptom distress, and advanced disease (Kurtz, Kurtz, 
Given, & Given, 2004). The prevalence of high emotional distress in caregivers is 
problematic for multiple reasons. Not only does it compromise their psychological 
well-being, but highly distressed caregivers may also experience changes to their 
immune system that can limit glucose control, promote flare-ups in autoimmune 
diseases, and increase vulnerability to cardiovascular diseases (Rohleder et al., 
2009). These biologic consequences of distress increase the potential for the 
caregiver’s own health to suffer and, consequently, impede their ability to provide 
adequate care to the individual with cancer. This clearly holds the potential to 
impact both the caregiver and the individual for whom they must provide care. 
Regarding the impact of caregiver distress on individuals with cancer, 
research indicates that because of caregivers’ negative emotional states and 
impaired cognitive and physical functioning, caregivers have more difficulty with 
the effective administration of medication (Lau et al., 2010) and provision of 
optimal care (Park et al., 2009; van Ryn et al., 2011) to individuals with cancer. 
With respect to psychological functioning, high levels of anxiety in caregivers 
have been shown to increase anxiety in the individuals with cancer (Segrin et al., 
2007), and longitudinal data suggest that when caregivers are highly distressed, 
there is a significant negative effect on the long-term adjustment of the individual 
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with cancer (Northouse et al., 2001). Consequently, it would appear that there is 
a reciprocal relationship between the psychological health of both caregivers and 
individuals with cancer. 
The findings of Northouse and colleagues (2001) are in line with the work 
of Hagedoorn and colleagues (2008) who conducted a meta-analysis of 46 
studies that examined distress in couples coping with cancer (n = 2,468 couples). 
They discovered a significant relationship between distress in caregivers and 
those with cancer (r = 0.29, p < .001) even after controlling for illness-related 
factors (e.g., disease stage). These findings indicate that both the individual with 
cancer and their caregiver’s emotional responses to the illness were interrelated. 
These results suggest that individuals with cancer and their caregivers react to 
the experience of cancer as an “emotional system”, and that both the individual 
and their caregiver(s) should be viewed as the recipients of care from the 
perspective of health practitioners (Northouse et al., 2012). In consideration of 
the dyadic nature of the patient-caregiver relationship, a greater understanding of 
the factors that influence caregiver distress may have important implications not 
only for improving caregiver outcomes, but also for the individuals with cancer, 
given that the distress level of one individual (e.g., the caregiver) may influence 
the distress level and overall experience of the other individual (e.g., the person 
with cancer), and vice versa (Northouse et al., 2001; Segrin et al., 2007).  
Benefits of distress management. When the psychological needs of 
individuals with cancer remain unresolved, these individuals are more likely to 
visit emergency rooms and make use of community health services (Carlson & 
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Bultz, 2004). This increased service utilization is related to the physical 
symptoms resulting from psychological distress such as sleep disturbances, 
headaches and gastrointestinal symptoms (Carlson & Bultz, 2004). 
Consequently, these individuals place greater demands on the increasingly 
scarce time of their healthcare providers. Additionally, clinical studies have 
demonstrated that certain forms of psychosocial intervention (e.g., cognitive 
behavioural therapy, psycho-educational interventions) are beneficial to 
individuals with cancer (Chambers, Pinnock, Lepore, Hughes, & O’Connell, 2011; 
Fors et al., 2010; Hammerlid et al., 1999; Newell, Sanson-Fisher, & Savolainen, 
2002). Newell and colleagues (2002) found that psychosocial interventions 
involving counseling (either structured or unstructured) and guided imagery have 
been shown to improve quality of life and the general functioning of individuals 
with cancer. Furthermore, participants from multiple studies asserted that they 
would use the psychological resources again and would recommend them to 
other individuals diagnosed with cancer (Hamilton, Miedema, MacIntyre, & 
Easley, 2011; Miller et al., 1998). Thus, this information suggests that if 
psychological distress can be identified early and addressed in a meaningful 
manner (i.e., lessened or alleviated), then perhaps we can improve the overall 
functioning of individuals with cancer and also possibly reduce the economic 
burden on the healthcare system that arises as a result of untreated or poorly 
managed distress. 
Several reviews of the literature have noted that psychological therapies 
may assist individuals in several ways including, improving sexual functioning 
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(Penedo et al., 2007), enhancing quality of life, emotional adjustment, and coping 
skills (Hamilton et al., 2011; Henderson et al., 2011), and increasing physical 
health and functional adjustment (Penedo et al., 2007). Further, such intervention 
has been reported to reduce disease- and treatment-related symptoms in 
individuals with cancer (Hart et al., 2012) and general physical symptoms in 
caregivers (Birnie, Garland, & Carlson, 2010). Addressing negative psychosocial 
outcomes such as distress is a critical component to the delivery of 
comprehensive healthcare. Without the early identification of problematic distress 
levels, individuals’ may experience innumerable consequences related to 
physical, psychological and social functioning – the core components of one’s 
evaluation of their perceived quality of life. Therefore, these consequences may 
ultimately result in decreased quality of life for those living with cancer as well as 
their caregivers.  
Thus, efforts to support the identification of distress in both individuals with 
cancer and their caregivers should be undertaken in an effort to inform the 
individuals charged with their care (and those most suited to assisting them) of 
when the level of psychosocial concern (e.g., distress) has reached a 
problematic point and specifically where intervention efforts may be directed in 
order to be of most benefit. Fortunately, a number of validated instruments have 
been devised which are capable of assessing the level of an individual’s 
perceived distress and their accompanying multidimensional concerns. The use 
of these tools in both clinical and research environments may help to develop a 
better understanding of not only the prevalence of distress in individuals with 
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head and neck cancer and their caregivers, but also the specific problems that 
these individuals face and the consequent impact of this distress and these 
perceived problems on their quality of life and daily functioning. Outlined next is a 
summary of the measures deemed best suited to address the specific objectives 
of this program of research. 
 
Measurement Instruments 
The measurement instruments utilized in the studies comprising the 
dissertation included: (1) the Distress Thermometer and accompanying Problem 
Checklist to measure distress and perceived problems; (2) the EORTC Quality of 
Life Questionnaire (EORTC-QLQ-C30), and (3) the EORTC Head and Neck 
module (EORTC-QLQ-H&N35), to evaluate both global and head and neck 
cancer-specific quality of life, and (4) the Caregiver Quality of Life-Cancer Scale 
(CQOLC) to assess quality of life from the perspective of caregivers. Additionally, 
all participants of the studies described in this dissertation were requested to 
complete a brief form to assess demographic information in addition to disease- 
and treatment-related variables. In the case of caregivers, the form requested 
both their personal demographic information and the disease- and treatment-
related information of their loved one with head and neck cancer. 
Distress Thermometer. The Distress Thermometer was developed in 
1999 by the National Comprehensive Cancer Network (NCCN) in an effort to 
provide a means of assessing psychological well-being in individuals with cancer 
in a non-stigmatizing manner (NCCN, 2013). The term “distress” was utilized 
because it was viewed as less stigmatizing than terms such as “psychiatric” or 
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“psychological” (NCCN, 2013). The “thermometer” component of the Distress 
Thermometer is comprised of an 11-point Likert scale ranging from 0 (no 
distress) to 10 (extreme distress). Respondents were asked to circle the number 
that best described how much distress they had been experiencing throughout 
the past week including the present day (NCCN, 2013). Owing to the brief nature 
of the Distress Thermometer as a means of assessing distress, it has been 
classified as an “ultrashort” measure based on the fact that it contains less than 
five items (Vodermaier, Linden, & Siu, 2009). To date, the Distress Thermometer 
has been validated extensively in oncology populations across various cancer 
sites (Butt et al., 2008; Gessler et al., 2008; Hegel et al., 2008; Hoffman, Zevon, 
D'Arrigo, & Cecchini, 2004; Jacobsen et al., 2005) and disease stages (Akizuki et 
al., 2003; Gessler et al., 2008; Gil, Grassi, Travado, Tomamichel, & Gonzalez, 
2005; Hegel et al., 2008; Recklitis, Licht, Ford, Oeffinger, & Diller, 2007). A 
systematic review of distress measures determined that the Distress 
Thermometer was found to have moderate reliability, validity and criterion 
measures based on a review of 15 studies that used the Distress Thermometer 
and comprised a total of 4,088 participants (Vodermaier et al., 2009).  
Although assessments of acceptable coefficient values of reliability are 
somewhat arbitrary, as a general guideline, reliability coefficients that fall below 
0.50 indicate poor reliability, while values that range between 0.50 and 0.75 
suggest moderate levels of reliability, and coefficients above 0.75 represent good 
reliability (Portney & Watkins, 2009). In their review of distress screening 
measures, Vodermaier et al. (2009) reported that the Distress Thermometer 
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demonstrated a moderate degree of reliability. Further, Vodermaier and 
colleagues (2009) found the measure to be generalizable based on its use in 
oncology-related populations including those with mixed diagnoses (e.g., multiple 
cancer sites), disease stages, and also in individuals awaiting bone marrow 
transplantation. While the Distress Thermometer has demonstrated moderate 
reliability and generalizability, questions may be raised as to the ability of a single 
item measure such as the Distress Thermometer to accurately capture the 
experience of distress in individuals. However, examination of the concurrent 
validity of the Distress Thermometer with other established measures of distress 
may prove to assuage these potential concerns. 
 With respect to validation of a screening tool such as the Distress 
Thermometer, data pertaining to the sensitivity and specificity of the measure 
may provide valuable information regarding the ability of the measure to 
accurately discern between the true presence, or absence, of clinically significant 
distress. Specifically, sensitivity measures the validity of a screening procedure 
and is based on the probability that an individual who is experiencing distress will 
test positive for distress according to the measure (e.g., a true positive), whereas 
a measure’s specificity is based on the probability that an individual who is not 
distressed will test negative for distress according to the measure (Portney & 
Watkins, 2009).  
Sensitivity values for the Distress Thermometer ranged from 0.59 to 0.89 
while specificity values fell between 0.49 and 0.85 in a systematic review of 
distress measures (Vodermaier et al., 2009). While these values appear to be 
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quite divergent, it should be noted that the cutoff scores used by researchers in 
the systematic review varied considerably. The lowest cutoff score used was 3 
(Gil et al., 2005), while the highest was 7 (Hegel et al., 2008), however scores of 
4 or 5 were the most commonly used cutoff scores. Despite the varying cutoff 
scores used by researchers, the NCCN has recommended that scores of 4 or 
higher be considered clinically significant (NCCN, 2013). This recommendation 
has been verified through the validation efforts of other researchers in both 
individuals with cancer (Hoffman et al., 2004; Jacobsen et al., 2005; Ransom, 
Jacobsen, & Booth-Jones, 2006) and caregiver populations (Zwahlen, 
Hagenbuch, Carley, Recklitis, & Buchi, 2008). As such, the present study 
employed the recommended cutoff score for analysis purposes. 
Furthermore, a recent meta-analysis of short screening tools for cancer-
related distress supported the use of the Distress Thermometer and noted that it 
is comparable to longer distress measures, but provides superior efficiency 
(Mitchell, 2010). Furthermore, in his review of short distress screening measures, 
Mitchell (2010) noted that the best available evidence supported the use of the 
Distress Thermometer due to its acceptability with participants, cost-
effectiveness, and overall accuracy, especially when compared with longer, 
multi-item screening measures, such as the Hospital Anxiety and Depression 
Scale (HADS). Furthermore, owing to its brief administration and simple scoring 
procedure (e.g., scores of greater than or equal to 4 suggest problematic 
distress), the Distress Thermometer provides an easy-to-use clinical screening 
measure that affords simple intra rater comparison of data. Hence, for busy 
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clinicians who may not have time to score and review longer measures, a quick 
comparison of an individual’s previous Distress Thermometer score(s) with a 
current score may provide useful clinical information (e.g., on previous clinic 
visits, the individual regularly rated their distress as a 2, however today they 
reported a 7, which alerts the clinician that follow-up may need necessary). This 
information can then be utilized in a discussion with the individual and if 
necessary, the offer of referral to supportive care services can be extended. 
 In addition to the single-item Likert scale assessment of distress, the 
Distress Thermometer contains a 38-item complementary Problem Checklist. 
The Problem Checklist seeks to determine whether problems exist in the 
practical, familial, physical, or spiritual domains of an individual’s life (NCCN, 
2013). A key benefit of the Problem Checklist is that it may enable clinicians to 
identify potential sources of distress quickly and subsequently address these 
concerns as part of the treatment of the whole individual (Gessler et al., 2008). 
With respect to the family members, recent efforts have been undertaken 
to validate the Distress Thermometer for use in the caregiver population 
(Zwahlen et al., 2008; Zwahlen et al., 2011). Findings from the validation efforts 
indicated that the Distress Thermometer had good diagnostic utility in caregivers 
and that a cutoff score of 4 maximized the sensitivity of the measure, which may 
reduce the risk of missing distressed family members (Zwahlen et al., 2008). 
Collectively, these validation efforts provide support for the use of the Distress 
Thermometer as a screening measure in family members of individuals 
diagnosed with cancer.  
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In summary, currently available evidence supports the use of the Distress 
Thermometer in both head and neck cancer and caregiver populations. Further, 
use of the accompanying Problem Checklist may enable clinicians to quickly 
identify areas of concern and determine where intervention efforts should be 
directed in order to provide the most benefit to those in need. Use of the Distress 
Thermometer and its accompanying Problem Checklist to screen for distress and 
related areas of concern in caregivers and those with head and neck cancer may 
help to elucidate the prevalence of distress in individuals in these populations 
and also target the specific problems facing these individuals. Additionally, in 
order to better understand the consequent impact of this distress and the related 
areas of concern, investigations into perceived quality of life among those with 
head and neck cancer and their caregivers are important. Thus, use of validated, 
multidimensional quality of life measures, such as those described next, may 
provide useful insight into the subjective impact of one’s perceived problems and 
level of distress. 
European Organisation for Research and Treatment of Cancer 
Measures. The EORTC is a series of self-administered cancer-specific 
measurement instruments that are designed to assess quality of life within 
oncology populations (Sherman et al., 2000). The core questionnaire, the 
EORTC-QLQ-C30 (version 3.0) (Aaronson et al., 1993), serves as a generic 
measure of quality of life for all cancer sites. It consists of 30 items, which are 
divided into five functional scales (physical, role, emotional, cognitive and social 
functioning), three symptoms scales (pain, fatigue, and nausea/vomiting) and a 
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measure of global health status, or quality of life (Fayers et al., 2001). 
Additionally, there are six single item scales included on the measure (dyspnea, 
insomnia, appetite loss, constipation, diarrhea, and financial concerns). The sum 
of all items provides an indication of an individual’s overall quality of life (Scott et 
al., 2008). Responses for items 1 through 28 are recorded on a 4-point Likert 
scale ranging from 1 (not at all) to 4 (very much). Responses for items 29 and 30 
are recorded on a 7-point Likert scale where 1 indicates very poor health or 
quality of life and 7 indicates excellent health or quality of life. Respondents are 
asked to answer each item relative to how they have been feeling ‘during the last 
week’ (Bjordal et al., 2000). Completion of the core questionnaire is anticipated to 
take less than 10 minutes. Both the subscale and overall scores are transformed 
to a scale of 0-100 with higher scores implying a high level of problems or 
symptoms or, alternatively, a high level of functioning or global quality of life, 
depending on which subscale is evaluated (Bjordal et al., 2000). The core 
instrument has been validated in diverse samples of oncology populations within 
North America and Western Europe (Aaronson et al., 1993; Bjordal & Kaasa, 
1992; Hjermstad, Fossa, Bjordal, & Kaasa, 1995; King, Dobson, & Harnett, 1996; 
Sherman et al., 2000). Overall, the core measure has demonstrated strong 
psychometric properties including reliability, validity and sensitivity to change 
(Bjordal et al., 2000; Sherman et al., 2000). Specifically, evaluations of validity 
and reliability have determined that all scales consistently show Cronbach’s 
alpha coefficients of > 0.70 (Bjordal et al., 2000), which suggests that all scales 
demonstrated at least moderate if not good levels of reliability according to the 
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criteria outlined by Portney and Watkins (2009). Consequently, the EORTC-QLQ-
C30 was determined to be a suitable measurement instrument for use in the 
current research efforts. 
While it is important to address general quality of life issues that may be 
relevant to most individuals diagnosed with cancer, there are a number of 
disease-specific issues that arise in head and neck cancer that also need to be 
addressed. With this in mind, the creators of the EORTC-QLQ-C30 stipulated 
that the core instrument was intended to be used in conjunction with an 
accompanying site-specific module, in order to provide a more comprehensive 
assessment of an individual’s difficulties (Sherman et al., 2000). Studies confirm 
that both general and site-specific measures each contribute unique and 
important information regarding quality of life (D'Antonio, Zimmerman, Cella, & 
Long, 1996; Gliklich, 1997). Notably, the EORTC has devised a range of cancer 
site-specific measures, which include, prostate, ovarian, esophago-gastric, 
esophageal, neuroendocrine carcinoid, multiple myeloma, lung, hepatocellular 
carcinoma, gastric, endometrial, colorectal liver metastases, colorectal, cervical, 
breast, brain, bone metastases, and head and neck cancer sites (EORTC, 2013). 
The EORTC-QLQ-H&N35 (Aaronson et al., 1993) was designed for use 
among a wide variety of individuals with head and neck cancer, varying in 
treatment modality and disease stage (Bjordal & Kaasa, 1992; Singer et al., 
2012). It is one of the most widely tested disease-specific quality of life measures 
for oncology populations (Bjordal et al., 2000); to date it has been used in 26 
countries and 19 languages indicating broad cross-cultural acceptance (Singer et 
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al., 2012). In total, the head and neck module contains 35 items divided into 
seven multi-item scales that assess pain, swallowing, senses (taste and smell), 
speech, social contact, social eating, and issues pertaining to sexuality 
(Aaronson et al., 1993). The module also contains eleven single items. Like the 
core questionnaire, responses for the first 30 items on the head and neck cancer 
module are recorded on a 4-point Likert scale ranging from 0 (not at all) to 4 
(very much), whereas the last five items are presented in a yes/no format. 
Respondents are asked to answer each item relative to how they have been 
feeling ‘during the last week’ (Bjordal et al., 2000). Completion of the head and 
neck cancer module is anticipated to take approximately less than 10 minutes 
(Bjordal et al., 2000). Like the core questionnaire (e.g., EORTC-QLQ-C30), the 
subscale and overall scores are transformed to a scale of 0-100 with higher 
scores implying a high level of problems or symptoms or, alternatively, a high 
level of functioning or global quality of life, depending on which subscale is being 
evaluated (Bjordal et al., 2000). The EORTC-QLQ-H&N35 module has been 
validated in diverse samples of head and neck cancer sites (Aaronson et al., 
1993; Bjordal & Kaasa, 1992; Sherman et al., 2000; Singer et al., 2012). Overall, 
the EORTC-QLQ-H&N35 module has demonstrated strong psychometric 
properties including reliability, validity, and sensitivity to change (Bjordal et al., 
2000; Sherman et al., 2000; Singer et al., 2012). Specifically, evaluations of test 
validity and reliability have determined that all scales consistently show 
Cronbach’s alpha coefficients of > 0.70 (values ranged from 0.75 to 0.95), with 
the exception of the senses scale which demonstrated a coefficient of 0.54 in one 
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study (Sherman et al., 2000), 0.68 in another (Bjordal et al., 2000), and 0.61 in a 
more recent evaluation (Singer et al., 2012). Overall, the EORTC core 
questionnaire and accompanying head and neck cancer module are reported to 
be excellent measures with good psychometric properties. Further, the H&N35 
has been used in both clinical trials and observational studies, and has proven to 
be well accepted and feasible in both settings (Singer et al., 2012). Owing to the 
sound psychometric properties, in addition to the proven record of acceptability 
and feasibility of the EORTC measures in previous observational research, the 
EORTC global and head and neck specific instruments were deemed suitable to 
assess perceived quality of life among the individuals diagnosed with head and 
neck cancer taking part in this investigation. 
Caregiver Quality of Life-Cancer Scale. The CQOLC is a 35-item self-
report measure of caregiver quality of life that contains four primary factors  
(burden, disruptiveness, positive adaptation and financial concerns) and a total 
CQOLC score (Weitzner, Jacobsen, Wagner, Friedland, & Cox, 1999). This brief 
measure was designed to assess the impact of supporting a loved one with 
cancer on the caregiver’s physical, emotional, social, financial and familial 
functioning (among other areas) (Edwards & Ung, 2002). Each item included in 
the CQOLC is rated on a 5-point Likert scale ranging from 0 (not at all) to 4 (very 
much). Respondents are asked to ‘indicate how true each statement has been 
for them during the past seven days’. The maximum total score on the CQOLC 
measure is 140 with a higher total score indicating better overall quality of life. 
With regard to the four subscale factors, lower scores in the burden, 
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disruptiveness and financial concerns domains indicate elevated levels of 
concern (or poorer quality of life). However, the positive adaptation factor is 
reverse-coded, so a lower score is indicative of better overall adaptation to the 
circumstances. In essence, since the positive adaptation domain assesses how 
well an individual is adapting to the situation and since it is reverse-coded, a 
lower score (e.g., -20) would indicate better adaptation than a higher score (e.g. -
10). Conversely, the remaining subdomains (e.g., burden, disruptiveness, 
financial concerns) are not reverse-coded; therefore a higher score on each 
domain (e.g., 20) would indicate a higher degree of perceived penalty than a 
lower score (e.g., 10). 
With respect to reliability, the internal consistency coefficient (Cronbach’s 
alpha) of the CQOLC was determined to be 0.91 while the test-retest correlation 
coefficient was 0.95 (Weitzner et al., 1999). Additionally, a review of the 
psychometric properties of quality of life measures for caregivers of individuals 
with cancer determined that the CQOLC was the best available quality of life 
measure for caregivers of individuals with cancer (Edwards & Ung, 2002). The 
review conducted by Edwards and Ung (2002) also noted that the CQOLC met or 
exceeded the minimum psychometric criteria for reliability and validity. Therefore, 
the CQOLC was determined to be a psychometrically sound measure. This 
factor, considered in conjunction with the findings of Edwards and Ung (2002) in 
their review of caregiver quality of life measures, contributed to the decision that 
the CQOLC was the most appropriate instrument for use in the evaluation of 
quality of life in caregivers of individuals diagnosed with head and neck cancer.  
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In addition to the evaluation and selection of measures, an equally 
important component of any research endeavour is the rationale for the design 
and implementation of the protocol. Thus, in addition to the description of the 
distress and quality of life measures and their validation characteristics, 
consideration for how the measures were to be distributed and the rationale 
surrounding the distribution method is warranted. 
Measurement Rationale 
As noted in the previous sections, questionnaires were selected as the 
means of obtaining data from participants for the present research initiatives. In 
general, questionnaires are structured surveys that are self-administered and 
utilize either pen and paper or electronic formats (Portney & Watkins, 2009). The 
questionnaires used in the present investigations were based on the traditional 
pen and paper format in an effort to ensure that participants who did not have 
access to the Internet were not excluded from participation. The use of 
questionnaires was determined to be the most efficient way to gather 
standardized data from a large sample of participants in a relatively short period 
of time (Portney & Watkins, 2009). The use of standardized written forms 
ensured that all participants were exposed to the same questions in the same 
manner, thus reducing the potential for bias from interactions with an interviewer 
(Portney & Watkins, 2009). Additionally, questionnaires have been found to be a 
useful research tool for examining phenomena that can be assessed through 
self-observation (Portney & Watkins, 2009), such as personal perceptions and 
values. 
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The use of written questionnaires to elicit survey data from participants is 
commonly referred to as self-report measurement, which offers a direct way to 
obtain information related to perceptions, fears, motivations and attitudes 
(Portney & Watkins, 2009). Additionally, due to limited time and resources during 
clinical encounters, it may be difficult to obtain the extensive amount of personal 
information and perspectives required for the proposed analyses. However, the 
use of written measures to evaluate the perceived level of distress and quality of 
life of those with head and neck cancer and their caregivers affords the possibility 
of gathering a great deal of subjective information in an efficient manner.  
Additionally, in an effort to minimize the potential for recall bias, or the 
possible inaccuracy of recalling previous experiences or medical history, all 
measurement instruments asked individuals to report their experiences based on 
how they had been feeling over the past seven days in order to allow participants 
to reflect on their general level of distress and quality of life. The relatively short 
time frame may help to minimize inaccuracies in the reports that may arise out of 
recall bias (e.g., the inability to accurately recall events or perceptions), however 
the seven day time period was also deemed long enough to ensure that 
participant responses were reflective of one’s general experience for that week 
rather than a reactionary or falsely elevated level of distress owing to a single 
event. Furthermore, research has shown that self-report measures are generally 
valid, despite the potential for recall bias (Portney & Watkins, 2009). Ultimately, 
the use of self-report measures may be particularly beneficial for evaluations of 
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quality of life and distress, where individuals may be hesitant to reveal sensitive 
mental health concerns in a time-limited clinical encounter.  
Despite the fact that distress may be causing disruptions in daily 
functioning, many individuals may conceal their distress from their primary 
physician and healthcare team (Weisman, 1976). Individuals displaying such 
behaviour may rationalize their secretive response as an appropriate one 
because they believe that their physician and healthcare team need to focus their 
energy on the treatment of their disease. Conversely, oncologists and healthcare 
team members may lack the time or skills required to accurately identify and refer 
individuals exhibiting significant distress to the appropriate psychological 
resources (Carlson et al., 2004; Sollner, 2001; Zabora, Loscalzo, & Weber, 
2003). The outcome of these combined elusive approaches is the collective 
avoidance of the problem. Consequently, distress may remain undisclosed and 
only become apparent when it has increased to a point where the individual is no 
longer able to independently manage the situation. However, the use of written, 
self-report measures to evaluate distress and quality of life of those with head 
and neck cancer and their caregivers affords the possibility of gathering a great 
deal of subjective information in a clinical situation where individuals may 
previously have chosen not to reveal sensitive mental health concerns. 
Thus, in summary the Distress Thermometer, EORTC and CQOLC 
assessment tools are psychometrically sound measurement instruments capable 
of detecting levels of quality of life and the presence of clinically significant 
distress among individuals diagnosed with head and neck cancer and their 
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caregivers. Further, the utilization of self-report techniques within the present 
study has the advantage of deriving data from the individual centrally involved in 
the phenomena. Perceptions of distress and quality of life are deeply personal 
experiences and thus, the individual at the center of that experience can provide 
the most meaningful and clinically relevant information. The use of data derived 
from psychometrically sound self-report measures to identify distressing areas in 
one’s life may allow for appropriate assistance and psychosocial intervention 
when warranted. Thus, through the valid identification of distress, the potential to 
improve quality of life and positively influence post-treatment outcomes may 
emerge. 
Summary of Problem 
A diagnosis of head and neck cancer carries with it a unique set of 
treatment-related challenges that influence physical function, social interaction 
and emotional expression. As a result of the anatomic characteristics of the head 
and neck region, treatment for head and neck cancer may result in deficits to 
one’s physical appearance and varying degrees of dysfunction in respiration, 
swallowing, and speech (Vartanian et al., 2004). Consequently, individuals may 
experience substantial problems in family and social settings (Semple et al., 
2004). Not surprisingly, treatment of head and neck cancer has been associated 
with some of the highest rates of anxiety, depression and suicide when 
compared with other cancer sites (Bjordal & Kaasa, 1995; Kendal, 2006; Misono 
et al., 2008). These findings suggest that head and neck cancer is highly 
traumatic psychosocially with a multitude of complex patient concerns emerging. 
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Relative to the caregiver experience, these individuals are expected to 
support the physical, psychological, social and practical needs of their loved one, 
while simultaneously grieving their own losses – both real and anticipated. They 
must also work to maintain their regular family and employment-related 
responsibilities, while balancing their fears, anxieties and concerns for the well-
being of their loved one. Ultimately, the provision of care for an individual with 
cancer may be a challenging, disruptive, and time-consuming endeavor (Williams 
& Bakitas, 2012). Given the level of burden facing caregivers, it is not surprising 
that multiple studies report higher levels of anxiety and depression in caregivers 
than in the individuals with cancer (Mellon et al., 2006; Vickery et al., 2003). 
Since the presence of elevated distress in caregivers has been identified as a 
factor that may compromise both the physical health and psychological well-
being of both caregivers and those with cancer (Hagedoorn et al., 2008; 
Northouse et al., 2001), investigations into the factors which can influence 
distress may inform our understanding of the caregiver experience. 
Psychological distress related to cancer is a persistent and universal 
concern that must be addressed in a clinically meaningful manner. Distress has 
become so problematic that the Canadian Strategy for Cancer Control has 
formally recognized it as the “sixth vital sign” (Rebalance Action Focus Group 
[RAFG], 2005), implying that distress monitoring should be undertaken as 
routinely as the monitoring of one’s heart rate or blood pressure. Despite this 
acknowledgment, less than 10% of distressed individuals are identified and 
referred to the appropriate psychosocial resources (Kadan-Lottick, 
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Vanderwerker, Block, Zhang, & Prigerson, 2005). Failure to acknowledge and 
treat elevated distress among individuals with head and neck cancer jeopardizes 
treatment outcomes, decreases quality of life, and increases healthcare costs 
(Zabora et al., 2001). Thus, in order to minimize the overall negative impact of 
head and neck cancer and address the consequences resulting from decreased 
quality of life and distress, efforts must be made to understand the presence of 
and variation in distress and quality of life across both individuals with head and 
neck cancer and their caregivers. 
Both individuals with head and neck cancer and their caregivers 
experience significant disruption in their lives as a result of the physical and 
psychological impact of the disease and its treatment. Currently, there exists a 
gap in the knowledge regarding how these individuals perceive this impact and 
the meanings associated with these disruptions. Thus the identification of 
distress and its potentially negative influence on quality of life is of paramount 
importance. Perhaps best stated by Owen and colleagues (2001), “until a major 
therapeutic breakthrough takes place reducing treatment morbidity, improving 
patients overall quality of life and minimizing the psychosocial impact will be our 
greatest challenge” (p.351). In order to attend to the psychosocial needs of 
individuals with head and neck cancer and their caregivers, it is imperative to 
develop an understanding of the life factors associated with elevated distress. 
For this reason, instruments exploring the multidimensional factors related to 
quality of life will be assessed in conjunction with validated measures of distress 
and demographic information in an effort to identify and characterize the 
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relationship between distress and quality of life in both individuals with head and 
neck cancer and their caregivers. With this information, healthcare practitioners 
may be able to identify those individuals most at risk for distress and 
subsequently recommend the appropriate psychosocial resources as required. 
Thus, the purpose of the present study is to address the following objectives: 
1. To assess perceived distress and quality of life in individuals with head 
and neck cancer and their caregivers. 
2. To explore the frequency of reported concerns (e.g., practical, physical, 
psychosocial, spiritual, etc.) in individuals with head and neck cancer and 
their caregivers. 
3. To determine the relationship between distress and specific disease- 
and/or treatment-related variables in caregivers of individuals with head 
and neck cancer.  
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Chapter 2 
Distress and quality of life in individuals diagnosed with head and neck cancer: A 
prospective, longitudinal analysis 
 
Background 
 Head and neck cancer consists of a group of related malignancies that 
arise in the skin, oral cavity, salivary glands, pharynx, larynx, nasal cavity and 
paranasal sinuses (Walden & Aygun, 2013). Owing to the location of the disease, 
individuals with head and neck cancer not only confront a potentially life-
threatening disease, but must also endure treatments which often cause 
significant highly visible disfigurement and disruptions to essential functions such 
as breathing, eating, swallowing, and speech (Doyle, 2005; Howren, 
Christensen, Karnell, & Funk, 2012). Even prior to treatment and depending on 
the primary site and extent of the disease, individuals may experience symptoms 
that include hoarseness, difficulty swallowing, enlarged cervical lymph nodes, 
nonhealing sores or ulcers in the mouth, ear pain, and/or nasal bleeding or 
blockage (Marur & Forastiere, 2008). As a result of these symptoms and the 
anatomical location of the disease, treatment considerations in head and neck 
cancer are often complex with a high probability of debilitating consequences. 
The delivery of current treatment options in head and neck oncology (e.g., 
surgery, radiation therapy, chemotherapy or a combination of multiple modalities) 
may result in a wide range of head and neck-specific side effects including the 
loss of taste and smell, decreased sensation, facial disfigurement, excessive dry 
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mouth, sticky (or thick) saliva, and residual pain and swelling (List & Bilir, 2004). 
Further, due to differences in the toxicity of treatment and the desire for organ 
preservation, head and neck cancer and the consequences of its treatment may 
present marked disability (List & Bilir, 2004), leaving nearly half of individuals with 
the disease unable to return to work for extensive periods of time following 
treatment, if at all (Shone & Yardley, 1991; Taylor et al., 2004). The treatment 
and recovery process may be further complicated by additional factors such as 
the presence of comorbidities (Paleri et al., 2010), continued use of tobacco and 
alcohol (Danker et al., 2011; Duffy et al., 2002; Gritz et al., 1999), and 
psychosocial concerns such as depression and poor social support which may 
influence compliance with prescribed treatment plans (DiMatteo, Lepper, & 
Croghan, 2000; McDonough, Boyd, Varvares, & Maves, 1996). Given these 
myriad concerns and potential complications, coupled with the sheer visibility of 
the disease and treatment sequelae, it is not surprising that researchers have 
classified head and neck cancer as the most emotionally traumatic form of 
cancer (Björklund, Sarvimäki, & Berg, 2010; Koster & Bergsma, 1990). This 
acknowledgment of the psychological toll of head and neck cancer has led to an 
increased emphasis in oncology research toward the evaluation and 
consideration of an individual’s subjective concerns, including perceived distress, 
throughout the continuum of care (Howren et al., 2012). Consequently, 
explorations into the experience of distress in individuals with head and neck 
cancer throughout the disease trajectory may provide valuable insight into the 
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factors that have led to its designation as the most emotionally traumatic form of 
cancer. 
Concerns throughout the continuum of care 
  Receiving a diagnosis of cancer represents the initial phase of what is 
termed the “continuum of care” in oncology. This continuum begins with the initial 
diagnosis of a malignancy and then proceeds to treatment, rehabilitation (if 
required) and then survivorship if the treatment has been successful, or palliation 
and death if treatment has not served to eliminate the disease (Byock, 2000). 
Because of the multidisciplinary nature of treatment for head and neck cancer 
and the length of time that is often required to complete treatment protocols and 
support long-term concerns, the continuum of care in head and neck cancer is 
particularly complex (Sharp et al., 2002). Owing to this increased complexity, a 
number of distinct head and neck-related concerns may arise at varying points in 
time. In order to better understand these multidimensional concerns, it may be 
useful to examine previous efforts to understand issues that arise over the period 
of care. 
  Diagnosis. Upon receiving a diagnosis of malignancy, individuals enter 
the initial phase of the care continuum. During this stage, individuals often find 
themselves overwhelmed with fear, anxiety, and thoughts related to their 
mortality (Ettema, Reminger, & Robbins, 2013). As they begin to interact with 
members of their healthcare team, individuals may find that they are required to 
absorb a vast amount of information and acquire new vocabulary related to their 
disease and its treatment; it is often not until after the healthcare team has left 
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the room and the reality of the diagnosis has set in, that individuals begin to 
process the information provided to them and formulate questions (Penson, 
2006). One’s initial response to receiving a diagnosis of head and neck cancer 
may be characterized by denial, disbelief, or despair, and researchers have 
reported that individuals may have difficulty making decisions and processing all 
of the information conveyed to them, which may increase levels of anxiety 
(Ettema et al., 2013). It is clear that the collective impact of a cancer diagnosis 
and all the subsequent, often rapidly emerging events can be overwhelming to 
the individual. 
 While most individuals will develop their own coping strategies to manage 
their emotional responses, it is important to acknowledge that there is no “ideal” 
way to cope (Ettema et al., 2013). The impact of receiving a diagnosis for head 
and neck cancer can be devastating as individuals must address both the 
physical and psychological consequences of the disease (Aarstad, Aarstad, Bru, 
& Olofsson, 2005). Understandably, this is a time often marked by elevated 
distress and anxiety (Singer et al., 2012), decreased energy, a worried outlook, 
difficulty sleeping, pain (Whelan et al., 1997), and head and neck-specific 
symptoms (Hammerlid et al., 2001). In addition to the potentially acute physical 
concerns, for many individuals, receiving a diagnosis of cancer can create 
substantial feelings of stress and worry (Johansson, Rydén, Ahlberg, & Finizia, 
2012; Johansson, Rydén, & Finizia, 2008). In fact, a hazard ratio1 concerning the 
                                                 
1
 A hazard ratio is a measure of how often a particular event happens in one group compared to 
how often it happens in another group, in the context of time. A hazard ratio of one indicates that 
there is no difference in survival between the two groups while a hazard ratio of greater than one 
indicates that one group had better survival rates (National Cancer Institute; NCI, 2009). 
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development of depressive symptoms in individuals with cancer was shown to be 
3.5 times higher in those who were recently diagnosed with cancer when 
compared to the general population (Polsky et al., 2005). Specific to head and 
neck cancer, a prospective analysis determined that following diagnosis, 
individuals reported elevated rates of depression, anxiety, anger, confusion, and 
overall mood disturbance (Gritz et al., 1999). Ledeboer and colleagues (2005) 
suggested that stress levels are likely to peak at the point of diagnosis 
(Ledeboer, van der Velden, de Boer, Feenstra, & Pruyn, 2005), therefore,  
receiving a diagnosis of cancer can be a traumatic experience, particularly when 
the prognosis is guarded or unfavourable. Receiving the diagnosis may generate 
anxiety and fears related to the uncertainty of what lies ahead, potentially painful 
and debilitating treatments, and the potential loss of life. In consideration of these 
factors, it is reasonable to suggest that the post-diagnostic period may be a time 
marked by uncertainty, anxiety, and fear. 
Treatment. Following the diagnostic work-up and treatment-planning 
stage, individuals often proceed to treatment2. Research conducted by Wolff, 
Leeper, Gratton, and Doyle (2004) advises that for some, the experience of head 
and neck cancer treatment and its associated side effects can be more 
devastating than the actual diagnosis of cancer itself. While not discounting the 
sheer burden of receiving such a devastating diagnosis, Wolff and colleagues’ 
(2004) finding points to the overwhelming nature of the treatment and its side 
effects. Side effects may include substantial changes to one’s physical 
                                                 
2
 Based on the severity of disease and one’s personal goals and preferences, some individuals 
may proceed directly to palliative care services or choose to forego medical treatment entirely. 
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appearance and ability to verbally communicate resulting in changes to 
perceived body image, self-esteem and self-concept (Doyle, 2005). Furthermore, 
treatment of head and neck cancer has been associated with some of the highest 
rates of anxiety, depression and suicide when compared with other cancer sites 
(Bjordal, Kaasa, & Mastekaasa, 1995; Dropkin, 1986; Misono, Weiss, Fann, 
Redman, & Yueh, 2008). These findings suggest that from a psychosocial 
perspective, head and neck cancer is a highly complex and traumatic form of 
illness with myriad concerns. As such, when treating an individual with head and 
neck cancer it is imperative to consider the multidimensional needs of the 
individual in an effort to address specific concerns and improve his or her overall 
quality of life and well-being.  
Research has shown that during treatment, quality of life in individuals 
with head and neck cancer is compromised across a broad range of domains, 
including physical (Bjordal et al., 2001), emotional, social, and role functioning 
(Johansson et al., 2008). Perceptions of global, or overall, quality of life also have 
been reported to be substantially compromised during this time (Johansson et 
al., 2008). Relative to specific physical concerns during treatment, researchers 
have noted that for those with head and neck cancer, physical concerns extend 
beyond those generally associated with cancer such as pain, nausea, vomiting, 
dyspnea (e.g., shortness of breath), constipation, diarrhea, decreased appetite, 
sleep disturbances, fatigue and issues with sexuality (Johansson et al., 2008; 
Ledeboer et al., 2005), to include additional challenges such as dysphagia (i.e., 
difficulty swallowing), odynophagia (i.e., painful swallowing), trismus (i.e., deficits 
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in the ability to open the mouth), xerostomia (i.e., dry mouth), sticky (or thick) 
saliva, facial weakness, drooling, limited shoulder mobility (a consequence of 
neck dissection), dental issues, compromised ability to taste and smell, altered 
voice and speech quality, and difficulties related to the airway such as breathing, 
eating, laughing, and crying (Doyle, 1994; Eadie, 2007; Gritz et al., 1999; 
Johansson et al., 2008; Ledeboer et al., 2005; Owen, Watkinson, Parcy, & 
Glaholm, 2001). Additional work has noted that the side effects and problems 
reported by individuals treated for head and neck cancer reach their peak shortly 
after the completion of treatment (Hammerlid et al., 1997; Neilson et al., 2012). 
Further, research has suggested that the type of treatment utilized (e.g., surgery, 
chemotherapy, radiation therapy or a combination of therapies) may influence the 
mental health of those with head and neck cancer (Singer et al., 2012), which is 
understandable given that each treatment method has been associated with 
significant acute side effects. For instance, radiation therapy may result in burns, 
ulcers, bleeding, and mucositis (Trotti et al., 2003). Ultimately, the burden of 
these added physical challenges may directly influence the psychological and 
social dimensions of quality of life and contribute to increasing levels of overall 
distress in some individuals.  
 Palliation. Unfortunately, when treatment efforts are unsuccessful or 
when the cancer has progressed too far at the point of diagnosis, palliative care 
may be offered to individuals in order to assist with end of life support. Palliative 
care aims to reduce suffering and provide support and closure throughout the 
final stages of an individual’s life (Lo, Quill, & Tulsky, 1999). Individuals with end 
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stage head and neck cancer experience distinct problems related to the impact of 
the tumour on the airway, the upper gastrointestinal tract, and the senses 
(Forbes, 1997). Assessments of the most significant physical concerns in 
individuals with head and neck cancer revealed fatigue, pain, weakness, 
dysphagia, xerostomia, communication deficits, and trouble with short walks 
outside, as most problematic during the palliative phase of care (Forbes, 1997; 
Lokker et al., 2012). With regard to psychosocial concerns, individuals with head 
and neck cancer reported worrying, sadness, tenseness, depressed mood, and 
feelings of powerlessness as most frequent at end of life (Lokker et al., 2012). 
These needs may be more pronounced in the palliative phase of care, 
particularly if the individual is experiencing problems with communication as a 
result of the disease or its treatment. As such, effective communication is vitally 
important to ensure optimal quality of life as one approaches the end of his or her 
life; not only does it permit communication of physical problems and 
requirements (e.g., pain medication), but it also allows for expression of 
emotions, intentions, and desires. Loss of the ability to communicate effectively 
may exacerbate distress at this important time.  
 Survivorship. For the purposes of this research, survivorship is defined 
as the “period in a cancer patient’s life, which is post treatment, separate from 
diagnosis and treatment and from end-of-life care” (Twombly, 2004, p. 1415). 
While the available treatments for head and neck cancer have increased the 
length of time that individuals may experience as disease-free, cure rates have 
not improved substantially over the last 50 years (Greene, Page, Fleming, Balch, 
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& Fritz, 2002). Further, the consequences of the disease and its treatment may 
be substantial. For instance, even after the successful completion of treatment, 
daily tasks such as eating, breathing, speaking and swallowing may pose 
significant difficulty for those treated for head and neck cancer. Consequently, 
survivors of head and neck cancer may require extensive rehabilitative treatment 
which may include swallowing rehabilitation, speech therapy, and dental and/or 
maxillofacial rehabilitation, in addition to physical and occupational therapies 
(Ward & van As-Brooks, 2007). As a result of these multifaceted challenges, 
individuals may experience substantial problems within the context of social and 
family settings and associated functioning (Semple, Sullivan, Dunwoody, & 
Kernohan, 2004). 
In light of these potential concerns, the survivorship phase of the 
continuum of care highlights the importance of assisting individuals as they work 
to adjust to potentially distressing disease- and treatment-related changes and 
ongoing quality of life concerns. Irrespective of an individual’s position along the 
continuum, the potential for elevated distress – and the negative sequelae 
associated with it – exists throughout all phases of one’s cancer-related 
experience. As such, investigations into the experience of distress throughout the 
continuum of care may afford a deeper understanding of the factors that serve to 
mitigate or exacerbate distress in these individuals. 
Distress in individuals with head and neck cancer 
The experience of distress, whether as subclinical depressive 
symptomatology or as a full clinical depressive or anxiety disorder, is common 
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among individuals with head and neck cancer and may arise throughout the 
course of illness, and even persist months or years beyond the completion of 
treatment in cancer survivors (Bjordal & Kaasa, 1995; Hutton & Williams, 2001; 
Massie, 2004; Neilson et al., 2012). The source of this distress is likely 
multifaceted and may be related to the diagnosis itself, the consequences of 
disease- and treatment-related sequelae, declines in general quality of life, 
and/or the potential for disease progression, recurrence, or death.  
Notably, the presence of distress has been reported to be more prevalent 
in head and neck cancer than in other types of cancer (Kendal, 2006; Massie, 
2004; Misono, Weiss, Fann, Redman, & Yueh, 2008). While estimates seem to 
vary depending on the method of assessment (i.e., diagnostic interview versus 
self-report questionnaires) and the point in time, data indicate that across the 
trajectory of illness, distress is present in approximately 15% to 58% of 
individuals diagnosed with head and neck cancer (Bjordal & Kaasa, 1995; Chen 
et al., 2009; Katz, Kopek, Waldron, Devins, & Tomlinson, 2004; Lydiatt, Moran, & 
Burke, 2009; Neilson et al., 2012). Further, the presence of elevated distress in 
individuals with head and neck cancer has been reported to influence 
immunocompetence, wound healing, treatment compliance, self-care behaviour, 
and social participation (DiMatteo et al., 2000; McDonough et al., 1996; Spiegel 
& Giese-Davis, 2003). Distress in individuals with head and neck cancer may be 
exacerbated by the fact that distress is often not reported to, nor recognized by, 
healthcare team members (Pirl et al., 2007). 
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 Relative to the experience of distress in individuals with head and neck 
cancer, research has yielded conflicting data. Specifically, researchers have 
reported trends of increased distress over time (Couper et al., 2010; Neilson et 
al., 2012; Wang, 2006), decreased distress over time (Carlson, Waller, Groff, 
Giese-Davis, & Bultz, 2013; Neilson et al., 2012), and also the maintenance of 
distress levels throughout the continuum of care (Akechi et al., 2006; Andreu et 
al., 2012; Carlson et al., 2013). Specifically, a recent study of distress in oncology 
found that over a one year period, some participants experienced a reduction in 
distress whereas for others, the rate remained the same (Carlson et al., 2013). 
Researchers noted that both demographic factors (e.g., not being married) and 
treatment-related factors (e.g., undergoing radiation therapy) predicted persistent 
distress, while the receipt of psychosocial support predicted its reduction 
(Carlson et al., 2013). Additionally, the maintenance of distress rates over time 
has been reported previously (Akechi et al., 2006; Andreu et al., 2012); whereas 
other longitudinal studies have reported increased rates of distress over time in 
individuals with breast, prostate, and lung cancer (Couper et al., 2010; Wang, 
2006). It is of concern, however, that cross-sectional research conducted on 
long-term (7-11 years) survivors of head and neck cancer has noted a high rate 
of distress present in long-term survivors (e.g., 31% of study participants), which 
is particularly problematic given that these individuals had completed the clinical 
follow-up program, which was typically five years in length and, thus, they were 
not being offered any form of support or psychological treatment (Bjordal & 
Kaasa, 1995). 
  
70 
Recent head and neck cancer-specific inquiries have reported similarly 
varied results. For instance, researchers have reported elevated rates of distress 
around the 3-week post-diagnostic mark, and declines to lower than baseline 
levels in long-term (e.g., 18 months) follow-up (Neilson et al., 2012). Yet others 
have reported opposite findings marked by a decline in distress following 
discharge from the hospital when compared to baseline assessments, and 
increases in distress to higher than baseline levels during a six-month follow-up 
(Singer et al., 2012). Reasons for these differing patterns may be attributable to 
characteristics of each study. For instance, work conducted by Neilson and 
colleagues (2012) was limited to individuals treated with radiotherapy, which may 
differ from the experiences of individuals treated with surgery, chemotherapy, or 
a combination of approaches. Likewise, Singer and colleagues (2012) were 
limited by both their research design (i.e. lack of standardized assessment 
periods) and the length of time permitted for follow-up (e.g., six months). In order 
to determine which factors may contribute to perceived distress and quality of life 
in individuals with head and neck cancer, an examination of the areas currently 
overlooked in distress-related literature may serve to highlight specific areas 
worthy of further investigation.  
Limitations to currently available research 
 Previous research focusing on distress in individuals with head and neck 
cancer has been limited in a number of important ways. First, owing to the 
heterogeneous nature of head and neck cancer and its treatment options, a 
number of studies have opted to focus the scope of their research on one 
  
71 
particular issue, such as the treatment type (Bjordal & Kaasa, 1995; Neilson et 
al., 2012; Singer et al., 2012), disease site (Johansson, Rydén, & Finizia, 2011; 
Kugaya et al., 2000), or phase along the continuum of care (Aarstad, Beisland, & 
Aarstad, 2012; Bjordal & Kaasa, 1995; Buchmann, Conlee, Hunt, Agarwal, & 
White, 2013; Elani & Allison, 2011; Horney et al., 2011; Hutton & Williams, 2001; 
Johansson et al., 2011; Katz et al., 2004; Kugaya et al., 2000). In terms of 
limitations based on treatment type, both Neilson and colleagues (2012) and 
Bjordal and Kaasa (1995) limited their participant pools to those undergoing only 
radiation therapy, while Singer et al. (2012) permitted those receiving radiation 
and/or chemotherapy, but not surgery. Additionally, site-specific research 
conducted to date has focused on either laryngeal cancer (Johansson et al., 
2011), or a combination of laryngeal, oral, and pharyngeal sites (Kugaya et al., 
2000). Relative to one’s position along the continuum of care in oncology, a few 
studies centered on distress in newly diagnosed individuals (Buchmann et al., 
2013; Horney et al., 2011; Kugaya et al., 2000), while a richer body of literature 
has examined survivorship concerns in those with head and neck cancer 
(Aarstad et al., 2012; Bjordal & Kaasa, 1995; Elani & Allison, 2011; Hutton & 
Williams, 2001; Johansson et al., 2011; Katz et al., 2004). While limiting the 
criteria for inclusion in a study may permit a more focused approach to the 
research findings, it also serves to limit the generalizability of findings. 
Second, most studies investigating the issue of distress in individuals with 
head and neck cancer employed a cross-sectional research design (Bjordal & 
Kaasa, 1995; Bornbaum et al., 2012; Buchmann et al., 2013; Elani & Allison, 
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2011; Horney et al., 2011; M. R. Katz et al., 2004; Kugaya et al., 2000; Pandey et 
al., 2007; Verdonck-de Leeuw et al., 2007), which may fail to describe distress 
and quality of life-related experiences relative to time or one’s progression 
through the continuum of care. 
 Third, there are a number of commonly used exclusion criteria in 
psychosocial oncology research that may serve to bias the results of the study 
towards a lower degree of distress. For instance, several studies have purposely 
excluded individuals with head and neck cancer who were not receiving 
treatment with a curative intent (Elani & Allison, 2011; Horney et al., 2011; Katz 
et al., 2004; Neilson et al., 2012; Pandey et al., 2007; Verdonck-de Leeuw et al., 
2007). This effort to limit the sample of participants to those with the potential for 
cure may bias the data towards a healthier subset of individuals and thus, may 
not accurately reflect the full range of distress and quality of life-related 
experiences in individuals diagnosed with head and neck cancer.  
Another common phenomenon in longitudinal oncology research is that 
individuals are frequently excluded from participation if they experience a 
recurrence or metastases of disease during the study (Aarstad et al., 2012; 
Bjordal et al., 1999; Horney et al., 2011; Neilson et al., 2012). However, 
exclusion of individuals during such a potentially distressing experience may 
serve to bias the sample towards a lower rate of distress. It also limits our 
understanding of how individuals react to and cope with these experiences. 
Some longitudinal studies excluded participants if they failed to return one of the 
data sets following a reminder call (Bjordal et al., 1999); this practice may not 
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account for myriad factors including the possibility of hospitalization and/or 
physical or psychological deterioration. Others have requested that participants 
only return follow-up questionnaires if they did not experience new serious 
disease (Beisland, Aarstad, Osthus, & Aarstad, 2013), which may fail to account 
for concerns arising during recurrence. Some researchers have opted to not 
include individuals who received “bad news” at follow-up appointments 
(Verdonck-de Leeuw et al., 2007), while others excluded participants with 
existing or previous psychological conditions (e.g., depression, anxiety) (Elani & 
Allison, 2011). Exclusion criteria that serve to restrict the pool of potential 
participants to only those who do not receive “bad news” at their appointments or 
to those with no history of psychological morbidity, fail to acknowledge the 
importance of identifying potential distress in these instances.  
Distress-related research that purposely excludes individuals experiencing 
a distressing life event (e.g., receipt of “bad news”, palliative phase of illness, 
disease recurrence, metastases, etc.) or those that may be prone to experiencing 
pathologic distress (e.g., those with a history of a psychological condition), fails to 
provide a comprehensive perspective on the very factors which may both cause 
and exacerbate distress. Collectively, these commonly applied exclusion criteria 
may serve to bias the data towards a lower rate of distress. In consideration of 
these existing practices, the present study was designed to broaden the range of 
concerns and potentially distressing factors accounted for beyond the 
parameters currently employed in longitudinal research in head and neck 
psychosocial oncology. Further, in consideration of the noted limitations to the 
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current literature, a number of specific objectives were developed for this 
research investigation. 
Study-specific research objectives 
The purpose of the current investigation was to explore the experience of 
distress in individuals with head and neck cancer at standardized three-month 
intervals throughout the first year following diagnosis. We further aimed to 
explore the pattern of commonly reported problems and perceptions of quality of 
life in these individuals. In addition, we sought to enhance the current body of 
literature to include considerations of individuals frequently excluded from 
participation in psychosocial oncology research, including those who had 
received “bad news”, were not receiving treatment for a curative intent, or 
experienced disease recurrence or metastases. 
Accordingly, a number of specific objectives for this inquiry were 
developed: (1) to determine the presence and trajectory of distress in individuals 
with head and neck cancer at standardized intervals (e.g., every three months) 
throughout the first year following diagnosis; (2) to describe the pattern in 
frequency of perceived problems (e.g., practical, familial, emotional, spiritual, 
physical) reported among participants at the same intervals; and (3) to assess 
global and disease-specific quality of life in participants over the same period. 
 
Method 
Participants 
All participants (n = 102) involved in this research protocol were recruited  
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by their physician at the London Regional Cancer Program (LRCP) at the London 
Health Sciences Centre, Victoria Campus, located in London, Ontario. This 
sample may be considered as a sample of convenience based on the willingness 
of individuals to participate following a request by their physician and subsequent 
follow up by a member of the research team (C.B.). Prior to undertaking this 
study, the Ethics Review Board at The University of Western Ontario approved 
this protocol; Approval # 18283E (see Appendix A).  
 Inclusion criteria. Participants were required to be at least 18 years of 
age and able to provide informed consent (i.e., no known cognitive impairments). 
They also must have received a diagnosis for a primary malignancy of the head 
and neck region. At the time of enrollment, individuals were required to be 
between zero and one month post-diagnosis and could not have commenced 
treatment. 
Exclusion criteria. If individuals were unable to read, write or understand 
English or if they were unable to visually see the questionnaires they were 
excluded since the tasks involved in this study required participants to read and 
understand the questionnaires in English, and respond to questions accordingly. 
In total, 175 individuals were identified as potential participants. Of these 
potential participants, 20 declined to participate while 155 individuals expressed 
interest in taking part in the study. Reasons identified for the 20 individuals who 
did not desire to participate included: too upset (n = 8), not interested (n = 5), too 
ill (n = 3), not enough time (n = 2), too angry (n = 1), and too many other health-
related concerns (n = 1). In total, 155 packages containing the letter of 
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information and consent, the demographic questionnaire, and the research 
instruments were disseminated. 
The age of participants taking part in this study ranged from 23 years to 92 
years (mean age 63.75, SD = 12.55). In total, the 71 male (mean age = 65.25 
years, SD = 12.41) and 31 female participants (mean age = 60.33 years, SD = 
12.39) resulted in a male-to-female ratio of approximately 2.3:1. Comprehensive 
demographic data for the participants are presented in Table 2.1, while the 
disease- and treatment-related data are presented in Table 2.2. 
In addition, data pertaining to the status of alcohol and tobacco use (e.g., 
currently used, formerly used, never used) were collected throughout the first 
year following diagnosis. The percentage of participants actively using tobacco 
decreased throughout the first year from 13.3% at diagnosis, to 12.9% at three-
months, 13.1% at six-months, 6.4% at nine-months, before increasing to 10.0% 
of participants at 12-months. Similarly, the percentage of participants actively 
consuming alcohol also declined throughout the first year from 53.3% at 
diagnosis, to 45.7% at three-months, 42.6% at six-months, 40.4% at nine-months 
post-diagnosis, with an increase to 50.0% of participants at 12-months. Further, if 
participants confirmed the active use of alcohol or tobacco products, they were 
asked to specify what quantity of each product was consumed in an average 
week. Regarding tobacco, participants decreased their mean cigarette pack use 
by 0.94 packs per week, while alcohol consumption decreased by a mean of 5.38 
beverages per week by the 12-month assessment.  
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Table 2.1   
Demographic Data of Individuals Diagnosed with Head and Neck Cancer 
Variable n  % 
Sex   
     Male 71 69.6 
     Female 31 30.4 
Marital status   
     Married/common-law 66 64.7 
     Separated/divorced/widowed/single 21 20.6 
     Unspecified 15 14.7 
Education   
     Completed post-secondary education or training 33 32.4 
     Completed high school 29 28.4 
     Completed some of/less than high school 16 15.7 
     Unspecified 24 23.5 
Occupational status   
     Retired 39 38.2 
     Working full-time 28 27.5 
     On disability/sick leave 15 14.7 
     Working part-time 4 3.9 
     Student 2 1.4 
     Unemployed/stay at home 1 0.7 
     Unspecified 13 12.7 
Household income   
     ≤ $25,000 7 6.9 
     $25,001 - $40,000 10 9.8 
     $40,001 - $55,000 5 4.9 
     $55,001 - $70,000 7 6.9 
     $70,001 - $85,000 8 7.8 
     > $85,000 14 13.7 
     Unspecified 51 50.0 
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Table 2.2   
Disease- and Treatment-Related Data for Individuals with Head and Neck 
Cancer  
Variable n  % 
Site of cancer   
     Oral cavity  31 30.4 
     Oropharynx 24 23.5 
     Multiple sites 14 13.7 
     Larynx 9 8.8 
     Ear 7 6.9 
     Nasal cavity and paranasal sinuses 4 3.9 
     Salivary glands 3 2.9 
     Neck 3 2.9 
     Unknown primary 3 2.9 
     Hypopharynx 2 2.0 
     Scalp 1 1.0 
     Nasopharynx 1 1.0 
Tumour stage of disease   
     T1 22 21.6 
     T2 24 23.5 
     T3 20 19.6 
     T4 25 24.5 
     Unspecified 11 10.8 
Treatment type   
     Chemotherapy and radiation therapy 35 34.3 
     Surgery  24 23.5 
     Surgery and radiation therapy 17 16.7 
     Radiation therapy  13 12.7 
     Surgery, chemotherapy and radiation therapy 11 10.8 
     Surgery and chemotherapy 1 1.0 
     No treatment  1 1.0 
Note. Data pertaining to pathological site of cancer are organized and reported according to the 
current standards set by the American Joint Committee on Cancer and endorsed by the American 
Academy of Otolaryngology – Head and Neck Surgery (Deschler & Day, 2008).  
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Procedure 
Data collection. All individuals who consented received a package 
containing a letter of information and consent (see Appendix C), a demographic 
questionnaire (see Appendix E), the Distress Thermometer and accompanying 
Problem Checklist (see Appendix I), the EORTC general quality of life 
assessment tool (EORTC-QLQ-C30) (see Appendix G), the EORTC head and 
neck cancer specific quality of life assessment tool (EORTC-QLQ-H&N35) (see 
Appendix H), a list with the contact information for local psychological support 
services (see Appendix K), and a self-addressed and prepaid return envelope to 
ensure that participants did not incur any undue financial burden for their 
participation.  
The letter of information informed the participant of the general purpose of 
the study, the risks and benefits associated with participating in the study, and 
also notified them that they were under no obligation to complete the 
questionnaires nor would they suffer any consequences for declining to 
participate. If an individual agreed to participate in the study, they were assigned 
a coded participant number at the outset and were assured that they would not 
be personally identified in any way other than by the primary researcher (C.B.) 
and her supervisor (P.D.). In compliance with ethical requirements, informed 
consent was indicated by the voluntary completion and return of the 
questionnaire to the researcher. This procedure of obtaining consent was 
explicitly stated in the letter of information. If any of the questionnaires were not 
completed in entirety with sufficient data to compute statistical analysis as per the 
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requirements specified in the standardized scoring and procedures manual for 
each questionnaire, they were destroyed and excluded from further data 
analysis.  
Sample size calculations. Sample size calculations were calculated 
using Horatio Software (Version 3.0a) (Lee, 2004) to determine the number of 
participants required to obtain adequate statistical power. It was determined that 
“a total sample size (n) of 14 individuals would be sufficient to detect the 
hypothesized effect (r2 = 0.12) of a five-level within-subject independent variable 
81.9 percent of the time using a 0.05 alpha level and assuming a within-subject 
correlation of 0.30” (Lee, 2004). Despite this modest number of required 
participants, it was determined that a total of up to 175 individuals would be 
invited to participate in the study in order to account for potential attrition among 
participants. The decision to increase our proposed number of participants 
beyond the recommended sample size was informed by previous longitudinal 
designs in head and neck oncology populations, which have noted significant 
attrition rates as high as 78.5% in one study (Mehanna & Morton, 2006) and 66% 
in another (Kelly, Paleri, Downs, & Shah, 2007). As expected in an oncology 
population, significant rates of attrition have been attributed to the death of 
participants and/or substantial declines in physical condition (Abendstein et al., 
2006; Bjordal & Kaasa, 1995; Bjordal, Kaasa, & Mastekaasa, 1994; Kelly et al., 
2007; Mehanna & Morton, 2006). Collectively, these factors contributed to the 
decision to increase the number of participants that would be recruited in order to 
  
81 
ensure that the study would have enough participants to be sufficiently powered 
statistically.  
Measurement instruments. The measurement instruments utilized in this 
study included: (1) the Distress Thermometer and accompanying Problem 
Checklist to assess distress and perceived problems (NCCN, 2010), (2) the 
EORTC global quality of life measure (EORTC-QLQ-C30) (Aaronson et al., 1993; 
Fayers et al., 2001) and (3) the EORTC head and neck quality of life module 
(EORTC-QLQ-H&N35) (Fayers et al., 2001), and (4) a demographic 
questionnaire to assess both personal demographic information and disease- 
and treatment-related characteristics of those with head and neck cancer. The 
order of the Distress Thermometer and EORTC questionnaires was randomly 
assigned as per predetermined stapling of the instruments (e.g., half of the 
packages provided the Distress Thermometer first, while the other half offered 
the EORTC measures first). This procedure of organizing the order of the 
instruments was conducted in an effort to reduce any potential response bias due 
to the influence of exposure to the preceding measure. Participants were 
instructed to complete each questionnaire as per the enclosed instructions 
provided on the measures themselves (e.g., the Distress Thermometer and 
EORTC measures) in a location of their choosing (i.e., home or private office). 
Additional pages were provided for participants to include any additional 
information that they felt was pertinent to the research topic (i.e., any concerns or 
life events that could serve as confounding factors influencing their distress or 
quality or life at the time of the survey). It was estimated that the completion of all 
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tasks would take 15-20 minutes. Within the packages distributed to all 
participants, the demographic items appeared first since they were simple and 
uncomplicated and helped transition the participant into answering the more 
sensitive items that followed in the accompanying distress- and quality of life-
related questionnaires (Portney & Watkins, 2009).  
 Demographic and disease-related information. Demographic items 
consisted of the participant’s age, sex, marital status, occupational status, 
highest level of education obtained, and approximate household income. Relative 
to the disease- and treatment-related characteristics, items for which data were 
collected included the length of time since diagnosis, the specific site of the 
malignancy (e.g., larynx, oral cavity, etc.), the pathological tumour stage of the 
disease, the type of treatment received, the status of treatment (e.g., awaiting, 
undergoing, completed, etc.), and whether or not the individual had experienced 
a recurrence of the disease. Data pertaining to the use of alcohol and tobacco 
products were also collected. 
Data analysis 
Raw data were analyzed using SPSS Statistics 20.0 for Macintosh (IBM, 
2011). Descriptive data for continuous scale items and scales (e.g., Distress 
Thermometer and EORTC measures) were presented through mean scores 
while descriptive information for categorical data were presented with 
frequencies and percentage values of subgroups (e.g., demographic, disease-, 
and treatment-related variables). Given that the research design for this study 
was prospective and longitudinal in nature, the possibility that participants may 
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not return all questionnaire packages had to be accounted for. Thus, if a 
participant failed to return a questionnaire package for a particular point of data 
collection, they were still invited to complete and return subsequent data 
packages. This decision was made in an effort to ensure the most complete data 
set possible while also accounting for potential confounding factors which may 
not permit a participant to return all data packages (e.g., hospitalization, too ill 
from the disease or effects of treatment, etc.). Additionally, an a priori alpha level 
of p ≤ 0.05 was used for statistical tests.  
Descriptive statistics. Descriptive statistics (e.g., means, standard 
deviations, frequency distributions, histograms, etc.) were calculated where 
applicable for demographic data, treatment- and disease-related variables, and 
the global and specific domains of each questionnaire (e.g., Distress 
Thermometer, EORTC-QLQ-C30, EORTC-QLQ-H&N35). These analyses were 
conducted in order to evaluate the normality of the sample and assess whether 
parametric statistics would be appropriate for statistical analyses.  
Objective one: Presence of distress. The presence of clinically 
significant distress was identified based on a Distress Thermometer score of ≥ 4 
in accordance with the recommendations of the National Comprehensive Cancer 
Network (NCCN) (2013). In order to determine if parametric statistics would be 
appropriate to use in the present analysis of distress, applicable histograms and 
the Kolmogorov-Smirnov test of normality for Distress Thermometer data were 
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analyzed3. Given that distress was evaluated by a continuous measure (e.g., 
Distress Thermometer) that was distributed to participants at five standardized 
time points, a repeated measures analysis of variance (ANOVA) was utilized to 
assess the relationship between the variables (e.g., distress and time). However, 
in an effort to maintain statistical rigor, only those participants who returned all 
data packages were included in the repeated measures analyses. In addition, the 
magnitude of effect for length of time since diagnosis on level of distress was 
determined through calculation of Eta Squared4 (Pallant, 2011). Effect sizes were 
interpreted according to the guidelines proposed by Cohen (1988): 0.01 
represented a small effect, 0.06 denoted a moderate effect, and 0.14 indicated a 
large effect (p.284-7). 
Despite the strict criteria of repeated measures analyses, all participant 
data (regardless of the number of questionnaire packages returned) were 
included in analysis of distress presence detected at each standardized interval. 
Specifically, the number of cases of distress (defined by a Distress Thermometer 
score of ≥ 4) were divided by the total number of respondents in order to 
determine the percentage of participants at each assessment point who 
experienced clinically significant distress. 
Relative to anticipated outcomes, it was hypothesized that the presence of 
distress detected within this sample would be highest at the point of diagnosis 
                                                 
3
 The Kolmogorov-Smirnov test evaluates whether a distribution of scores is significantly different 
from a normal distribution; a statistically significant value indicates a deviation from normality 
(Field, 2009). 
4
 Eta Squared is an effect size statistic that ranges from zero to one and “represents the 
proportion of variance in the dependent variable that is explained by the independent (group) 
variable” (Pallant, 2011, p.242). 
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and shortly following treatment (e.g., at the post-diagnostic and three-month 
assessment points) (Hammerlid et al., 1997; Ledeboer et al., 2005; Neilson et al., 
2012). Further, in terms of the pattern of distress, it was anticipated that the 
severity of distress would also peak at the point of diagnosis and shortly following 
treatment before gradually declining in longer-term follow up (Neilson et al., 
2012).  
Objective two: Perceived problems. Perceived problems were assessed 
through use of the Problem Checklist which accompanies the Distress 
Thermometer (NCCN, 2013). The specific subdomains of the Problem Checklist 
include practical, familial, emotional, spiritual/religious, and physical problems. 
Frequency data were presented for each subdomain at standardized three-month 
intervals in an effort to explore the most commonly reported concerns among 
participants. Given the potential for substantial physical impairment related to 
both head and neck cancer and its treatment, it was hypothesized that physical 
problems (e.g., pain, fatigue, nausea, mouth sores, etc.) would be the most 
frequently reported concerns among participants at each time interval. 
Objective three: Global and head and neck cancer-specific quality of 
life. We sought to descriptively compare the mean differences in EORTC scores 
for each component of quality of life between participants at each time interval. 
All participant data (regardless of the number of questionnaire packages 
returned) were included in the analyses at each standardized interval. 
Furthermore, we compared the level of mean change between baseline 
assessments of quality of life with mean scores reported at both the three-month 
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and 12-month assessments in order to determine if any clinically significant 
differences had occurred.  
In order to facilitate the interpretation of results, clinically significant 
differences in quality of life data were assessed. Clinical significance is denoted 
by the practical implications of the differences relative to the impact on an 
individual’s health or well-being (Hammerlid et al., 2001). Clinical significance 
data provide important information relative to the interpretation of clinically 
meaningful differences between groups, or in the present case, points in time 
following diagnosis. Specifically, score changes of 10 points or greater indicated 
a clinically significant difference (Aaronson et al., 1993).  
Based on previous findings in the literature, it was hypothesized that 
symptom burden would peak during and just after treatment (i.e., around the 
three-month post-diagnostic mark for most individuals) (Bjordal et al., 2001; 
Hammerlid et al., 1997), with a slow recovery process where most symptoms and 
quality of life-related concerns level off around 12-months following diagnosis 
(Bjordal et al., 2001). It was anticipated that role functioning would decline 
significantly shortly following treatment, but return to near baseline levels by the 
12-month follow-up; emotional functioning was anticipated to be lowest at the 
point of diagnosis and increase slightly throughout time (Bjordal et al., 2001). The 
remaining functional domains (e.g., social, cognitive) were not anticipated to 
change in a clinically significant manner (Bjordal et al., 2001). 
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Results 
Response rate. Overall, 65.8% of individuals (n = 102) completed and 
returned at least one questionnaire throughout the 12-month data collection 
period. Notably, 12.1% of participants (n = 17) returned all five data packages. 
Comprehensive data pertaining to the individual response rates for each 
standardized time interval is presented in Table 2.3.  
Additionally, in an effort to enhance the current body of literature beyond 
the existing body of exclusion criteria, this study included participants who had 
developed metastases (n = 3), were not being treated with a curative intent (n = 
2), experienced a recurrence of disease (n = 1), discontinued treatment prior to 
completion due to complications (n = 1), and had a pre-existing psychological 
disorder (e.g., depression) (n = 1). 
Furthermore, a subset of the 155 potential participants (n = 7) opted to 
withdraw from the study: two withdrew after returning the three-month follow-up 
package, three withdrew after the six-month assessment, and two withdrew after 
the nine-month assessment. Reasons for withdrawal from the study were only 
provided by two participants; one noted that she was too ill to continue while the 
other reported that his treatment had not been successful and no longer wished 
to participate. In addition, seven individuals died during the course of the study. 
Notably, participants who completed all questionnaires in the study did not differ 
from participants who did not complete all components of the study in terms of 
distress when measured at both baseline (t(73) = -1.80, p = 0.076) and 12-
months (t(28) = -0.482, p = 0.633) post-diagnosis.  
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Table 2.3   
Response Rate Data for Individuals Diagnosed with Head and Neck Cancer 
Point of 
assessment 
Diagnosis 3-month 6-month 9-month 12-month Total 
Withdrawals 
(n) 
0 0 2 3 2 7 
Deceased 
(n) 
2 1 4 0 0 7 
Maximum 
possible 
participants 
(n) 
153 152 146 143 141 155 
Total 
responses 
(n) 
75 70 61 47 30 102 
Response 
rate (%) 
49.0 46.1 41.8 32.9 21.3 65.8 
 
Note. The column of total values represents a summary of participant response rate data for the 
entire study. As a result, data in this column may not represent a summative value of the data 
contained in the corresponding row. 
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Data analysis 
 Objective one: Presence of distress. Based on a Distress Thermometer 
score of ≥ 4 (NCCN, 2013), clinically significant distress was identified in 35 of 75 
individuals (46.7%) immediately following diagnosis, in 29 of 70 individuals 
(41.4%) three months following diagnosis, in 19 of 61 individuals (31.2%) six 
months following diagnosis, in 10 of 47 individuals (21.3%) nine months following 
diagnosis, and in 10 of 30 individuals (33.3%) one year following diagnosis of 
head and neck cancer. In addition, when the frequency of Distress Thermometer 
scores was examined at each time point (see Figure 2.1), it was apparent that 
while Distress Thermometer scores of zero were most frequently reported by 
participants, that a diverse range of higher scores were also reported by 
participants at each time interval. 
In addition, statistical tests evaluating the parametric nature of data 
revealed that none of the Kolmogorov-Smirnov statistic values for Distress 
Thermometer scores were found to be statistically significant (e.g., post- 
diagnosis, p = 0.200; three-month, p = 0.178; six-month, p = 0.200; nine-month, p 
= 0.186; 12-month, p = 0.052). These Kolmogorov-Smirnov findings, taken in 
conjunction with the relatively normal distributions of data evident in the 
histograms of Distress Thermometer data (see Appendix L), indicated that 
parametric statistics were appropriate to assess the trajectory of distress in this 
participant sample. Consequently, a repeated measures ANOVA was employed 
for temporal-based statistical analysis.  
A one-way repeated measures ANOVA was conducted to compare scores 
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Figure 2.1. Frequency of Distress Thermometer Scores at Each Assessment 
Point for All Participants (n = 102) 
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on the Distress Thermometer at the point of diagnosis, and the three-, six-, nine-, 
and 12-month follow-up assessments. The means and standard deviations of the 
data included in the repeated measures analysis are presented in Table 2.4. 
Findings related to Mauchly’s test5 indicated that the assumption of sphericity 
had been violated 2(9) = 20.34, p = 0.017, thus, degrees of freedom were 
corrected using the Greenhouse-Geisser estimate of sphericity (Epsilon;  = 
0.72) (Field, 2009). Results from the repeated measures ANOVA indicated that 
there was a significant effect of time on distress, F (2.87, 40.19) = 4.11, p = 0.01, 
Multivariate Partial Eta Squared = 0.45. Notably, when the F-statistic from the 
present analysis (F = 4.11) was compared with the critical value6 for the F- 
distribution (FCritical = 2.83) (Field, 2009), it was determined to be greater than the 
critical value, thus indicating that the length of time since diagnosis did influence 
perceived distress. Further, when the magnitude of effect (Multivariate Partial Eta 
Squared = 0.45) was evaluated according to the guidelines for effect size 
(Cohen, 1988), it was apparent that the length of time since diagnosis 
demonstrated a very large effect on the perceived level of distress. 
Since an F-ratio is an omnibus test, post-hoc tests were required in order to 
determine specifically which time point(s) significantly influenced the perceived 
level of distress in individuals with head and neck cancer. Consequently, pairwise 
 
                                                 
5
 Mauchly’s test evaluates the hypothesis that the variances of the differences between time 
points are equal. Therefore, if Mauchly’s test is significant it indicates that there are significant 
differences between the variances of differences, and thus the condition of sphericity (i.e. the 
equality of variances of the differences between time intervals) is not met (Field, 2009). 
6
 The critical value is the number that a test statistic must exceed in order to reject the null 
hypothesis (Field, 2009). 
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Table 2.4   
Descriptive Statistics for Distress Thermometer Scores for Individuals Diagnosed 
with Head and Neck Cancer throughout the First Year Following Diagnosis Who 
Returned all Packages 
Assessment time n Distress 
Thermometer Score 
≥ 4 (n) 
Mean Distress 
Thermometer Score 
SD 
At diagnosis 17 13 5.27 2.79 
3-month follow-up 17 8 3.07 1.98 
6-month follow-up 17 7 3.80 2.96 
9-month follow-up 17 5 2.67 2.66 
12-month follow-up 17 6 3.07 3.04 
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comparisons7 of Distress Thermometer scores were conducted. Since multiple 
comparisons were conducted, a Bonferroni correction was applied to the alpha 
level in order to control the overall Type I error rate (Field, 2009). Interestingly, 
only the nine-month follow-up assessment demonstrated a statistically significant 
improvement from baseline (e.g., at diagnosis) Distress Thermometer scores (p = 
0.05). No other statistically significant differences were detected between the 
assessment times. 
With respect to the specific trajectories of distress evident in those 
participants who returned all data packages (n = 17), a number of specific 
patterns of distress emerged (see Figure 2.2). Specifically, several participants 
initially noted high levels of distress, which gradually decreased with time (n = 6; 
see P1-P6 in Figure 2.2). Other participants reported elevated distress following 
diagnosis with a decline following treatment and subsequent increase at long 
term follow-up (n = 3; P7, P9, P15). Some participants reported low levels of 
distress during both the initial and long-term (e.g., 12-month) follow-up 
assessments, but noted a peak in distress following treatment (n = 2; P10, P11), 
while others noted consistently low levels of distress throughout the entire 
trajectory (n = 2; P12, P13). Conversely, a number of participants reported 
persistently high levels of distress throughout the entire trajectory of assessment 
(n = 3; P8, P14, P16). One additional participant reported generally low levels of 
distress with two peaks of distress at both the diagnostic and six-month follow-up 
points (n = 1; P17).  
                                                 
7
 Pairwise comparisons are comparisons of pairs of the mean values for scores at each interval of 
time (Field, 2009). 
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Figure 2.2. Trajectory of Distress via Distress Thermometer Data for Participants 
Who Returned Data at All Assessment Points (n = 17) 
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Objective two: Perceived problems. Perceived problems were assessed 
through use of the Problem Checklist (NCCN, 2013) and organized into five 
subdomains (practical, familial, emotional, spiritual/religious, and physical). 
Notably, participants cited emotional and physical problems frequently at all time 
intervals. In particular, worry was reported as the most commonly cited emotional 
problem with 58.7% of participants reporting it at diagnosis. Reports of 
problematic worry declined to 38.6% at three-months, and 32.8% at six-months 
before increasing to 36.2% at nine-months and 40.0% at 12-months. Most of the 
other emotional problems (e.g., depression, fears, nervousness) displayed a 
similar pattern of peaked frequency at diagnosis and one-year follow-up. Relative 
to physical concerns, problems with eating, fatigue and sleep presented ongoing 
challenges for participants. Comprehensive data pertaining to the frequency of 
reported problems on the Problem Checklist are presented in Table 2.5 
Objective three: Global and head and neck cancer-specific quality of 
life. Clinically significant change was evaluated at three- and 12-months 
following baseline assessments at diagnosis. Clinically significant differences in 
quality of life scores were defined by a difference in EORTC scores of greater 
than or equal to 10 points (Aaronson et al., 1993; Osoba et al., 1998). 
Comprehensive data pertaining to the quality of life scores among participants 
throughout the three-month standardized intervals are presented in Table 2.6. 
With regard to the general quality of life measure (e.g., EORTC-QLQ-C30), a 
clinically significant decline in role functioning was detected at the three-month 
follow-up, but appeared to resolve by the 12-month follow-up when compared to  
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Table 2.5   
Problem Checklist Data for Individuals Diagnosed with Head and Neck Cancer 
throughout the First Year Following Diagnosis 
Variable At diagnosis 
n (%) 
3 month 
n (%) 
6 month 
n (%) 
9 month 
n (%) 
12 month 
n (%) 
n 75 70 61 47 30 
Practical problems      
     Child care 1 (1.3) 1 (1.3) 0 (0.0) 0 (0.0) 0 (0.0) 
     Housing 1 (1.3) 3 (4.3) 5 (8.2) 1 (2.1) 3 (10.0) 
     Insurance/Financial 13 (17.3) 9 (12.9) 7 (11.5) 7 (14.9) 4 (13.3) 
     Transportation 8 (10.7) 10 (14.3) 5 (8.2) 2 (4.3) 2 (6.7) 
     Work/School 10 (13.3) 5 (7.1) 4 (6.6) 2 (4.3) 3 (10.0) 
Family problems        
     Dealing with children 8 (10.7) 0 (0.0) 1 (1.6) 0 (0.0) 1 (3.3) 
     Dealing with partner 7 (9.3) 6 (8.6) 4 (6.6) 5 (10.6) 4 (13.3) 
Emotional problems       
     Depression 25 (33.3) 21 (30.0) 15 (24.6) 7 (14.9) 5 (16.7) 
     Fears 32 (42.7) 21 (30.0) 11 (18.0) 11 (23.4) 9 (30.0) 
     Nervousness 32 (42.7) 17 (24.3) 14 (23.0) 11 (23.4) 9 (30.0) 
     Sadness 20 (26.7) 24 (34.3) 13 (21.3) 8 (17.0) 8 (26.7) 
     Worry 44 (58.7) 27 (38.6) 20 (32.8) 17 (36.2) 12 (40.0) 
     Loss of interest in usual 
activities 20 (26.7) 21 (30.0) 19 (31.2) 9 (19.2) 6 (20.0) 
Spiritual/religious problems      
     Spiritual/religious 7 (9.3) 3 (4.3) 3 (4.9) 1 (2.1) 3 (10.0) 
Physical problems       
     Appearance 19 (25.3) 24 (34.3) 14 (23.0) 9 (19.2) 9 (30.0) 
     Bathing/dressing 6 (8.0) 3 (4.3) 4 (6.6) 0 (0.0) 1 (3.3) 
     Breathing 14 (18.7) 11 (15.7) 11 (18.0) 2 (4.3) 4 (13.3) 
     Changes in urination 3 (4.0) 7 (10.0) 6 (9.8) 4 (8.5) 3 (10.0) 
     Constipation 14 (18.7) 14 (20.0) 12 (19.7) 4 (8.5) 6 (20.0) 
     Diarrhea 10 (13.3) 10 (14.3) 6 (9.8) 2 (4.3) 2 (6.7) 
     Eating 30 (40.0) 35 (50.0) 20 (32.8) 16 (34.0) 10 (33.3) 
     Fatigue 36 (48.0) 34 (48.6) 18 (29.5) 17 (36.2) 12 (40.0) 
     Feeling swollen 14 (18.7) 14 (20.0) 10 (16.4) 9 (19.2) 8 (26.7) 
     Fevers 2 (2.7) 3 (4.3) 4 (6.6) 1 (2.1) 0 (0.0) 
     Getting around 7 (9.3) 14 (20.0) 9 (14.8) 1 (2.1) 4 (13.3) 
     Indigestion 10 (13.3) 8 (11.4) 10 (16.4) 5 (10.6) 5 (16.7) 
     Mouth sores 18 (24.0) 24 (34.3) 10 (16.4) 5 (10.6)  3 (10.0) 
     Nausea 10 (13.3) 14 (20.0) 7 (11.5) 5 (10.6) 4 (13.3) 
     Nose dry/congestion 18 (24.0) 29 (41.4) 15 (24.6) 11 (23.4) 9 (30.0) 
     Pain 33 (44.0) 29 (41.4) 19 (31.2) 10 (21.3) 10 (33.3) 
     Sexual 14 (18.7) 15 (21.4) 11 (18.0) 6 (12.8) 2 (6.7) 
     Skin dry/itchy 18 (24.0) 26 (36.6) 19 (31.2) 16 (34.0) 11 (36.7) 
     Sleep 41 (54.7) 23 (32.9) 19 (31.2) 8 (17.0) 7 (23.3) 
     Tingling in hands/feet 13 (17.3) 13 (18.6) 15 (24.6) 9 (19.2) 11 (36.7) 
Note. n = number of patients at each assessment point (some did not return all questionnaires).  
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Table 2.6   
EORTC Quality of Life Mean Score Data for Individuals Diagnosed with Head 
and Neck Cancer throughout the First Year Following Diagnosis 
Variable At 
diagnosis 
3 
month 
6 
month 
9 
month 
12 
month 
0  3 
month ∆ 
0  12 
month ∆ 
n 75 70 61 47 30 --- --- 
EORTC QLQ-C30        
     Global health status 64.04 56.57 59.84 68.97 63.89 -7.47 +0.15 
Functioning scales        
     Physical functioning 80.27 73.90 72.51 83.12 81.72 -6.37 +1.45 
     Role functioning 72.52 60.33 66.80 79.79 75.81 -12.19* +3.29 
     Emotional functioning 69.41 74.30 73.57 79.61 77.15 +4.89 +7.74 
     Cognitive functioning 80.82 77.93 80.46 85.11 81.18 -2.89 +0.36 
     Social functioning 72.83 65.96 67.62 79.08 77.69 -6.87 +4.86 
Symptom scale/single items        
     Fatigue scale 33.93 41.63 39.44 28.37 32.97 -7.70 -0.96 
     Nausea/vomiting scale 7.88 17.84 7.79 4.07 11.83 -9.96 +3.95 
     Pain scale 26.58 28.05 23.77 19.86 24.73 -1.47 +1.85 
     Dyspnea 13.96 17.84 19.67 13.12 16.13 -3.88 +2.17 
     Insomnia 39.19 29.11 30.60 17.73 23.66 +10.08* -15.53* 
     Appetite loss 22.52 39.44 28.96 25.53 25.81 -16.92* -3.29 
     Constipation 14.86 17.37 16.94 9.93 13.98 -2.51 -0.88 
     Diarrhea 5.02 10.80 6.01 3.55 4.30 -5.78 -0.72 
     Financial difficulties 17.81 19.48 21.86 15.60 13.98 -1.67 -3.83 
EORTC QLQ-H&N35        
     Pain scale 27.14 29.11 21.72 17.91 15.32 -1.97 +11.82* 
     Swallowing scale 18.58 26.64 22.61 18.62 17.75 -8.06 +0.83 
     Senses scale 18.02 32.04 37.16 31.38 33.33 -14.02* -15.31* 
     Speech scale 20.87 24.33 22.13 17.02 17.92 -3.46 -2.95 
     Social eating scale 23.20 31.92 28.42 21.16 25.00 -8.72     +1.80 
     Social contact scale 14.68 18.22 16.12 14.26 15.05 -3.54 +0.37 
     Sexuality scale 26.58 33.80 37.16 24.61 33.32 -7.22 +6.74 
     Teeth problems 16.67 15.49 21.86 13.48 22.58 +1.18 +5.91 
     Opening mouth 17.12 27.70 20.77 13.48 24.73 -10.58* +7.61 
     Dry mouth 31.53 41.31 54.64 49.65 47.31 -9.78 -15.78* 
     Sticky saliva 29.28 48.36 52.19 46.81 36.56 -19.08* +7.28 
     Coughing 30.59 39.20 27.05 26.95 21.47 -8.61 -9.12 
     Feeling ill 15.77 23.00 13.11 4.96 13.98 -7.23 -1.79 
     Pain killers 56.76 43.66 42.62 36.88 48.39 +13.10* +8.37 
     Nutritional     
supplementation 
41.89 56.34 52.46 36.17 51.61 -14.45* +9.72 
     Feeding tube 5.41 14.08 11.48 12.77 12.90 -8.67 -7.49 
     Weight loss 31.08 42.25 31.15 19.15 32.26 -11.17* +1.18 
     Weight gain 14.86 22.54 29.51 21.28 25.81 -7.68 +10.95* 
Note. n = number of patients at each assessment point (some did not return all questionnaires).  
a
High score on function scales and the global quality of life scale imply high function. 
b
High score on symptom scales/single items imply high level of perceived problems. 
c
∆ = mean individual change over time (∆ ≥ 10 = clinical significance). 
d
+ = improved function or reduced level of symptoms over time. 
e
- = deteriorated function or increased level of symptoms over time.  
* = clinically significant difference. 
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baseline values. Further, a clinically significant increase in symptom burden 
between baseline and three-month assessment scores was reported for loss of 
appetite, while a clinically significant reduction in symptom burden was observed 
for insomnia at both the three- and 12-month assessments.  
With respect to the EORTC-QLQ-H&N35, data revealed the presence of 
clinically significant differences in a number of the head and neck-specific items 
detected for changes to senses (e.g., taste and smell), difficulty opening mouth 
(e.g., trismus), sticky saliva, and reductions in weight. Further, the use of 
nutritional supplementation appeared to increase in a clinically significant 
manner, while the use of pain medication appeared to decrease in a clinically 
significant manner when three-month assessments were compared with baseline 
values. Furthermore, at the 12-month follow-up assessment, clinically significant 
reductions in head and neck symptom burden were reported in assessments of 
pain and weight gain, while clinically significant increases in head and neck 
symptom burden were reported for dry mouth (e.g., xerostomia) and senses 
 (e.g., taste and smell). No other changes in symptoms or functional domains 
were found to be clinically significant when evaluated at the three- and 12-month 
assessments and compared to mean baseline values. 
 
Discussion 
This investigation explored the experience of distress in individuals with 
head and neck cancer at standardized three-month intervals throughout the first 
year following diagnosis. We further sought to describe the pattern of commonly 
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reported problems and perceptions of quality of life of these individuals while 
including considerations of those frequently excluded from psychosocial 
oncology research. With regard to the specific objectives of this study, the 
presence of distress, perceived problems, and quality of life concerns were 
explored. 
Presence of distress 
 With respect to the presence and trajectory of distress, it was anticipated 
that the level of distress detected within this sample would be highest shortly 
following treatment (e.g., at the post-diagnostic and three-month assessment 
points) and then gradually decline throughout long-term follow-up. However, 
while the mean pattern of distress appeared to almost meet the hypothesized 
trajectory (see Table 2.4); in fact, the rates of distress appeared to increase in 
severity at both the six- and 12-month follow-ups, which was contrary to the 
predicted trend of declining presence and severity. Further, data revealed that 
clinically significant distress was present in a portion of participants throughout 
the first year following diagnosis. In particular, when the mean scores from all 
participants (regardless of how many envelopes they returned) were examined, 
distress appeared to peak at the point of diagnosis and subsequently declined at 
nine-month follow-up, but was followed by a surge at the 12-month follow-up. 
Thus, the hypothesis that the presence of distress reported by participants would 
be highest at the point of diagnosis and shortly following treatment (e.g., at the 
post-diagnostic and three-month assessment points) was supported by the 
present findings. A similar pattern was detected when the mean scores of the 17 
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participants who returned all envelopes were examined. While the frequency and 
pattern of these data might suggest that in general, distress is most elevated at 
the point of diagnosis and declines gradually following treatment (Coyne, 2013), 
in fact, examination of mean and frequency/proportion-related data alone may 
only reveal a small fragment of this phenomenon.  
 To elaborate, Coyne’s (2013) suggestion that distress in individuals with 
cancer decreases following the diagnosis and treatment stages of cancer is 
widely accepted, but it has recently been shown to be an incomplete observation 
(Fielding & Lam, 2013). The problem with this generalized description of the 
phenomenon of distress in oncology centers on the manner in which distress 
data are analyzed; in particular, the use of group mean values as the primary 
(and often sole) outcome of the trajectory of distress. For instance, as noted by 
Fielding and Lam (2013),  
If in a study 50% of the sample score 10 out of 10 on a notional distress 
scale declining to 0 out of 10 over time, whereas the other 50% score 0 
out of 10 increasing to 10 out of 10 over the same period, the observed 
group mean will remain at 5 out of 10 and the conclusion would be there is 
no change in distress. (p.1). 
Based on this anecdote, the conclusion that there was no change in distress is 
inaccurate based on the individual scores; however, when data are evaluated 
based on mean scores alone, it does appear as though the distress remained 
unchanged throughout the study. In an effort to overcome the limitations of 
mean-based analyses, some researchers have begun to utilize a method of 
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statistical analysis termed growth mixture modeling8, which essentially breaks 
down longitudinal data samples into distinct patterns or trajectories (Fielding & 
Lam, 2013). When this growth mixture modeling technique was applied to 
distress data from individuals with cancer, distinct patterns of distress emerged 
that were substantially different from the commonly accepted notion that distress 
declines over time (Henselmans et al., 2010; Lam et al., 2011; Lam, Shing, 
Bonanno, Mancini, & Fielding, 2012). 
 Ultimately, four distinct patterns of distress emerged through analyses of 
multiple participant groups in varying disease sites (e.g., breast cancer, 
nasopharyngeal cancer) (Henselmans et al., 2010; Lam, Ye, & Fielding, 2012; 
Lam et al., 2009; Lam et al., 2011). The first and most commonly occurring 
pattern suggests that the majority of individuals with cancer (approximately 60 
percent) are resilient and experience persistently low levels of distress with 
minimal and transient increases in distress throughout the cancer experience 
(Fielding & Lam, 2013). The second pattern more closely resembles the classic 
pattern of high levels of perceived distress early in the trajectory of disease with a 
gradual decline in distress over time. The third is represented by those who 
report low levels of distress early in the trajectory of disease with a gradual 
increase in distress that peaks around the end of treatment before declining 
substantially afterwards. Finally, the fourth pattern, evident in approximately 5-
                                                 
8
 Growth mixture modeling “represents unobserved heterogeneity between subjects in their 
development using random effects and finite mixtures. This allows different sets of parameter 
values for mixture components corresponding to different unobserved subgroups of individuals, 
capturing latent trajectory classes with different growth curve shapes”, p.143-144). Thus, this 
modeling approach permits detection of individual nuances in the data that might remain 
unidentified using other analytic approaches. 
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20% of individuals with cancer, demonstrates consistent levels of high distress 
that persist throughout the cancer trajectory (Fielding & Lam, 2013; Henselmans 
et al., 2010; Lam et al., 2012; Lam et al., 2009; Lam et al., 2011; Lam et al., 
2012). Consequently, these chronically distressed individuals present the largest 
psychosocial need and would likely benefit most from psychosocial interventions 
when compared to those with lower grade, and/or transient distress.  
While the sample size of the present investigation was too small to permit 
the mixture growth modeling technique described above, examination of the 
individual trajectories of participants who completed all data sets provided some 
interesting insights. In particular, all four patterns described above were detected 
within the present sample. Specifically, out of the 17 participants who returned all 
data sets, 11.8% of participants noted persistently low levels of distress, 
consistent with the most commonly occurring pattern described by Fielding and 
Lam (2013). A further 35.3% of participants reported the classic pattern of high 
initial distress that decreased over time, while an additional 17.7% of participants 
reported high initial distress followed by a decline, however, for these individuals, 
distress levels increased for a second time during long-term follow-up. In 
addition, 17.7% participants demonstrated low initial distress with a gradual 
increase that peaked around the end of treatment before declining substantially 
afterwards, while a further 17.7% participants reported chronic levels of high 
distress throughout the entire study, thus representing the fourth pattern 
described by Fielding and Lam (2013). Additionally, one participant (5.9%) 
reported elevated distress at both diagnosis and the six-month follow-up. This 
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participant could likely be classified according to the pattern marked by 
persistently low levels of distress accompanied by periodic and transient 
increases in distress throughout the continuum of care (Fielding & Lam, 2013).  
While the course of distress is a deeply personal experience that may be 
influenced by a number of potential factors, ultimately, developing a deeper 
understanding of distress is important because distress patterns in the first year 
following diagnosis can predict distress levels up to six years later (Lam et al., 
2011; Lam et al., 2012). Thus, if we can determine which trajectory of distress an 
individual is experiencing within the first year, we will likely be able to better 
target psychosocial resources to the individuals who will require them and may 
receive the greatest benefit. Further, in addition to enhancing our understanding 
of both the presence and trajectory of distress in individuals with head and neck 
cancer, it is also important to identify and attend to the range of perceived 
problems that may contribute to elevated levels of distress.  
Perceived problems 
 Throughout the first year following diagnosis, both physical and emotional 
concerns represented the most commonly reported problems among 
participants. Notably, a number of physical and emotional concerns were 
consistently reported by a high proportion of participants; in particular, problems 
with fatigue, eating, and worrying were cited by at least 30 percent of participants 
at each follow-up interval, with myriad additional concerns arising in varying 
proportion throughout the trajectory of disease. These results were contrary to 
the hypothesis that physical concerns would be cited most frequently at all time 
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points. In fact, physical concerns (e.g., eating) were reported to be most frequent 
at only the three-month follow-up. While the Problem Checklist was not intended 
to be a comprehensive measure of the potential range of problems facing the 
participants, it does offer insight into some of the most commonly reported areas 
of concern. For instance, “problems with eating” was a frequently reported 
concern among participants. However, when “problems with eating” are 
considered through a qualitative context, it is apparent that the meaning 
associated with such symptoms may actually change significantly over the 
trajectory of disease. 
For example, a recent qualitative study reported that during the acute 
phase of illness (i.e., during treatment) some individuals with head and neck 
cancer were unable to eat due to the side effects of treatment (e.g., mucositis, 
pain, difficulty swallowing, etc.) and, thus, were reliant on nutritional support such 
as feeding tubes or fortified drinks (Ottosson et al., 2013). Others who were still 
able to eat reported having to adjust their food intake to soft or liquid foods that 
were quite neutral in flavour (i.e. no dry or spicy foods). These changes were 
perceived as stressful by participants as they struggled to consume an adequate 
amount of calories to continue treatment (Ottosson et al., 2013). As time 
progressed, attitudes concerning eating shifted from a requirement for survival to 
the attempt to accept that eating may never again be a pleasurable activity for 
some (Ottosson et al., 2013). Thus, while “problems with eating” were noted 
during treatment and in long-term follow-up in the present study, the meaning 
associated with these problems to the individual may be varied and significant.  
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An additional treatment-related problem that may also create substantial 
physical, psychological and social losses for individuals with head and neck 
cancer is fatigue. Research indicates that fatigue is common in individuals with 
cancer, but unfortunately it can be difficult to treat (Cruciani, 2006). It is important 
to understand the impact of fatigue on individuals with head and neck cancer in 
order to ascertain why such a high proportion of participants in the present study 
reported fatigue as being problematic. Similar to our findings, a qualitative study 
conducted by Molassiotis and Rogers (2012) noted that for individuals with head 
and neck cancer, fatigue persisted throughout the first year following diagnosis 
and actually worsened at the one-year follow-up. The worsened fatigue noted 
during the long-term follow-up by Molassiotis and Rogers (2012) may have been 
attributable to the recent return to work by some of their participants who noted 
that their fatigue made the return to work experience very stressful. In general, 
fatigue appeared to cause considerable frustration for participants who reported 
that they were unable to do the things they used to do, which resulted in 
restrictions to their activity level, ability to complete household tasks and errands, 
and overall social participation (Molassiotis & Rogers, 2012). While the burden of 
fatigue is substantial on its own, the problem with fatigue is that it often serves to 
exacerbate other problems (e.g., swallowing problems, pain, altered taste, dry 
mouth) (Ottosson et al., 2013). Furthermore, fatigue has recently been related to 
depression and negative perceptions of quality of life (Sawada et al., 2012), 
suggesting that the consequences of fatigue extend beyond the physical realm 
into psychological and social domains. 
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 In addition to physical concerns, participants in the present study reported 
a number of ongoing emotional problems. In particular, worrying was reported by 
a high proportion of participants at all assessment points. While research specific 
to the term “worry” in head and neck cancer is sparse, researchers have 
previously classified this concern in individuals with cancer into two domains, 
namely cancer-specific worries (e.g., future diagnostic tests, cancer recurrence, 
diagnosis of another type of cancer) and health-related worries (e.g., health, 
dying) (Gotay & Pagano, 2007). While these domains are certainly not 
exhaustive, they do highlight the fact that thoughts of one’s own mortality are 
deeply connected to the source of worry in individuals with cancer. Additionally, 
for those living with cancer who have significant others, aging parents, and/or 
young children, worries related to the long-term security and well-being of these 
individuals may also be pervasive (Davis-Ali, Chesler, & Chesney, 1993). Also, 
worries related to one’s cancer experience may shift as time progresses and 
even after the successful completion of treatment, worries about the potential 
recurrence of disease may persist (Savard & Ivers, 2013). While the present 
study did not investigate specific sources of participants’ worry, the high 
proportion of participants who reported it to be problematic throughout the 
trajectory of disease, suggests it to be a pervasive problem. 
Relative to commonly reported problems, the present study observed that 
in general participants noted problems with eating, fatigue, and worry most often. 
Recent evidence increasingly suggests that unresolved symptoms (including 
problems with eating and fatigue), can significantly predict trajectories of distress 
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in individuals with cancer (Lam et al., 2012). Thus, while the course of distress is 
a deeply personal experience that may be influenced or exacerbated by a 
number of potential factors, it is important to acknowledge that physical and 
psychological symptoms are not mutually exclusive. Furthermore, data derived 
from the Problem Checklist in the present study have provided empirical 
confirmation of the qualitative accounts articulated by both Ottosson and 
colleagues (2013) with regard to problems with eating and Molassiotis and 
Rogers (2012) in relation to problems with fatigue. While emotional and physical 
problems represented the highest proportion of reported concerns among 
participants in the present study, the prevalence of these reports should in no 
way diminish the impact of less frequently reported problems such as 
“work/school”, “insurance/financial” or “dealing with partner”, since issues such 
as these have the potential to be immensely distressing. In essence, the 
subjective experience of an item such as, “problems dealing with partner” cannot 
be inferred through mere acknowledgment on a brief questionnaire. As such, 
considerations of an individual’s subjective perception of quality of life remain 
important in order to better understand the experience of distress in individuals 
with head and neck cancer. 
Global and head and neck cancer-specific quality of life 
 The concept of quality of life has been defined by the World Health 
Organization (WHO) as: 
an individual’s perception of their position in life, in the context of their 
culture and values system where they live, and in relation to their goals, 
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expectations, standards and concerns. It is a broad ranging concept, 
incorporating in a complex way a person’s physical health, psychological 
state, level of independence, social relationships, personal beliefs and 
relationship to salient features of the environment. (WHO, 1998, p.17). 
An essential component to the concept of quality of life is the notion that these 
domains are interrelated and must be considered collectively; they must also be 
evaluated relative to the meaning and value that the individual places on each 
component. Consequently, in order for assessments of quality of life to have 
clinical or research utility, they must be capable of accounting for the factors 
most relevant to one’s current life situation – in this case, his or her experience 
with head and neck cancer and its accompanying consequences.  
Owing to the myriad potential concerns of an individual with head and 
neck cancer, a key objective of the present study explored the perceived quality 
of life globally, and relative to a number of specific areas known to be 
problematic for those with head and neck cancer. As such, numerous specific 
concerns (e.g., role functioning, symptom burden) were found to change in a 
clinically significant manner over the course of the study; consequently, these 
areas are explored below. 
Role functioning. Within the context of the EORTC-QLQ-C30, role 
functioning was assessed according to an individual’s ability to meet work-related 
obligations, engage in daily activities, and pursue hobbies and/or other leisure 
time activities (Aaronson et al., 1993). Data from the present study were 
consistent with predictions and indicated a clinically significant decline in one’s 
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ability to fulfill meaningful roles at the three-month assessment when compared 
to evaluations at diagnosis. These findings are in line with previous longitudinal 
work (Bjordal et al., 2001; Hammerlid et al., 1997). Similar to the findings of 
Bjordal and colleagues (2001) and Hammerlid et al. (1997), the clinically 
significant decline in role functioning observed at the three-month assessment 
appeared to resolve by the one-year follow-up. Previous research into the factors 
that contribute to role functioning in individuals with cancer has determined that 
one’s level of symptom burden (e.g., fatigue, appetite loss, insomnia, etc.) is 
closely aligned with one’s ability to fulfill role-based activities and obligations 
(Aaronson et al., 1993; Bjordal et al., 2001). As predicted, in the present study 
participants’ symptom-related burden peaked at the three-month assessment 
and leveled off around 12-months for most items, however, certain exceptions to 
this pattern were evident. Specifically, items such as insomnia, senses, sexuality, 
problems with teeth, dry mouth, pain killers, and weight gain demonstrated 
alternative patterns in symptom burden. As such, exploration into the clinically 
significant differences in symptom burden detected at the three-month 
assessment (e.g., insomnia, pain, appetite loss, etc.) may provide some context 
regarding the temporary depletion of role functioning among individuals with 
head and neck cancer.  
Insomnia. Insomnia has been characterized as difficulty associated with 
sleeping that may involve challenges with initiating sleep and/or trouble 
maintaining effective sleep (Savard & Morin, 2001). Sleep disturbances, including 
insomnia, have been shown to decrease mental health, quality of life, and work 
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productivity, to increase utilization of healthcare resources, and also to predict 
future complications in individuals with cancer (Katz & McHorney, 2002; 
Manocchia, Keller, & Ware, 2001; Roscoe et al., 2007). Previous research has 
indicated that sleep disorders such as insomnia are common in individuals with 
head and neck cancer (Duffy et al., 2008; Shuman et al., 2010). The present 
study detected a similar problem with sleep-related concerns as evidenced by 
the high proportion of participants reporting problematic sleep and/or fatigue at 
multiple assessment points on the Problem Checklist. Relative to the specific 
influence of these perceived problems on one’s quality of life, evidence from the 
present study indicated a clinically significant decline in reported insomnia at both 
the three- and 12-month assessments when compared with assessments at 
diagnosis. These findings were contrary to our prediction that symptom-related 
burden would peak in severity at the three-month post-diagnostic point. However, 
our findings were in line with the work of both Savard and colleagues (Savard, 
Ivers, Villa, Caplette-Gingras, & Morin, 2011) and Shuman et al. (Shuman et al., 
2010) who both observed elevated rates of insomnia prior to treatment with 
gradual declines as time progressed. Additionally, Shuman et al. (2010) 
postulated that the elevated rates of pre-treatment insomnia could possibly be 
attributed to anxiety related to the recent diagnosis in conjunction with symptoms 
stemming from the malignancy, such as pain. 
Pain. Within the present sample, a clinically significant reduction in 
perceived pain was observed at 12-month assessments when compared with 
values obtained at diagnosis. Despite the rich body of literature noting the 
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presence of long-term pain in individuals with head and neck cancer (Breivik et 
al., 2009; Chua et al., 1999; Funk et al., 2012; Shuman, 2012; Whale et al., 
2001), the present data are in line with the recent work of Shuman and 
colleagues (2012) who noted an improvement in pain in individuals with head 
and neck cancer one-year following diagnosis when compared to pre-treatment 
levels.  
Interestingly, a clinically significant reduction in the use of painkillers was 
observed at the three-month follow-up in the present study, suggesting that pre-
treatment pain (as inferred through the elevated use of pain alleviation 
medication prior to treatment) was actually worse than pain levels during and/or 
shortly following treatment. While surprising, this finding of elevated pre-
treatment pain suggests that the physical burden associated with an untreated 
tumour in the head and neck region can be substantial (Shuman, 2012). 
Consequently, assessments of quality of life in head and neck cancer would be 
remiss if they failed to acknowledge the impact of pain on an individual’s 
perceived well-being and overall functioning. Not only can elevated pain 
negatively influence one’s perceived quality of life (Funk et al., 2012), but it has 
also been shown to reduce functional capacity (Vallerand, Templin, Hasenau, & 
Riley-Doucet, 2007), and to predict disability (Taylor et al., 2004), depression 
(Shuman, 2012) and insomnia (Shuman, 2012), and further, to compromise 
nutritional intake and weight maintenance (Paillaud et al., 2003) in individuals 
with head and neck cancer. As a result, addressing pain may help to reduce or 
alleviate numerous multidimensional concerns. 
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Weight-related changes. In the present study, participants reported 
clinically significant weight loss, reductions in appetite, and increased use of 
nutritional supplementation three months following diagnosis. Fortunately, by the 
12-month assessment, participants reported a clinically significant increase in 
weight when compared to assessments at diagnosis. The weight loss observed 
in the present study (at the three-month post-diagnostic mark) is significant 
because the involuntary loss of even five percent of one’s body weight over a six 
month period has been related to increased treatment toxicities, treatment 
delays, complications, extended hospital stays, and decreased survival (Dewys 
et al., 1980; Kubrak et al., 2009). Further, individuals with cancer who are 
nutritionally compromised are at an increased susceptibility to infections and 
generally demonstrate poorer responses to treatment (Nitenberg & Raynard, 
2000), which likely contributes to the decreased rates of survival among these 
individuals. 
 Furthermore, the type of treatment employed may also influence nutrition 
and one’s ability to maintain their weight. Specifically, chemotherapy and 
radiation therapies have been shown to cause acute mucositis, loss of taste 
sensation, compromised salivary gland function, dysphagia, odynaphagia, 
nausea, vomiting, loss of appetite, etc. – all of which may negatively influence 
nutritional and subsequent functional status (Garg, Yoo, & Winquist, 2010; 
Paccagnella et al., 2009; Payakachat, Ounpraseuth, & Suen, 2012). Moreover, 
severe malnutrition can cause unintentional treatment breaks and 
hospitalizations, which may consequently reduce treatment efficacy (Barret et al., 
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2012; Cox et al., 1992). These nutrition-related complications have been 
associated with significant costs to both the individuals and the healthcare 
system (Garg et al., 2010; Paccagnella et al., 2009). Thus, attending to the 
quality of life concerns of individuals with head and neck cancer may serve to not 
only improve individual well-being, but may also provide economic benefits to the 
healthcare system at large. Thus, it is imperative to be aware of these problems 
so that the consequences of head and neck cancer may be alleviated whenever 
possible in order to optimize quality of life. 
Possible confounding factors 
 Since the source of distress is certainly not limited to the consequences of 
cancer and its treatment-related sequelae, participants were invited to disclose 
any information that they felt may have influenced their perceived level of 
distress or quality or life at the time of the survey. Regarding specific disclosures, 
one participant reported being worried about his spouse’s health in addition to his 
own health-related concerns. Another participant disclosed that he was 
experiencing residual problems related to a car accident several years prior. 
Understandably, these experiences may have influenced how these individuals 
were able to cope with their disease and its treatment. Relative to the distress of 
these participants, the individual who had been in a car accident reported 
clinically significant distress at the three-month assessment. However, the 
participant who was concerned about his spouse’s health did not report clinically 
significant distress at any of the assessment intervals. While the frequency of 
these potentially confounding factors is too low to draw any firm conclusions, 
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future research into the influence of co-existing stressful life events may provide 
interesting insights into how individuals cope with the experience of cancer while 
managing significant co-existing life challenges.  
Limitations of Current Study 
First, the sample size and rate of attrition serve as noteworthy limitations 
to the present study. While substantial declines in participant responses occurred 
throughout the 12-month data collection period, the rates of attrition were 
particularly elevated at the nine- (67.1% attrition) and 12-month (78.7%) follow-
up assessments. While attrition in the present study was higher than rates 
reported in previous longitudinal studies in head and neck oncology – 78.5% 
reported by Mehanna and Morton (2006) and 66% reported by Kelly et al. (2007) 
– the differences are not substantial. Furthermore, despite the high proportion of 
participants who did not complete all of the follow-up assessments, we did gather 
a total of 17 completed participant data sets; based on sample size calculations, 
only 14 completed participant data sets were required for the study to be 
sufficiently powered (Lee, 2004). In an effort to ensure that those participants 
who completed all data sets did not differ substantially from participants who did 
not complete all data sets, t-test analyses were performed in order to compare 
the mean Distress Thermometer scores of respondents at both baseline and 12-
months post-diagnosis. Since no statistically significant differences were 
detected at either point in time, we believe that the rate of attrition detected in this 
sample did not bias the results relative to the levels of perceived distress 
observed.  
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Second, this study design did not permit assessment of pre-diagnostic 
distress given that participants were recruited following their diagnosis. Previous 
research conducted in women with breast cancer has shown that the period of 
time prior to diagnosis (i.e. following detection and symptoms and throughout 
diagnostic workup) may be slightly more distressing than other points along the 
continuum of care, including during treatment and in long-term follow-up (Nosarti, 
Roberts, Crayford, McKenzie, & David, 2002; Vahdaninia, Omidvari, & Montazeri, 
2009). Given this potential for elevated distress prior to receiving a confirmed 
diagnosis, it is possible that the trajectories of distress detected in the present 
sample would be altered if pre-diagnostic distress-related data were included. 
Consequently, future work examining the influence of pre-diagnostic distress on 
the trajectory of distress in individuals with head and neck cancer is 
recommended. 
Furthermore, the length of current follow-up time was restricted to 12 
months. While the literature pertaining to distress-related concerns in long-term 
survivors of head and neck cancer is well established (Mehanna & Morton, 2006; 
Semple, 2001; Ward & van As-Brooks, 2007), the decision to limit the length of 
study inquiry to 12 months was based on two primary factors. The first was due 
to the feasibility of the study given that the data collection procedure was 
conducted primarily by a single investigator (C.B.). The second factor supporting 
a 12-month follow-up assessment period was the collective findings of Lam et al. 
(2011) and Lam et al. (2012) who have shown that the trajectory of distress in the 
first year following diagnosis significantly predicts one’s level of distress up to six 
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years following diagnosis. Thus, the decision to limit the length of inquiry to 12 
months following diagnosis was deemed appropriate given the predictive 
relationship between the trajectories of distress reported in the first year post-
diagnosis with long-term levels of distress in individuals with cancer.  
Conclusion 
 This study investigated distress, quality of life, and commonly reported 
problems in 102 individuals diagnosed with head and neck cancer. Data indicate 
that: (1) distress was most prevalent at the point of diagnosis and (2) that the 
length of time following diagnosis had a large effect on the level of perceived 
distress. Additionally, clinically significant declines in role functioning and 
increases in symptom burden (e.g., pain, insomnia, senses, trismus, xerostomia, 
sticky saliva, appetite loss, and weight loss) were observed early on following 
treatment, but with exception of xerostomia and reduced senses, appeared to 
resolve by the one-year follow-up. In addition, participants most frequently 
reported physical and emotional concerns as being problematic throughout the 
trajectory of disease.  
While most individuals with cancer are resilient and tend to experience 
persistently low levels of distress (Fielding & Lam, 2013), this is not the case for 
all individuals. Recent evidence increasingly suggests that the presence of 
unresolved symptoms (e.g., pain, fatigue, etc.) is a major predictive factor in the 
trajectory of cancer-related distress (Lam et al., 2012). The results of the present 
investigation would seem to provide support for this notion. Further, the 
connection between unresolved symptoms and persistent distress suggests that 
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improving symptom management in individuals with cancer may provide a cost-
effective means of reducing some cancer-related distress (Fielding & Lam, 
2013). Although Fielding and Lam (2013) have suggested that most individuals 
find a way to cope with the experience and challenges of cancer, the challenge 
for healthcare practitioners lies in seeking to identify and assist those who 
cannot. The present findings support the systematic monitoring of distress and 
the factors which may compromise quality of life, and through this process, 
healthcare providers may efficiently identify those individuals who are 
experiencing elevated distress and/or disease-related burden in hopes of 
optimizing short- and long-term outcomes. 
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Chapter 3 
A Cross-Sectional Analysis of Distress in Caregivers of Individuals Diagnosed 
with Head and Neck Cancer 
 
Background 
 The diagnosis of head and neck cancer brings with it profound changes 
for not only the individual with cancer, but also for the loved ones who often play 
a critical role in their care. Owing to the broad range of potential impairments and 
psychosocial needs of individuals with head and neck cancer (Bornbaum et al., 
2012; Doyle, 1994; Payakachat, Ounpraseuth, & Suen, 2012), caregivers often 
fulfill an indispensable role in an individual’s support team throughout the 
treatment and post-treatment period (Kagan, Clarke, & Happ, 2005). Caregivers 
provide a wide range of support to their loved ones which often includes 
emotional support (e.g., talking about worries, fears, etc.), instrumental support 
(e.g., liaising with medical team, communicating with distant family members), 
tangible support (e.g., assistance with transportation, finances, household tasks), 
and medical support (e.g., accompaniment to treatments, help with administering 
medications) (Yabroff & Kim, 2009).  
 A recent review into the role of caregiving in head and neck cancer 
evaluated both the presence of distress and the factors known to influence such 
caregiving (Longacre, Ridge, Burtness, Galloway, & Fang, 2012). Longacre and 
colleagues observed that throughout the studies included in their review, 
between 20-40% of caregivers reported experiencing clinically significant levels 
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of distress. Further, caregivers of individuals with head and neck cancer were 
more likely to experience poorer rates of psychological wellbeing when compared 
to both population norms (e.g., the general public, assumed healthy individuals) 
(Ostroff, Ross, Steinglass, Ronis-Tobin, & Singh, 2004; Vickery, Latchford, 
Hewison, Bellew, & Feber, 2003) and those with head and neck cancer (Hodges 
& Humphris, 2009; Vickery et al., 2003). Longacre and colleagues (2012) noted 
that, in general, caregivers of those with head and neck cancer were primarily 
female spouses in their mid- to late-fifties, a finding that is understandable given 
that men are most often afflicted with the disease and that the median age of 
diagnosis was recently reported as between 50-59 years of age (Cooper et al., 
2009). While acknowledgement of the most common characteristics of those 
providing care for individuals with head and neck cancer remains important, it 
may fail to adequately convey the gravity of precisely what the role of providing 
care to a person with head and neck cancer actually entails and the impact that 
caregiving has on those who serve in that capacity. 
The diagnosis of head and neck cancer forces both the individual with 
cancer and their caregiver to confront not only a life threatening disease, but also 
a series of potential and actual losses related to the disease and its treatment. 
Owing to the anatomic characteristics of the head and neck region, treatment of 
head and neck cancer may result in deficits to the individual’s physical 
appearance that cannot easily be hidden, in addition to varying degrees of 
dysfunction in respiration, eating, swallowing, and communication (Chen et al., 
2009; Katz, Irish, Devins, Rodin, & Gullane, 2003; Koster & Bergsma, 1990). 
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Following treatment for head and neck cancer, additional undesirable side effects 
such as facial weakness, drooling, trismus (i.e., difficulty opening the jaw), 
physical scarring, and poor speech intelligibility may persist (Doyle, 2005; 
Jeremic et al., 2011; Katz et al., 2003). The presence of these side effects may 
cause embarrassment and significantly impact not only the individual’s 
internalized feelings of self-esteem and self-concept, but also their willingness to 
interact socially (Doyle, 2005; Semple, Sullivan, Dunwoody, & Kernohan, 2004). 
Formerly simple pleasures such as dining out at a restaurant may become a 
source of tremendous stress and embarrassment for those with head and neck 
cancer. As a result, individuals may choose to not participate in these types of 
social situations which may then coincidently restrict the social activities of the 
caregiver if the caregiver is a spouse or family member of the individual with 
cancer (Roing, Hirsch, & Holstrom, 2008).  
Although the individual with cancer sits at the core of diagnosis and 
treatment, the needs of caregivers are often forgotten or overlooked throughout 
the cancer care process (Eton, Lepore, & Helgeson, 2005; Northouse, 2002; 
Zwahlen, Hagenbuch, Jenewein, Carley, & Buchi, 2011). Though such exclusion 
is not intentional, failure to acknowledge the caregiver in the context of the 
person with cancer is problematic because the role of caregiving is immensely 
challenging. The role of caregiving is complex, yet highly unique to every 
individual; this is not only due to the numerous medical terms and procedures 
that a caregiver may have to understand or be able to perform (e.g., wound 
cleaning, dressing changes, etc.), but also because caregivers must learn to 
  
131 
reconcile their own sense of helplessness during a time when strength and 
support are required (Blood, Simpson, Dineen, Kauffman, & Raimondi, 1994). 
Undoubtedly, the challenges of cancer and its treatment have an enormous 
impact on the psychosocial functioning of both individuals with head and neck 
cancer and their caregivers. As a result, it is important to evaluate the 
psychosocial functioning of these caregivers in order to identify factors that may 
influence distress so that the appropriate resources and interventions can be 
offered when required.  
 At present, a key barrier to the recognition of distress in caregivers lies in 
the fact that throughout the continuum of care, the individual with cancer, as 
opposed to their caregiver, is the focus of the cancer care team. As a result, the 
individual with cancer has a higher probability of receiving a referral for 
supportive care services (Zwahlen et al., 2011) such as psychological 
counseling, support groups, and assistance with practical concerns through 
social work departments. Caregivers of individuals with cancer have reported 
receiving low levels of support from others, including specialists (Northouse, 
2002) and from the individual with cancer themselves (Eton, Lepore, & Helgeson, 
2005). Understandably, caregiver concerns often remain relegated to the 
background, while attention is focused on the individual with cancer (Zwahlen et 
al., 2011). Caregivers have reported finding it challenging, and have even 
reported feeling guilty, when seeking support for themselves (Eriksson & Lauri, 
2000). However, when caregivers do not directly seek out assistance for their 
distress and/or broader concerns, these problems often go unnoticed by those 
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most able to provide direct assistance (e.g., medical professionals and support 
staff) (Zwahlen et al., 2011). As a result, it is important to understand the factors 
that may contribute to elevated distress in caregivers of individuals with head and 
neck cancer so that those most at risk of experiencing elevated distress may be 
identified in order to ensure that the appropriate resources and interventions can 
be recommended when required. The ability to understand the impact of cancer 
on both “patient” and caregiver, cannot be discounted and efforts to understand 
the phenomena associated with distress is clearly warranted. 
Distress in caregivers of individuals with head and neck cancer  
 In an effort to understand and describe the variables related to distress in 
caregivers of individuals with cancer, Sherwood and colleagues (2008) 
developed a conceptual framework to address these types of concerns. In their 
framework they posited that a caregiver’s psychological health (e.g., distress, 
depressive symptoms, anxious symptoms, etc.) is influenced by two primary 
factors; these factors include both the disease characteristics of the individual 
with cancer (e.g., time since diagnosis, disease stage, patient functioning and 
needs) and the caregiver’s personal characteristics and resources (e.g., 
sociodemographic factors, social support, coping style) (Sherwood et al., 2008).  
Relative to the known disease-related characteristics associated with 
psychological health in caregivers of those with head and neck cancer, data 
indicate that the time frame following diagnosis and during treatment (e.g., 2-6 
months post-diagnosis) is particularly stressful for caregivers (Blood et al., 1994). 
Following this time period, the level of burden experienced by caregivers was 
  
133 
perceived to decrease in association with increasing time following diagnosis 
(Blood et al., 1994). Further, while not extensively assessed to date, some 
researchers have noted that caregivers report a high degree of fear related to the 
possibility that the cancer will recur (Watt-Watson & Graydon, 1995); these fears 
in caregivers are sometimes even stronger than those of the patients themselves 
(Hodges & Humphris, 2009). Thus, the very real emotional fears that may be 
experienced by caregivers can have a substantial impact on their psychological 
health and overall well-being. 
With regard to the relationship between caregiver psychological health 
and personal characteristics and/or resources, several variables have been 
examined to date. Specifically, research into one’s level of education has 
revealed somewhat mixed results. Some authors have found no relationship 
between education and psychological health (Ross, Mosher, Ronis-Tobin, 
Hermele, & Ostroff, 2010), whereas others have reported that caregivers with 
higher education levels placed increased value on the use of psychological 
support (for both themselves and the patient) and subsequently, actively sought 
more contact with psychological resources (e.g., self-help groups) (Baghi et al., 
2007). Research into the effect of sex on perceived distress again has been 
mixed, with some investigators noting an increased desire for psychological 
support among women (Baghi et al., 2007), while others have reported no 
significant associations between sex and psychological health (Ross et al., 2010; 
Verdonck-de Leeuw et al., 2007). To date, no significant associations have been 
detected between age and psychological health in caregivers of individuals with 
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head and neck cancer (Ross et al., 2010; Verdonck-de Leeuw et al., 2007). 
Nevertheless, research into the factors that underlie and contribute to distress 
and decreased quality of life are important because perceptions of burden and 
lowered quality of life in caregivers have been established as early predictors of 
prolonged hospital stays in individuals with dementia (Lang et al., 2010). It is 
possible that a similar effect may be present when considering caregivers of 
individuals with head and neck cancer. Investigating the factors that predict 
distress may facilitate the early identification of vulnerable individuals, which may 
allow for the delivery of targeted services and interventions that prevent severe 
and/or persistent symptoms of distress and ultimately facilitate long-term 
adjustment (Neilson et al., 2012) of caregivers. Hence, developing a greater 
understanding of the factors that contribute to caregiver distress and quality of 
life may have important implications not only for improvement of caregiver 
outcomes, but also for the individual with head and neck cancer. In order to 
determine which specific factors may contribute to caregiver distress and 
perceptions of quality of life, an examination of areas that are currently 
overlooked in the caregiver distress literature may serve to highlight avenues of 
research that warrant investigation. 
Limitations of the current literature  
Previous research into distress in caregivers of individuals with head and 
neck cancer has been limited in a number of important ways. First, currently 
available resources related to the caregiving experience of individuals with head 
and neck cancer have included participants who cared for individuals who were 
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generally between two and 48 months post-diagnosis (Baghi et al., 2007; Hodges 
& Humphris, 2009; Ross et al., 2010; Verdonck-de Leeuw et al., 2007). These 
studies included a range of lengths in time since diagnosis which included, three 
to six months post-diagnosis (Hodges & Humphris, 2009), six to 24 months post-
diagnosis (Baghi et al., 2007; Ross et al., 2010; Verdonck-de Leeuw et al., 2007), 
and two to 48 months post-diagnosis (Blood et al., 1994). There has also been a 
subset of research focused on issues arising in early survivorship; more 
specifically, studies have included caregivers of individuals who were between 
one and five years post-diagnosis (Drabe et al., 2008; Mellon, Northouse, & 
Weiss, 2006). However, since distress-related concerns have been reported in 
individuals with head and neck cancer in both the newly diagnosed (Haisfield-
Wolfe, McGuire, & Krumm, 2012) as well as long-term survivorship phases 
(Bjordal & Kaasa, 1995), and since previous research has demonstrated a 
relationship between distress levels of those with cancer and their caregivers 
(Zwahlen et al., 2011), it would appear reasonable to assume that distress-
related concerns may arise in primary caregivers during both the newly 
diagnosed and long-term survivorship phases. As such, the present investigation 
sought to broaden the spectrum of exploration into caregiver concerns relative to 
the length of time since diagnosis.  
In addition to research related to the specific length of time since provision 
of a diagnosis, to the author’s knowledge, research exploring the relationship 
between caregiver distress and the treatment status of the individual with head 
and neck cancer (e.g., awaiting treatment, undergoing treatment, completed 
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treatment) has not previously been explored. While data do exist related to 
concerns that may arise in the context of survivorship (e.g., post-treatment) for 
caregivers of individuals who have been treated for head and neck cancer 
(Drabe et al., 2008; Mellon et al., 2006), there is a paucity of comparative data 
related specifically to the relationship between stage of treatment and caregiver 
distress. This paucity of data is particularly problematic because research into 
those with head and neck cancer has revealed that the presence of distress is 
related to one’s treatment status (Neilson et al., 2012; Zabora et al., 1997), and 
further, the transmission of distress from the person receiving treatment to their 
caregiver may be particularly strong in “caregiver-care recipient” systems 
(Hodges, Humphris, & Macfarlane, 2005; Mellon, Kershaw, Northouse, & 
Freeman-Gibb, 2007). Thus, research which explores the direct effect of 
treatment status on caregiver distress may be beneficial since information related 
to highly distressing periods throughout the continuum of care may help clinicians 
to better target their psychosocial resources to the most distressing events 
known to exist along the continuum of care in caregivers. 
Furthermore, all distress-related research efforts to date in this population 
have involved the use of multi-item distress measures (Longacre et al., 2012). 
This includes the use of measures such as the Hospital Anxiety and Depression 
Scale (Zigmond & Snaith, 1983), the Mental Health Inventory (Veit & Ware, 
1983), and the Global Assessment of Recent Stress (Linn, 1985), among others 
(Longacre et al., 2012). The utility of an “ultrashort” (Vodermaier, Linden, & Siu, 
2009) measure such as the Distress Thermometer has been established in 
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caregiver oncology populations (Zwahlen, Hagenbuch, Carley, Recklitis, & Buchi, 
2008; Zwahlen et al., 2011), and ultrashort measures have been found 
particularly useful and effective for distress screening purposes in busy, clinical 
environments (Vodermaier et al., 2009). Yet despite these findings, to date, the 
Distress Thermometer has only been utilized to assess distress in caregivers of 
individuals with brain cancer (Keir, Calhoun-Eagan, Swartz, Saleh, & Friedman, 
2008). Consequently, use of an ultrashort measure, such as the Distress 
Thermometer, to assess distress in caregivers of individuals with head and neck 
cancer may enhance the opportunity to promote the regular screening of distress 
in this population, given the tool’s reliability and ease of clinical use (Vodermaier 
et al., 2009). In consideration of these noted limitations to the current literature, a 
number of specific objectives were developed related to this research 
investigation and are discussed below. 
Study-specific research objectives 
The overarching purpose of the present investigation was to determine 
what factors were associated with elevated distress among caregivers of 
individuals with head and neck cancer. We further aimed to explore how distress 
may be related to certain outcomes in those caregivers. Specifically, we sought 
to understand how both the caregiver’s personal demographic factors and the 
disease- and treatment-related characteristics (e.g., treatment status) of the 
individual with head and neck cancer may contribute to elevated distress and 
decreased quality of life in caregivers of individuals with head and neck cancer. 
Distress in caregivers was assessed through use of an ultrashort distress 
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screening tool, the Distress Thermometer (National Comprehensive Cancer 
Network [NCCN], 2013). Further, because current resources are limited to the 
experiences of head and neck cancer caregivers between two months and five 
years following the point of diagnosis, we sought to enhance the literature to 
include considerations of caregivers in both the newly diagnosed and long-term 
follow-up (e.g., survivorship) phases of the continuum of care. Accordingly, a 
number of specific objectives for this inquiry were developed: (1) to determine the 
presence of distress in caregivers of individuals diagnosed with head and neck 
cancer; (2) to describe the range of perceived problems (e.g., practical, familial, 
emotional, spiritual, physical) reported among caregiver participants; (3) to 
assess the relationship between distress and quality of life in caregivers of 
individuals with head and neck cancer; (4) to evaluate if a relationship existed 
between perceived distress level and specific demographic characteristics of 
caregivers; and (5) to determine if a relationship existed between caregiver 
distress and the disease- and/or treatment-related characteristics of the 
individual with head and neck cancer. 
 
Method 
Participants 
Participants (n = 119) involved in this research protocol were recruited in-
person through one of two possible venues. The first was through their physician 
in the London Regional Cancer Program (LRCP) at the London Health Sciences 
Centre, Victoria Campus, located in London, Ontario. The second possible venue 
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was the annual meeting of the International Association of Laryngectomees. The 
decision to recruit at two venues was based on the effort to increase the 
maximum possible number of participants in the sample and also to enhance the 
generalizability of the data to a group beyond Southwestern Ontario. This sample 
may be considered as a sample of convenience based on the willingness of 
individuals to participate following a request by their physician or a member of 
the research team (e.g., C.B., P.D.). Prior to undertaking this study, the Ethics 
Review Board at The University of Western Ontario approved this protocol; 
Approval # 18019E (see Appendix B). 
Inclusion criteria. In order to be included in this study, participants were 
required to be at least 18 years of age and able to provide informed consent (i.e., 
no known cognitive impairments). They were also required to identify themselves 
as the primary caregiver of an individual diagnosed with head and neck cancer.  
Exclusion criteria. If individuals were unable to read, write or understand 
English or if they were unable to visually see the questionnaires they were 
excluded since the tasks involved in this study required participants to read and 
understand the questionnaires in English, and respond to questions accordingly. 
In total, 200 individuals were identified as potential participants and 
subsequently received packages containing the letter of information and consent, 
the demographic questionnaire, and the research instruments. The age of 
participants in this study ranged from a minimum of 28 years to a maximum of 83 
years. The mean age for all participants was 61.60 years (SD = 11.19). In total, 
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the 90 female (mean age = 59.03 years) and 29 male participants (mean age = 
61.56 years) resulted in a female-to-male ratio of approximately 3:1.  
In addition, the length of time since the individual with head and neck 
cancer had received his or her diagnosis ranged from 0 to 274 months (mean = 
26.59; SD = 49.92). When divided into intervals of time since diagnosis, data 
revealed a large number of participants in the newly diagnosed phase including 
those less than one month from diagnosis (n = 14) and those who were between 
one and three months post-diagnosis (n = 31). Other lengths of time following 
diagnosis reported by caregivers included: four to six months (n = 10), seven to 
nine months (n = 8), 10 to 12 months (n = 9), 13 to 18 months (n = 9), 19 to 24 
months (n = 3), 25-60 months (n = 15), 61 to 120 months (n = 7), 121-240 
months (n = 8), and greater than 240 months (n = 1). Comprehensive 
demographic data for these participants are presented in Table 3.1, while the 
disease- and treatment-related data for the individuals for whom they were 
providing care are presented in Table 3.2. 
Procedure 
Data collection. All individuals who consented to participate received a 
package containing a letter of information and consent form (see Appendix D), a 
demographic questionnaire (see Appendix F), the Distress Thermometer and 
accompanying Problem Checklist (NCCN, 2013) (see Appendix I), the Caregiver 
Quality of Life-Cancer Scale (CQOLC) (Weitzner, Jacobsen, Wagner, Friedland, 
& Cox, 1999) (see Appendix J), a list with the contact information for local 
psychological support services (see Appendix K), and a self-addressed and  
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Table 3.1   
Demographic Data of Caregiver Participants 
Variable n  % 
Sex   
     Female 90 75.6 
     Male 29 24.4 
Relationship to patient   
     Spouse 98 82.4 
     Family member 19 16.0 
     Friend 2 1.7 
Marital status   
     Married/common-law 107 89.9 
     Separated/divorced/widowed/single 11 9.2 
     Unspecified 1 0.8 
Education   
     Completed college/university 61 51.3 
     Completed high school 46 38.7 
     Completed less than high school 12 10.1 
Occupational status   
     Retired 60 50.4 
     Working full-time 33 27.8 
     Working part-time 15 12.6 
     Unemployed/stay at home 6 5.0 
     Receive disability benefits 5 4.2 
Household income   
     ≤ $25,000 8 6.7 
     $25,001 - $40,000 15 12.6 
     $40,001 - $55,000 17 14.3 
     $55,001 - $70,000 12 10.1 
     $70,001 - $85,000 5 4.2 
     > $85,000 27 22.7 
     Unspecified 35 29.4 
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Table 3.2   
Disease- and Treatment-Related Data for Individuals with Head and Neck 
Cancer Cared for by Caregiver Participants 
Variable n  %* 
Site of cancer   
     Oral cavity  39 32.8 
     Larynx 24 20.2 
     Pharynx  18 15.1 
     Multiple sites 11 9.2 
     Sinuses/paranasal sinuses 6 5.0 
     Salivary glands 6 5.0 
     Neck 6 5.0 
     Ear 5 4.2 
     Scalp 1 0.8 
     Unknown primary 3 2.5 
Stage of disease   
     T1 13 10.9 
     T2 7 5.9 
     T3 15 12.6 
     T4 29 24.4 
     Unspecified 55 46.2 
Treatment status   
     Awaiting treatment 42 35.5 
     Undergoing treatment 25 21.0 
     Completed treatment 46 38.7 
     Unspecified 6 5.0 
Treatment type   
     Surgery  36 30.3 
     Surgery and radiation therapy 25 21.0 
     Chemotherapy and radiation therapy 22 18.5 
     Surgery, radiation therapy, chemotherapy 11 9.2 
     Radiation therapy  10 8.4 
     Unspecified 8 6.7 
     Surgery and chemotherapy 5 4.2 
     Chemotherapy 2 1.7 
Recurrence of cancer   
     Recurrence 29 24.4 
     No recurrence 90 75.6 
Note. Not all columns add to 100. 
  
143 
prepaid return envelope to ensure that participants did not incur any undue 
financial burden for their participation in this study.  
The letter of information informed the participant of the general purpose of 
the study, the risks and benefits associated with participating in the study, and 
also notified them that they were under no obligation to complete the 
questionnaires nor would they suffer any consequences for declining to 
participate. In compliance with ethical requirements, informed consent was 
indicated by the voluntary completion and return of the questionnaire to the 
researcher. This procedure of obtaining consent was explicitly stated in the letter 
of information. If any of the questionnaires were not completed in entirety with 
sufficient data to compute statistical analysis as per the requirements specified in 
the standardized scoring and procedures manual for each questionnaire, they 
were destroyed and excluded from data analysis.  
Sample size calculations. Sample size calculations were conducted 
using G*Power 3 Software (Version 3.1) (Faul, Erdfelder, Lang, & Buchner, 
2007) in order to identify the number of participants required to obtain adequate 
statistical power. It was determined that a total sample size (n) of 54 individuals 
would be sufficient to detect the hypothesized effect (d = 0.5) of a within-subject 
independent variable design 95.0 percent of the time using a 0.05 alpha level 
(Faul et al., 2007). Despite this relatively low number of required participants, it 
was determined that a total of 200 individuals would be invited to participate in 
the study with the goal of obtaining a response rate of approximately 50% 
(Baruch, 1999).  
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Measurement instruments 
The measurement instruments utilized in this study included: (1) the  
CQOLC to assess quality of life, (2) the Distress Thermometer and 
accompanying Problem Checklist to assess distress and perceived problems, 
and (3) a demographic questionnaire to assess both the caregiver’s personal 
demographic information and the disease- and treatment-related characteristics 
of the individual for whom they were providing care (i.e. the individual with head 
and neck cancer). The order of the Distress Thermometer and CQOLC 
questionnaires was randomly assigned as per predetermined stapling of the 
instruments (e.g., half of the packages provided the Distress Thermometer first, 
while the other half offered the CQOLC first). This procedure of organizing the 
order of the instruments was conducted in an effort to reduce any response bias 
due to the influence of exposure to the preceding measure. Participants were 
instructed to complete each questionnaire as per the enclosed instructions 
provided on the measures themselves (e.g., the Distress Thermometer and 
CQOLC) in a location of their choosing (i.e., home or private office). Additional 
pages were provided for participants to include any additional information that 
they felt was pertinent to the research topic (i.e., any concerns or life events that 
could serve as confounding factors influencing their distress or quality or life at 
the time of the survey). It was anticipated that completion of all tasks would take 
approximately 10-15 minutes.  
 Demographic information. Demographic items consisted of the 
participant’s age, sex, relationship to the individual with head and neck cancer 
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(e.g., spouse, family member, friend, etc.), marital status, occupational status, 
highest level of education obtained, and approximate household income. Relative 
to the disease- and treatment-related characteristics of the individual for whom 
they were providing care, items for which data were collected included the length 
of time since diagnosis, the specific site of the malignancy (e.g., larynx, oral 
cavity, etc.), the tumour stage of the disease, the type of treatment received, the 
status of treatment (e.g., awaiting, undergoing, completed, etc.), and whether or 
not the individual had experienced a recurrence of the disease.  
Data analysis 
Raw data from the current study were analyzed using SPSS 20.0 for 
Macintosh (IBM, 2011). Moreover, an a priori alpha level of p ≤ 0.05 was used for 
statistical tests. 
 Descriptive statistics. Initially, descriptive statistics (e.g., means, 
standard deviations, frequency distributions, histograms, etc.) were calculated for 
demographic data, treatment- and disease-related variables, and the global and 
specific domains of each questionnaire (e.g., Distress Thermometer, CQOLC). 
These analyses were conducted in order to evaluate the normality of the sample 
and to assess whether parametric statistics would be appropriate for statistical 
analyses.  
 Objective one: Presence of distress. The presence of clinically 
significant distress was identified based on a Distress Thermometer score of ≥ 4 
in accordance with the recommendations of the National Comprehensive Cancer 
Network (NCCN) (2013). Rates of distress detected in this sample were then 
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compared to previous findings in the literature. It was hypothesized that the rate 
of distress detected within this sample would fall within 20-40% of participants, in 
accordance with the rates described in current literature (Longacre et al., 2012).  
Objective two: Perceived problems. Data pertaining to perceived 
problems were derived from the Problem Checklist, which accompanies the 
Distress Thermometer (NCCN, 2013). Frequency data were presented for each 
of the Problem Checklist items in an effort to explore the most commonly 
reported concerns among caregivers of individuals with head and neck cancer. It 
was hypothesized that emotional problems (e.g., worry, fears, sadness, 
nervousness, decreased interest, depression) would be the most frequently 
reported concerns among participants. 
Objective three: Relationship with quality of life. Relationships 
between distress level and the global (e.g., overall) and specific domains (e.g., 
burden, disruptiveness, financial concerns, and positive adaptation) of quality of 
life were evaluated. Given that both the Distress Thermometer and the CQOLC 
outcomes were comprised of continuous variables, a correlation coefficient was 
utilized. Additionally, coefficients of determination9 were calculated for any quality 
of life outcomes that demonstrated a significant relationship with distress in order 
to describe the level of variance shared by the two variables (Pallant, 2011). 
Interpretation of the correlations was based on the evaluation criteria cited in 
Portney and Watkins (2009).  
                                                 
9
 A coefficient of determination (r
2
) is the “coefficient representing the amount of variance in one 
variable (Y) that can be explained (accounted for) by a second variable (X)” (Portney & Watkins, 
2009, p.865). 
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In addition, it was hypothesized that there would be a moderate degree of 
association between distress and global quality of life in caregivers of individuals 
with head and neck cancer. Based on previous work related to quality of life and 
distress in individuals with head and neck cancer (Bornbaum et al., 2012; 
Pandey, Devi, Ramdas, Krishnan, & Kumar, 2009), it was also predicted that this 
correlation would be negative, indicating that as one’s level of distress increased, 
that their perceived quality of life would decrease. Relative to the specific 
domains of quality of life (e.g., burden, disruptiveness, financial concerns, and 
positive adaptation), it was hypothesized that both burden and disruptiveness 
would demonstrate a moderate degree of relationship with distress. Both level of 
burden and perceived disruptiveness have been related to psychological health 
(e.g. distress) in previous investigations of the caregiver experience in head and 
neck oncology (Longacre et al., 2012). 
Objective four: The influence of demographic characteristics. To 
assess the relationship between perceived distress level and the demographic 
characteristics of caregivers, variables such as sex, age, marital status, 
occupational status, household income, level of education, and relationship to the 
individual with cancer were evaluated. Given that both age and Distress 
Thermometer scores were continuous variables, and since several of the 
demographic variables (e.g., occupational status, household income, level of 
education) were ordinal variables, the Spearman’s Ranked Correlation 
Coefficient was employed. In addition, coefficients of determination were 
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calculated for variables that indicated a significant relationship with distress 
(Pallant, 2011).  
Lastly, since sex was a nominal, dichotomous variable and it was 
evaluated relative to a continuous variable (e.g., Distress Thermometer score), 
an unpaired, or independent-samples, t-test was utilized for statistical analysis. 
The magnitude of effect was determined through calculation of Eta Squared10 
(Pallant, 2011). Interpretation of the effect size of a variable was based on the 
guidelines proposed by Cohen (1988). 
Relative to hypotheses, it was anticipated that caregiver sex would 
demonstrate a moderate relationship with distress. This hypothesis was based 
on previous research into the relationship between sex and caregiver distress, 
which found that female caregivers typically reported a higher rate of perceived 
distress than their male counterparts (Baghi et al., 2007). Consistent with 
previous findings (Ross et al., 2010; Verdonck-de Leeuw et al., 2007), a strong 
relationship with age was not anticipated. Moreover, no significant relationships 
were expected between distress and the remaining demographic variables (e.g., 
marital status, occupational status, household income, level of education). 
Objective five: Distress and patient-related characteristics. To assess 
the relationship between perceived distress level and the disease- and treatment-
related characteristics of the individual with head and neck cancer, variables 
such as disease stage, number of treatment methods, and time since diagnosis 
                                                 
10
 Eta squared is an effect size statistic that ranges from zero to one and “represents the 
proportion of variance in the dependent variable that is explained by the independent (group) 
variable” (Pallant, 2011, p.242). 
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were explored. Given that both the Distress Thermometer score and length of 
time since diagnosis were continuous variables and since several of the disease- 
and treatment-related variables (e.g., disease stage, number of treatment 
methods) were ordinal variables, Spearman’s Ranked Correlation Coefficient 
was utilized for statistical analysis. Coefficients of determination were calculated 
for any variables that demonstrated a significant relationship with distress 
(Pallant, 2011).  
Since disease recurrence was a nominal, dichotomous variable and it was 
evaluated relative to a continuous variable (e.g., Distress Thermometer score), 
an unpaired t-test was employed for statistical analysis. Lastly, a one-way 
between-groups analysis of variance (ANOVA) was performed in order to explore 
the impact of treatment stage on level of distress. Treatment stage was divided 
into three groups; those awaiting treatment, those currently undergoing 
treatment, and those who had completed treatment. Magnitude of effect for both 
the t-test and ANOVA was determined through calculation of Eta Squared 
(Pallant, 2011). 
Similar to previous findings we hypothesized that disease recurrence 
(Hodges & Humphris, 2009; Watt-Watson & Graydon, 1995), and time since 
diagnosis (Blood et al., 1994) would each demonstrate small, but significant 
relationships with distress. To the authors’ knowledge, a relationship between 
caregiver distress and treatment stage (e.g., awaiting, undergoing, completed) 
has not been reported previously. Nevertheless, we predicted that distress and 
treatment stage would reveal a significant relationship. We further anticipated 
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that disease stage would not demonstrate a significant relationship with distress, 
despite conflicting evidence on the topic (Kugaya et al., 2000; Verdonck-de 
Leeuw et al., 2007). 
 
Results 
Participants  
Response rate. Overall, 59.5% of individuals (n = 119) returned the 
completed questionnaire package. Most participants were recruited through the 
LRCP at the London Health Sciences Centre (n = 109; 91.6%), while only a small 
percentage of participants were successfully recruited through the annual 
meeting of the International Association of Laryngectomees (n = 10; 8.4%).  
Data analysis 
Descriptive statistics. In order to assess the normality of the data 
sample, descriptive statistics (e.g., means, standard deviations, frequency 
distributions, and histograms) were calculated for demographic data, treatment- 
and disease-related variables, and the global and specific domains of each 
questionnaire (e.g., Distress Thermometer, CQOLC). While the majority of 
variables were normally distributed, both age (SD = 11.19) and time since 
diagnosis (SD = 49.92) demonstrated a high degree of variance. Consequently, 
histograms for both age and time since diagnosis were reviewed (see Figure 
3.1). In essence, these data indicate that most participants in the present study 
fell within the middle-aged range (e.g., between mid-forties and late-sixties) and 
provided care for an individual who had received a diagnosis within the previous 
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five years. Additionally, the CQOLC global and specific outcomes demonstrated 
moderate-to-high degrees of variance. Consequently, statistical analyses 
pertaining to these items employed the use of non-parametric statistics. The 
results of the histogram analyses are shown in Figure 3.1 while additional 
descriptive analyses are presented in Table 3.3.  
Objective one: Presence of distress. When based on a Distress 
Thermometer score of ≥ 4 (NCCN, 2013), clinically significant distress was 
identified in 54 of the 119 participants (45.4%). Consequently, the incidence of 
distress was higher than the predicted range of 20-40%, which was based on 
currently available literature (Longacre et al., 2012). Comprehensive data on the 
frequency of Distress Thermometer scores is presented in Figure 3.2.  
Objective two: Perceived problems. While emotional concerns 
comprised five of the eight most frequently reported problems among caregivers 
(e.g., worry, 64.7%; fears, 44.5%; sadness, 43.7%; nervousness, 41.2%; 
decreased interest in typical activities, 20.2%), certain physical concerns were 
also prominent (e.g., sleep, 44.5%; fatigue, 43.7%; eating, 20.2%). 
Comprehensive data pertaining to the frequency of perceived problems reported 
by caregivers are presented in Figure 3.3. 
Objective three: Relationship with quality of life. Correlations between 
the dependent variables: distress, global quality of life, and the specific domains 
of quality of life (e.g., burden, disruptiveness, financial concerns, and positive 
adaptation) were assessed. Since the variables were continuous and because  
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Figure 3.1. Histogram Representations of the Distribution of Age and Time 
(Months) Since Diagnosis Data for Caregiver Participants (n = 119) 
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Table 3.3   
Descriptive Statistics for Caregiver Data 
Variable n  Range Min. Max. Mean SD 
Age (years) 119 55 28 83 61.60 11.19 
Sex 119 1 0 1 0.24 0.43 
Marital status 119 2 0 2 1.08 0.31 
Education 119 2 0 2 1.41 0.67 
Occupational status 119 4 0 4 2.08 1.40 
Household income 119 6 0 6 2.72 2.31 
Relationship to patient 119 2 1 3 1.19 0.43 
Time since diagnosis (months) 119 274 0 274 26.59 49.92 
Recurrence 119 1 0 1 0.24 0.43 
Cancer site 119 9 1 10 4.28 2.64 
Speech method 119 5 0 5 0.44 1.17 
Stage 119 4 0 4 1.58 1.71 
Surgery? 119 1 0 1 0.65 0.48 
Radiation? 119 1 0 1 0.57 0.50 
Chemotherapy? 119 1 0 1 0.34 0.47 
No. treatment methods 119 3 0 3 1.54 0.79 
Treatment stage 119 3 0 3 1.93 0.97 
Burden (CQOLC) 119 40 0 40 22.77 9.30 
Disruptiveness (CQOLC) 119 28 0 28 21.74 5.74 
Positive adaptation (CQOLC) 119 28 -28 0 -15.95 5.80 
Financial concerns (CQOLC) 119 12 0 12 9.77 3.19 
Total quality of life (CQOLC) 119 98 0 98 50.93 20.61 
Distress (DT score) 119 10 0 10 3.61 2.90 
 
 
 
 
  
154 
 
 
Figure 3.2. Frequency of Distress Thermometer Scores Reported Among 
Caregivers of Individuals with Head and Neck Cancer  
 
     = Clinically significant distress (Distress Thermometer scores ≥ 4) 
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Figure 3.3. Frequency of Reported Problems in Caregivers of Individuals with 
Head and Neck Cancer  
Note. (Pr) = Practical concerns; (F) = Family concerns; (E) = Emotional concerns; (S) = 
Spiritual/Religious concerns; (Ph) = Physical concerns 
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CQOLC scores did not demonstrate a normal distribution (see Table 3.3), the 
Spearman’s Rank Correlation Coefficient was utilized. Data indicate that there 
was a moderate-to-good degree of correlation observed between distress and 
global quality of life (rs = -.521, p = .000). This statistically significant relationship 
accounted for 27.14% of variance in the sample. Significant correlations were 
also detected between distress and perceived burden (rs = -.606, p = .000) and 
disruptiveness (rs = -.405, p = .000) subscales of the CQOLC quality of life 
measure. While the burden subscale demonstrated a moderate-to-good degree 
of association and explained 36.72% of the variance in respondents’ scores on 
the Distress Thermometer, the disruptiveness subscale demonstrated only a fair 
degree of association and, thus, only accounted for 16.40% of variance. The 
relationships between distress and both financial concerns (rs = -.095, p = .305) 
and positive adaptation (rs = .048, p = .604) did not reveal statistically significant 
relationships. 
The negative correlations between global quality of life and distress 
indicated that there was an inverse relationship between distress and one’s 
overall quality of life implying that as distress increases, one’s perceived level of 
quality of life decreases. The same principle applies to the positive adaptation 
subdomain; that is, as one’s level of positive adaptation increases, the level of 
perceived distress decreases. However, due to scoring practices, inverse 
correlations between the remaining subdomains of quality of life (e.g., burden, 
disruptiveness, financial concerns) do not imply an inverse effect. For instance, 
as one’s level of perceived burden increases, so does one’s level of distress. 
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Comprehensive data pertaining to the correlations between distress and quality 
of life scores among participants are presented in Table 3.4.  
Objective four: The influence of demographic characteristics. 
Statistical analysis was conducted utilizing Spearman’s Ranked Correlation 
Coefficient for several of the variables (e.g., distress, sex, age, marital status, 
occupational status, household income, level of education, and relationship to the 
individual with cancer). Although data pertaining to age was collected as a 
continuous variable, it did not demonstrate a normal distribution when subjected 
to descriptive analysis (see Figure 3.1) and, thus, was included in the 
Spearman’s Rank Correlation Coefficient analysis. Data revealed that none of 
the demographic variables demonstrated a statistically significant relationship 
with the perceived level of distress (see Table 3.5). Thus, no coefficients of 
determination were calculated for any of the variables. Comprehensive data 
pertaining to the correlations between distress and the demographic 
characteristics of participants are available in Table 3.5.  
In addition, an independent-samples t-test was conducted to compare 
distress scores for male and female caregivers. Prior to analyzing the output of 
data, Levene’s test for equality of variances was performed11. Since Levene’s 
test was significant (F = 8.866, p = .004), equal variances between male and 
female participants were not assumed. Data indicated that there was a significant 
difference in scores between female participants (M = 3.92, SD = 3.05) and male  
                                                 
11
 Levene’s test compares the level of variance between the two groups and when the difference 
between the groups is statistically significant, equal levels of variance between the variables 
cannot be assumed (Portney & Watkins, 2009). 
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Table 3.4   
Correlations Between Distress and Quality of Life (n = 119) 
  
Burden Disruptive 
Positive 
Adapt. Finance 
 
Global 
QOL Distress 
Burden Spearman’s 
rho 
Correlation 
1 .579* .168 .274* .889* -.606* 
 p level  .000 .067 .003 .000 .000 
Disruptiven
ess 
Spearman’s 
rho 
Correlation 
 1 -.017 .334* .723* -.405* 
 p level   .852 .000 .000 .000 
Positive 
Adaptation 
Spearman’s 
rho 
Correlation 
  1 .015 .381* .048 
 p level    .867 .000 .604 
Financial 
Concerns 
Spearman’s 
rho 
Correlation 
   1 .398* -.095 
 p level     .000 .305 
Global  
QOL 
Spearman’s 
rho 
 Correlation 
    1 -.521* 
 p level      .000 
Distress  
 
Spearman’s 
rho 
Correlation 
     1 
 p level       
   * Correlation is significant at the minimum level of p ≤ 0.05 level (2-tailed). 
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Table 3.5   
Correlations Between Distress and Demographic Characteristics (n = 119) 
  
Age 
Marital 
Status 
Occup. 
Status Income Educat. 
 
Relation
ship Distress 
Age Spearman’s 
rho 
Correlation 
1 -.217 -.584* -.387* -.212 -.311* -.173 
 p level  .018 .000 .000 .020 .001 .060 
Marital 
Status 
Spearman’s 
rho 
Correlation 
 1 .195 -.041 .112 .382* -.024 
 p level   .033 .660 .225 .000 .796 
Occupation 
Status 
Spearman’s 
rho 
Correlation 
  1 .216* .145 .187* .076 
 p level    .018 .115 .041 .411 
Household 
Income 
Spearman’s 
rho 
Correlation 
   1 .267* .110 .177 
 p level     .003 .233 .054 
Education Spearman’s 
rho 
 Correlation 
    1 .100 .017 
 p level      .277 .857 
Relationship 
to patient 
Spearman’s 
rho 
 Correlation 
     1 -.010 
 p level       .915 
Distress  
 
Spearman’s 
rho 
Correlation 
      1 
 p level        
   * Correlation is significant at the minimum level of p ≤ 0.05 level (2-tailed). 
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participants (M = 2.655, SD = 2.13; t (68.06) = 2.49, p = .015, two-tailed), 
suggesting higher perceived distress among female caregivers. However, the 
magnitude of the differences in the means (mean difference = 1.27, 95% CI: .25 
to 2.28) was small (Eta Squared = 0.02) (Cohen, 1988), since only 2% of the 
variance in caregiver distress was explained by sex.  
Objective five: Distress and patient-related characteristics. Data 
revealed that disease stage, number of treatment methods, and length of time 
since diagnosis did not demonstrate a significant correlation with distress. As a 
result, no coefficients of determination were calculated for the variables. 
Comprehensive data pertaining to the correlations between caregiver distress 
and the disease- and treatment-related variables of individuals diagnosed with 
head and neck cancer are presented in Table 3.6.  
In addition, an independent-samples t-test was conducted to compare 
distress scores for caregivers of individuals with head and neck cancer who had 
experienced a recurrence in disease versus those who had not experienced a 
recurrence. Since Levene’s test for equality of variances was not significant (F = 
1.22, p = .271), equal variances between the groups were assumed. Contrary to 
our prediction, there was no significant difference in distress scores for 
caregivers of individuals who had experienced a recurrence (M = 4.31, SD = 
2.56) versus caregivers of those who had not experienced a recurrence (M = 
3.39, SD = 2.97; t (117) = -1.489, p = .137, two-tailed). The magnitude of the 
differences in the means (mean difference = -.92, 95% CI: -2.14 to .30) was small 
(Eta Squared = 0.01) since only 1% of the variance in caregiver distress was  
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Table 3.6   
Correlations Between Distress and Patient-Related Variables (n = 119) 
  
Disease 
Stage 
Number of 
Treatment 
Methods 
 Time Since 
Diagnosis Distress 
Disease 
Stage 
Spearman’s 
rho 
Correlation 
1 .375 .095 -.034 
 p level  .000 .303 .710 
Number of 
Treatment 
Methods 
Spearman’s 
rho 
Correlation 
 1 .208 -.037 
 p level   .023 .686 
Time Since 
Diagnosis 
Spearman’s 
rho 
 Correlation 
  1 -.168 
 p level    .068 
Distress  
 
Spearman’s 
rho 
Correlation 
   1 
 p level     
   * Correlation is significant at the minimum level of p ≤ 0.01 level (2-tailed). 
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explained by disease recurrence. Thus disease recurrence was neither a 
statistically, nor clinically significant factor influencing caregiver distress in this 
sample of participants. 
A one-way between-groups ANOVA was also performed in order to 
explore the impact of treatment stage on level of distress. Participants were 
divided into three groups according to their stage in the treatment process (e.g., 
awaiting treatment, undergoing treatment, completed treatment) with a fourth 
group denoting those who did not specify the treatment stage of their loved one. 
Levene’s test was not violated (p = .112). There was a statistically significant 
difference at the p < .05 level in distress scores between the treatment status-
related groups: F (3, 115) = 6.90, p = .000. In addition to reaching statistical 
significance, the actual difference in mean scores between the groups was 
substantial. The effect size, calculated using Eta Squared, was .15, indicating a 
large effect (Cohen, 1988). Post-hoc comparisons using the Tukey’s Honestly 
Significant Difference12 (HSD) test indicated that the mean distress score for 
caregivers of individuals awaiting treatment (M = 4.81, SD = 2.74) was 
significantly different from caregivers of those who had completed treatment (M = 
2.28, SD = 2.29). Caregivers of individuals currently undergoing treatment (M = 
3.76, SD = 3.02), and caregivers who did not specify treatment stage (M = 4.83, 
SD = 3.92) did not differ significantly from caregivers of those who had either 
completed treatment or were awaiting treatment. 
 
                                                 
12
 Tukey’s honestly significant difference is “a multiple comparison test for comparing multiple 
means following a significant analysis of variance” (Portney & Watkins, 2009, p.878). 
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Discussion 
The overarching aim of this investigation sought to explore the factors that 
contribute to elevated distress and decreased quality of life in caregivers of 
individuals with head and neck cancer. Specifically, this inquiry aimed to expand 
the literature on caregiver distress to include considerations of the influence of 
treatment status on caregiver distress, in addition to both the newly diagnosed 
and long-term follow-up (e.g., survivorship) phases of the continuum of care. 
Further, this project utilized an ultrashort measure of distress (e.g., the Distress 
Thermometer) in a sample of caregivers of individuals who had been diagnosed 
with head and neck cancer. Relative to the precise objectives of this study, a 
number of areas of inquiry related to distress were explored. 
Incidence of distress 
With regard to the first objective concerning the presence of distress in 
caregivers of individuals diagnosed with head and neck cancer, data revealed 
that distress was present in approximately 45% of participants, which is notably 
higher than our prediction and previously reported rates of between 20% in one 
sample (Verdonck-de Leeuw et al., 2007) to 38% in others (Drabe et al., 2008; 
Ross et al., 2010). The variability in reported incidence rates of distress in 
caregivers may be related to a number of factors including the severity of 
disease, which has previously been shown to influence distress in individuals 
with head and neck cancer (Kugaya, Akechi, Okamura, Mikami, & Uchitomi, 
1999; Kugaya et al., 2000). For instance, earlier research has noted a predictive 
relationship between advanced stage head and neck cancer and psychologic 
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distress (Kugaya et al., 2000). This relationship between advanced stage of 
disease and distress in head and neck cancer may be attributed to several 
potential factors including malnutrition (Neilson et al., 2012), physiologic 
dysfunction (Ettema, Reminger, & Robbins, 2013), and poor performance status 
(Kirkova et al., 2009), among others. Furthermore, the sheer fact that an 
individual has been diagnosed with a late-stage level of disease (e.g., T3 or T4) 
may produce feelings of distress (Kugaya et al., 2000).  
Additionally, differences in the way that distress is defined and/or 
diagnosed may contribute to the variability in reported rates of distress in 
caregivers; for instance, studies utilizing formal, structured diagnostic instruments 
or interviews tend to detect lower rates of distress than those which utilize self-
report inventories (Miller & Massie, 2009), such as the one utilized in this study. 
The reason for this disparity may be related to the fact that diagnostic 
instruments and/or interviews seek specific information related to the presence of 
a diagnosable, pathologic condition (e.g., clinical depression, generalized anxiety 
disorder), whereas self-report distress measures generally seek to identify a 
broad continuum of distress-related experiences (e.g., lower threshold of 
distress), and may include more inclusive criteria related to distress-inducing 
factors (e.g., symptom distress, practical problems). Consequently, the higher 
incidence rate of distress detected in the present study may be related to the use 
of the self-report distress screening measure (e.g., the Distress Thermometer), 
as opposed to a structured diagnostic measure of clinical depression. 
Additionally, a number of authors have also suggested that the recommended 
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cutoff score for determining clinically significant distress on the Distress 
Thermometer (e.g., scores greater than or equal to four) should be altered (e.g., 
raised or lowered) in order to optimize the accuracy of the Distress Thermometer 
(Akizuki et al., 2003; Dolbeault et al., 2008; Gessler et al., 2008; Gil, Grassi, 
Travado, Tomamichel, & Gonzalez, 2005; Hegel et al., 2008; Vodermaier et al., 
2009). 
Despite the recommendation by the creators of the Distress Thermometer 
to use a cutoff score of four (NCCN, 2013), previous research conducted with the 
Distress Thermometer has used both the recommended cutoff score, and other 
self-designated cutoff scores which included scores of three (Dolbeault et al., 
2008; Dolbeault et al., 1999; Gil et al., 2005) and seven (Hegel et al., 2008; 
Vodermaier et al., 2009), with a cutoff score of five (Akizuki et al., 2003; Butt et 
al., 2008; Gessler et al., 2008; Trask et al., 2002; Tuinman, Gazendam-Donofrio, 
& Hoekstra-Weebers, 2008) representing the most common alternative to the 
creator-recommended score of four (NCCN, 2013).  
The debate over which cutoff score provides the most accurate 
assessment of actual distress appears to stem from a series of validation studies 
performed on individuals afflicted with a range of cancer sites (e.g., breast, lung, 
brain, colorectal, prostate, ovarian, head and neck, bone, bladder, non-Hodgkin’s 
lymphoma, etc.) (Butt et al., 2008; Jacobsen et al., 2005), and treatment states 
including those awaiting treatment (Trask et al., 2002), in active treatment (Butt 
et al., 2008; Jacobsen et al., 2005) and those in survivorship (Recklitis, Licht, 
Ford, Oeffinger, & Diller, 2007). The creators of the Distress Thermometer have 
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recommended utilization of a cutoff score of 4 for distress screening purposes. 
This recommendation has been verified through the validation efforts of other 
researchers in both patient (Hoffman, Zevon, D'Arrigo, & Cecchini, 2004; 
Jacobsen et al., 2005; Ransom, Jacobsen, & Booth-Jones, 2006) and caregiver 
(Zwahlen et al., 2008) populations. As such, the present study employed the 
recommended cutoff score for analysis purposes and consequently, the lower 
cutoff score (in contrast to a score of five, or even seven) may have contributed 
to the elevated rate of distress detected in this sample. Interestingly, if the 
frequently used cutoff score of five had been utilized in the present study, the 
presence of distress would have been reduced to 39.5% of participants (n = 47) 
in contrast to the current rate of 45.4% of participants (n = 54). Thus, in terms of 
difference between groups, the actual percentage of difference when comparing 
Distress Thermometer cutoff scores of four versus five is relatively small (5.9%) 
in the present sample. In addition, the elevated rate of distress detected in this 
sample may have been related to a host of other factors including the range of 
perceived problems experienced by caregivers. 
Perceived problems 
As predicted, emotional concerns such as worry, fear, sadness, 
nervousness, and decreased interest in usual activities, represented the most 
frequently reported problems among caregiver participants. However, physical 
concerns such as difficulties with sleep, fatigue and appetite were also noted 
frequently, followed by problems with one’s partner and additional practical and 
physical concerns. Interestingly, the most commonly reported physical concerns 
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(e.g., sleep, fatigue, appetite) were well aligned with the diagnostic criteria for 
depression (Miller & Massie, 2009). A diagnosis of major depression consists of 
symptoms, which last for at least two weeks, and include depressed mood or 
anhedonia (i.e., the inability to experience pleasure from activities typically found 
to be enjoyable) in addition to four of the following symptoms experienced daily: 
altered appetite; fatigue; guilt; worthlessness; diminished concentration; insomnia 
or hypersomnia; psychomotor retardation or agitation; or recurrent thoughts of 
death including suicidal ideation (Miller & Massie, 2009). Notably, the 
development of major depression is not a typical or anticipated response in 
caregivers of individuals with head and neck cancer, however, it may be 
considered a significant complication of the caregiver role that requires 
individualized assessment and treatment given its potential to compromise the 
quality of life and functional status (Miller & Massie, 2009) of the caregiver. 
Regardless of the severity of the symptoms detected, the identification of 
elevated distress and perceived problems in caregivers of individuals with head 
and neck cancer may permit healthcare practitioners to offer targeted 
psychosocial support and interventions in an effort to decrease distress and 
reported problems in caregivers. While the Problem Checklist is by no means a 
comprehensive measure of the potential range of problems facing a caregiver, it 
does provide some insight into some of the most commonly reported areas of 
concern.  
While emotional and physical problems were the most frequently reported 
concerns among caregivers in the present study, the prevalence of these reports 
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should not in any way diminish the impact of less frequently reported problems 
such as “memory/concentration” or “dealing with children”, since issues such as 
these have the potential to be tremendously distressing for caregivers. In 
essence, the subjective experience of an item such as, “problems dealing with 
partner” cannot be inferred through simple acknowledgment on a questionnaire. 
Consequently, considerations of one’s subjective quality of life remain important 
in order to better understand the experience of distress in caregivers of 
individuals with head and neck cancer. 
Relationship with quality of life 
Quality of life refers to an individual’s subjective perception of their 
position in life relative to a variety of factors that may include one’s “physical 
health, psychological state, level of independence, social participation” (WHO, 
1998, p.17), among other components. Key to this broad-ranging concept is the 
fact that all of these factors must be considered collectively and from the 
perspective of the individual in order to account for the meaning and emphasis 
that may be placed on one area over another. Therefore, in order for 
assessments of quality of life to be useful for clinical or research purposes, they 
must be able to account for the factors most relevant to one’s current life 
situation. Due to the numerous potential concerns of a caregiver of an individual 
with head and neck cancer, a key objective of the present study was to evaluate 
the perceived quality of life of caregivers both globally, and relative to a number 
of specific areas known to be problematic for caregivers. Thus, caregiver quality 
of life was measured through an individual’s experience of burden, the disruption 
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caused to their life, their financial concerns, and any positively adaptive 
behaviour that may have reduced the negative impact of the disease. In addition, 
one’s overarching assessment of quality of life was also evaluated. It is clear that 
multiple facets of concern influence perceived quality of life, thus, the ability to 
address an array of areas that may be impacted for the caregiver is essential. 
Relative to global quality of life, the current data indicated that caregiver 
distress and quality of life were inversely related to a moderate extent. This 
inverse relationship between the two constructs suggests that as one’s level of 
distress increased, perceived quality of life decreased. This finding is similar to 
previous work in samples of individuals diagnosed with head and neck cancer 
(Bornbaum et al., 2012; Pandey et al., 2009). Given that there is often a 
tremendous burden placed on caregivers to provide physical, psychological, and 
practical support (Blood et al., 1994), disruptions to one’s quality of life and 
psychological well-being are understandable. In addition to global quality of life, 
significant relationships were also detected between the burden and 
disruptiveness domains of the caregiver quality of life measure; a finding that 
aligned with our earlier predictions. 
Caregiver burden is a commonly acknowledged phenomenon among 
psychosocial oncology scholars (Stenberg, Ruland, & Miaskowski, 2010). The 
concept of burden in head and neck oncology has been evaluated as both a 
correlate of distress (Verdonck-de Leeuw et al., 2007) and as a psychological 
outcome of providing care for an individual with cancer (Blood et al., 1994; Chen 
et al., 2009). Similar to Verdonck-de Leeuw et al. (2007), the present study 
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demonstrated a significant relationship between caregiver burden and perceived 
distress. Ultimately, because measures of caregiver burden purportedly assess 
the psychological impact of providing care, its significant correlation with 
perceived distress, also a psychological construct, is logical. In addition, the 
concept of disruptiveness (also commonly referred to as “caregiver strain”) 
measured the adverse impact of providing care on the life of the caregiver 
(Longacre et al., 2012). Relative to the CQOLC measure, disruptiveness was 
evaluated through such item subjects as, “impact on daily schedule”, 
“maintenance of outside activities”, and “responsibility for patient’s care”, among 
others (Weitzner et al., 1999). When correlated with distress, disruptiveness 
demonstrated a fair relationship that was determined to be statistically significant. 
These findings are particularly salient given that previous research has 
determined that greater perceived disruption to an individual’s daily routine was 
associated with poorer psychological health (Blood et al., 1994). 
Interestingly, results from the present study suggest that one’s ability to 
adapt positively to the situation did not impact the perceived level of distress 
detected among participants. These findings are consistent with previous 
research conducted by Ross and colleagues (2010). Additionally, financial 
concerns, evaluated through items related to “financial strain”, “insurance 
coverage”, and one’s “anticipated economic future” (Weitzner et al., 1999), were 
not shown to influence caregiver distress. This finding was consistent with 
frequency data obtained through the Problem Checklist, where just over 10% of 
participants noted problems with finances and/or insurance. Previous 
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researchers have also noted the lack of a relationship between caregiver distress 
and socioeconomic factors (Ross et al., 2010). In order to further explore the role 
of financial status and other personal characteristics of caregivers, analysis of the 
demographic factors relative to distress may provide useful insights.  
The influence of demographic characteristics 
As anticipated, no statistically significant correlations were detected 
between perceived distress level and the majority of demographic characteristics 
of caregivers. While the literature on existing relationships between caregiver 
distress and demographic factors is mixed (Baghi et al., 2007; Ross et al., 2010; 
Verdonck-de Leeuw et al., 2007), our data suggesting no significant correlations 
with caregiver distress were aligned with the findings of earlier research (Ross et 
al., 2010; Verdonck-de Leeuw et al., 2007). Interestingly, a small but significant 
difference in perceived distress was detected between male and female 
participants, with a higher level of distress reported by female caregivers. Thus, 
the hypothesis that sex would demonstrate a moderate relationship with distress 
was not entirely supported given the small magnitude of effect detected in this 
sample. Several other authors have reported similar results when investigating 
differences between the sex of caregivers (Baghi et al., 2007; Blood et al., 1994; 
Zwahlen et al., 2011). However, when the effect size of the current data was 
determined, the actual effect of this difference was found to be quite small 
suggesting that the influence of one’s sex only accounted for a small proportion 
of the variance in perceived distress among participants. Given that the 
demographic characteristics of participants did not serve to explain the high rate 
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of distress detected in this sample, examination of the disease- and treatment-
related characteristics of the individuals with cancer may provide a greater 
degree of insight into the factors related to elevated distress in caregivers of 
individuals with head and neck cancer. 
Distress and patient-related characteristics 
As predicted, disease stage and number of treatment methods did not 
demonstrate a statistically significant relationship with the perceived level of 
distress. Additionally, in line with earlier findings (Blood et al., 1994), it was 
hypothesized that the length of time since diagnosis would demonstrate a small, 
but significant relationship with distress. While this prediction did not prove to be 
accurate in the present sample, it did highlight some items that warrant further 
consideration. Relative to the length of time since diagnosis, the present study 
included a wide range of caregiving experiences. Specifically, this sample 
consisted of a range of caregivers of individuals who were less than a week from 
the point of diagnosis to those supporting long-term survivors (>20 years). 
Existing research into the experience of caregivers of individuals with head and 
neck cancer centers around data collected between two and 48 months post-
diagnosis (Hodges & Humphris, 2009; Ross et al., 2009; Verdonck-de Leeuw et 
al., 2007; Blood et al., 1994), in addition to a subset of work focused on issues in 
short- to medium-term survivorship (e.g., one to five years following diagnosis) 
(Mellon et al., 2007). However, concerns may arise at any point along the 
continuum of care in oncology, from the point of a new diagnosis continuing 
through long-term survivorship (e.g., greater than 10 years following diagnosis) 
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phases. While no statistically significant effect was found related to the length of 
time since the individual’s diagnosis, current findings suggest that perhaps it is 
not the length of time that influences distress, but rather one’s position along the 
continuum of care. For instance, analysis of the impact of treatment stage (e.g., 
awaiting treatment, currently undergoing treatment, completed treatment) 
revealed a significant difference in distress scores between caregivers of those 
who were awaiting treatment when compared with those who had completed 
treatment. Further, this difference demonstrated a large effect, suggesting that 
one’s treatment stage may have a sizeable and significant impact on perceptions 
of caregiver distress. While additional work is required in order to verify this 
relationship, the present findings suggest an interesting area for future research, 
particularly given the potential implications for providing caregiver-targeted 
psychosocial interventions. In addition, any examination of caregiver distress 
would be remiss without consideration of factors that may serve to potentially 
confound the results of the analyses. 
Possible confounding factors 
Distress is a natural human experience, which may arise from, or be 
exacerbated by consequences unrelated to the cancer or the role of providing 
care (NCCN, 2013). Consequently, information related to possible confounding 
factors was collected from caregivers in an effort to identify any life events that 
may have potentially influenced the distress level of the caregivers. Relative to 
the collection of the data, no specific criteria for the type of information to be 
disclosed were outlined, however participants were invited to share any 
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information that they felt may have influenced their distress or quality or life at the 
time of the survey. Consequently, a broad range of responses was collected from 
participants.  
Regarding the specific disclosures of possible confounding factors, one 
participant reported the recent loss of a sibling while another informed the team 
that she had recently undergone surgery and was still recovering despite 
providing care for her husband. One participant disclosed that she was a breast 
cancer survivor while another noted that he had been a caregiver twice before. 
Understandably, these experiences may have directly influenced, either 
positively or negatively, the manner in which these individuals approached their 
role as a caregiver. 
Relative to the perceived level of reported distress, both the individual who 
had recently lost her sibling and the participant who had recently undergone 
surgery reported clinically significant levels of distress according to the Distress 
Thermometer (both participants reported Distress Thermometer scores of five). 
However, the cancer survivor and the participant who had previously served as a 
caregiver reported low levels of distress (Distress Thermometer scores of three 
and zero, respectively). While the frequency of these reports is far too low to 
draw any definite conclusions, future research into the influence of personal 
survivorship from cancer and previous experience as a caregiver may provide 
interesting insights into how individuals cope and experience the caregiver role 
following these life experiences.  
Limitations 
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As with any research protocol, certain limitations must be considered.  
First, while two venues were used for recruitment in an effort to enhance the 
external validity of the data to a group beyond Southwestern Ontario, data 
accrual from the international site was minimal. Consequently, the increased 
generalizability that was sought cannot be assumed in the present sample. 
Second, the demographic measure used in the present study did not 
directly assess whether the participant had previously served as a caregiver for 
an individual with cancer (or another chronic illness). It also did not directly 
assess if the caregiver themselves had previously been diagnosed with or 
treated for cancer. In retrospect, data of this type may have provided valuable 
information relative to one’s perceived levels of distress and quality of life 
throughout their caregiving experience. Future research regarding distress in 
caregivers should ensure to take one’s previous experience as a caregiver 
and/or as a cancer survivor into consideration in order to comprehensively 
address the multidimensional issues related to distress in caregivers of 
individuals with cancer.  
Third, this study did not evaluate psychological characteristics of 
caregivers, existing social support, or coping mechanisms, all of which may have 
provided useful information related to the high levels of distress detected in 
participants. For instance, a pessimistic attitude, poor levels of social support, 
and maladaptive coping styles have been associated with psychological strain in 
individuals with cancer (Shapiro, Lopez, Schwartz, Braden, & Kurker, 2001). 
Thus, in order to account for a broader range of psychosocial factors that may 
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have contributed to perceptions of distress in caregivers of individuals with head 
and neck cancer, it is recommended that future inquiries assess a broader range 
of psychological characteristics of the participants. 
Lastly, in an effort to broaden the spectrum of time since diagnosis in 
caregiver participants to include both newly diagnosed and long-term survivors, a 
cross-sectional research design was employed for this study. However, cross-
sectional research designs do not permit causal analysis of factors that may 
contribute to distress and perceived quality of life. Consequently, it is 
recommended that future research into distress and quality of life in caregivers of 
individuals with head and neck cancer employ research designs that are 
prospective and longitudinal in nature. Such designs are appropriate in efforts 
that seek to evaluate potential causal relationships between distress and the 
factors which serve to induce and/or exacerbate it. 
Conclusion 
 This study was designed to investigate and describe distress, quality of 
life, and commonly reported problems in caregivers of individuals diagnosed with 
head and neck cancer. Data indicated that distress was present in approximately 
45% of all participants and that both caregiver sex and the treatment status of the 
individual with head and neck cancer influenced perceptions of distress in 
participants. Additionally, an inverse relationship between quality of life and 
distress was evident, suggesting that as one’s level of distress increases, 
perceived quality of life may consequently decrease. Perceived burden and the 
level of disruptiveness to one’s life were significantly related to a caregiver’s 
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reported level of distress. Emotional concerns were most frequently identified as 
problematic by caregivers, followed closely by physical concerns that are closely 
related to experiences of depression and grief (e.g., problems with sleeping, 
fatigue, eating) (American Psychological Association, 2000; Miller & Massie, 
2009). This study further revealed that being a female caregiver who provides 
care for an individual who is either awaiting treatment or who has completed 
treatment may contribute to elevated levels of perceived distress. In addition, the 
Distress Thermometer proved to be a valuable screening tool for distress within 
the present study. 
Since data from the present investigation revealed that distress and the 
problems associated with it, are indeed prevalent in caregivers of individuals with 
head and neck cancer, and since caregivers often do not directly request 
assistance for their distress and/or broader concerns (Zwahlen et al., 2011), 
caregiver distress and the factors which serve to exacerbate it are often 
overlooked by those most able to provide assistance (e.g., medical professionals, 
psychologists, social workers, etc.). Ultimately, the goal of conducting research 
into caregiver distress is to support caregivers’ ability to provide effective care 
without sacrificing their own health and well-being (Northouse, Katapodi, 
Schafenacker, & Weiss, 2012). Consequently, an important first step in the 
process is to identify the factors that most significantly influence distress in 
caregivers and thus inhibit their ability to deliver care. Therefore, if distress can 
be identified early through efficient distress screening mechanisms and 
addressed in a constructive manner, then perhaps the quality of life of caregivers 
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– and by extension the experience of the individuals for whom they provide care 
– may be enhanced.  
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Chapter 4 
General Discussion and Integration of Findings 
 
 The overarching purpose of this program of research sought to provide 
insight into the experience of distress and quality of life in individuals with head 
and neck cancer and that of their caregivers. The first study (Chapter 2) 
examined both the presence and trajectory of distress in addition to quality of life 
concerns and commonly reported problems among individuals with head and 
neck cancer. This focus was also enhanced with the solicitation of information at 
standardized three-month intervals throughout the first year following diagnosis. 
The second study (Chapter 3) explored these same dimensions (e.g., distress, 
quality of life, and commonly reported problems) from the perspective of 
caregivers of individuals with head and neck cancer. Collectively, this program of 
research sought to provide a multidimensional perspective on how living with 
head and neck cancer – either as a person with the disease or as a caregiver – 
may contribute to perceptions of distress and quality of life at various points 
throughout the continuum of care. To this end, the integration of findings from 
both the individual- and caregiver-based studies will be discussed in the following 
sections; this will include interpretation in the context of both research and clinical 
implications. 
Distress in head and neck cancer 
In general, findings from the present studies have demonstrated that 
elevated distress can exist at any point along the continuum of care in both 
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individuals with head and neck cancer and their caregivers. In particular, data 
pertaining to individuals with head and neck cancer indicated that distress was 
most prevalent at the point of diagnosis and that the length of time following 
diagnosis had a large effect on the level of perceived distress. These findings 
suggest that for some individuals, time may be an important factor in adapting to 
the challenges associated with the diagnosis of head and neck cancer and its 
treatment. However, the elevated rates of distress detected throughout the 
continuum of care in individuals with head and neck cancer suggest that for 
others, distress may remain an ongoing concern. Meanwhile, data from the 
caregiver study indicated that distress was present in approximately 45 percent 
of all caregiver participants. Further, both the sex of the caregiver and the 
treatment status (i.e., awaiting treatment, undergoing treatment, completed 
treatment) of the individual for whom they were providing care influenced 
perceptions of distress in caregivers. Additionally, the level of perceived burden 
and disruptiveness to one’s life were significantly related to a caregiver’s reported 
level of distress. Despite these trends, it is important to acknowledge that 
individualized responses and variability in data can be expected due to the 
multidimensional subjective nature of distress.  
Notably, an important finding from this program of research was that 
analyses based on mean or frequency-related data alone may reveal only a 
small fragment of the phenomenon of distress in oncology. To elaborate, when 
individual trajectories of distress were analyzed longitudinally, distinct patterns 
emerged (e.g., high-decreasing, low-increasing, consistently low, persistently 
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high reports of distress). This finding provides clear evidence that perceptions of 
distress are indeed individualized and heterogeneous in nature. Similar patterns 
of distress have also been reported in caregiver populations (Choi et al., 2012). 
Consequently, future work that centers on elucidating trajectories of distress (i.e., 
through growth mixture modeling) in both patient and caregiver populations may 
be important for enhancing our understanding of persistent, or chronic distress in 
these individuals. However, despite the potential benefits of trajectory-based 
research, the sheer prevalence and perceived severity of distress observed in 
the present studies suggests that better identification of distress is important in 
order to facilitate the provision of support for those who require it most. As such, 
the employment of routine distress screening represents a critical first step in the 
identification of elevated distress in both those with head and neck cancer and 
their caregivers. 
Accordingly, use of the Distress Thermometer with its accompanying 
Problem Checklist revealed that the potential sources of distress in participants 
were often multifaceted. As such, data from the present studies suggest that not 
everyone who experienced clinically significant distress would necessarily meet 
the standard criteria for a diagnosis of major depression or an anxiety disorder 
(American Psychological Association [APA], 2000). These findings are important 
because they broaden our understanding regarding the range of factors (e.g., 
problems with partner, children, insurance, finances, work, housing, 
concentration, etc.) that may contribute to elevated distress in both caregivers 
and those with head and neck cancer. Currently, most of the commonly used 
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distress assessment measures (e.g., Brief Symptom Inventory, Beck Depression 
Inventory, Hospital Anxiety and Depression Scale, etc.) evaluate the construct of 
distress according to the criteria for depression and/or anxiety disorders (Beck, 
Steer, & Brown, 1993; Derogatis, 2001; Zigmond & Snaith, 1983). Granted, 
distress is defined as an unpleasant emotional experience, but as noted in the 
definition offered by the National Comprehensive Cancer Network (NCCN), it is 
also a multifactorial and multidetermined experience (NCCN, 2013). That is, 
distress emerges as a clinical entity due to the multiple domains that are 
influenced by myriad factors that may change dramatically over time, even over 
relatively short temporal periods. Consequently, it is important that assessments 
of distress in oncology utilize an accompanying multidimensional Problem 
Checklist (or similar multi-item measure) to ascertain specific information 
regarding the myriad potential sources of distress in individuals with head and 
neck cancer and their caregivers (e.g., problems with family, employment, 
nutrition, spirituality, etc.). It is through the consideration of these perceived 
problems and the subjective experience of them, that we may be able to better 
target the sources of support that are required in order to alleviate or mitigate 
elevated distress in these individuals. 
Considerations of quality of life and commonly reported problems 
 It is apparent from the present studies that the concerns facing individuals 
with head and neck cancer and their caregivers are diverse and multidimensional 
in nature. Relative to the subjective experiences of participants, findings from the 
present work suggest that numerous quality of life concerns exist for both 
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individuals with head and neck cancer and caregivers at various stages 
throughout the continuum of care. While the specific concerns cited by 
participants were diverse and clearly based on each person’s experience as 
either the individual with cancer or the caregiver, the common theme that 
emerged from participants in both studies pertained to the perception of elevated 
burden in three primary domains: role fulfillment, physical functioning, and 
psychological well-being.  
Specifically, concerns related to one’s ability to fulfill meaningful roles and 
responsibilities were cited by both caregivers and individuals with cancer. Role 
functioning was assessed according to an individual’s ability to meet work-related 
obligations, engage in daily activities, and pursue hobbies and/or other leisure 
time activities (Aaronson et al., 1993; Weitzner, Jacobsen, Wagner, Friedland, & 
Cox, 1999). The ability to fulfill one’s “roles” in life (e.g., as an employee, spouse, 
parent, etc.), or more importantly, the potential inability to fulfill roles due to 
illness or the demands associated with caring for one who is ill, serves as a 
critical barometer of perceived well-being and associated quality of life. Given 
that previous research has determined that greater perceived disruption to an 
individual’s daily routine resulted in poorer psychological health (Blood, Simpson, 
Dineen, Kauffman, & Raimondi, 1994), the decreased role functioning observed 
in both participant sets in the present studies suggests that these individuals may 
be more susceptible to experiencing elevated distress. A recent investigation into 
the relationship between role functioning and distress has reported similar 
findings (Mols, Thong, de Poll-Franse, Roukema, & Denollet, 2012). 
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Furthermore, existing data on factors that contribute to role functioning in 
individuals with cancer and caregivers has determined that one’s level of 
symptom burden (e.g., fatigue, appetite loss, insomnia, etc.) directly influences 
one’s ability to fulfill role-based activities and obligations (Aaronson et al., 1993; 
Bjordal et al., 2001; Given et al., 2004). Collectively, these data suggest that the 
experience of head and neck cancer, whether as a patient or caregiver, is 
marked by disruption to multiple interrelated domains of functioning, with an 
emphasis on decrements to psychological, role and physical functioning (i.e. 
symptom burden). 
With regard to the issue of reported symptom burden in the present 
studies, not unexpectedly, physical concerns were reported by most individuals 
with head and neck cancer throughout the year following diagnosis. Clinically 
significant increases in symptom burden were observed for several symptoms at 
the three-month assessment (e.g., pain, trismus, xerostomia, sticky saliva, etc.). 
While most symptoms had resolved by the one-year follow-up, clinically 
significant problems related to xerostomia and decreased taste and smell 
persisted. Given that several of the participants underwent radiation therapy as a 
component of their treatment protocol, and since radiation therapy to the head 
and neck region is known to cause these types of treatment-related problems 
(Hunter & Jolly, 2013), these findings were consistent with previous research. 
Additionally, while one might anticipate physical concerns to be prevalent for an 
individual with head and neck cancer given that he or she must live with the 
physical consequences of the disease and its treatment, results from the 
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caregiver study suggest that caregivers also experience an increased level of 
perceived physical burden while serving as a caregiver.  
Interestingly, the most prominent physical concerns reported by caregivers 
(e.g., problems with sleep, fatigue, appetite) were closely aligned with the 
diagnostic criteria for depression (Miller & Massie, 2009). While a formal 
assessment of depression was not conducted in the present study for the 
caregivers, the presence of physical symptoms that have been established as 
physical correlates of depression, suggests that this is an area worth 
investigating further relative to the caregiver experience. While development of 
depression is not believed to be a typical response in caregivers, it may be 
characterized as a significant complication secondary to the increasing demands 
of the caregiver role. As such, it may require individualized assessment and 
treatment given its potential to compromise quality of life and functional status 
(Miller & Massie, 2009).  
With respect to elevated psychological burden, in several instances in the 
present work both caregivers and those with head and neck cancer revealed the 
highest proportion of concerns on the Problem Checklist as emotional problems 
including worry, fears, sadness, nervousness, among others. While the Problem 
Checklist does not assess the perceived severity of the problem experienced, the 
fact that such a high proportion of participants in both studies reported multiple 
emotional items as being problematic (and in the case of the patient study, these 
concerns persisted over time) suggests that emotional problems are common. As 
such, emotional concerns in those with head and neck cancer and those that 
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emerge in caregivers likely warrant further investigation and subsequent action 
towards the mitigation of these concerns where possible. Adding support to this 
interpretation, previous researchers have also suggested that “the ideal 
screening system would include a useful distress screening tool in combination 
with a Problem Checklist” (Zabora & MacMurray, 2012, p.632). Ultimately, the 
present findings support the notion that multidimensional concerns in caregivers 
and individuals with head and neck cancer do in fact exist and that these issues 
must be carefully considered and addressed as part of the comprehensive care 
process. If such a consideration is avoided or disregarded, it is possible that 
one’s level of distress (and the factors contributing to its exacerbation) would 
increase in severity with consequent reductions to one’s perceived quality of life. 
Ultimately, distress is a dynamic experience that can become increasingly 
elevated and burdensome when significant concerns are not addressed in a 
timely manner. As such, the early identification and management of clinically 
significant distress is imperative.  
Identifying and responding to psychological distress  
In order to respond to the consequences of distress among individuals 
with head and neck cancer and their caregivers, it is imperative to first recognize 
its presence. Despite the fact that distress may be causing disruptions in daily 
functioning, many individuals may actively conceal their distress from their 
primary physician and healthcare team (Weisman, 1976; Zabora & MacMurray, 
2012). Individuals displaying such behaviour may rationalize their secretive 
response as an appropriate one because they believe that their physician and 
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healthcare team members need to focus their energy on the treatment of the 
disease (Zabora & MacMurray, 2012), or in the case of caregivers, of their loved 
one’s disease (Zwahlen, Hagenbuch, Jenewein, Carley, & Buchi, 2011). 
Additionally, individuals may not feel comfortable acknowledging that they are not 
coping as well as they believe they should be and that, in fact, they require 
assistance. Conversely, oncologists and healthcare team members may lack the 
time or skills required to accurately identify and refer individuals exhibiting 
significant distress to the appropriate psychological resources (Carlson & Bultz, 
2004; Sollner, 2001; Zabora, Loscalzo, & Weber, 2003). The intersection 
between these two areas of concern (i.e., the inability or unwillingness of either 
the patient or clinician to address the problem) may have devastating 
consequences. More specifically, the outcome of these combined elusive 
approaches is the collective avoidance of the problem in both those with cancer 
and their loved ones. Consequently, distress may remain undisclosed and only 
become apparent when it has increased to a point where the individual is no 
longer able to independently manage the situation. This in turn may then create a 
cascade of psychosocial consequences that become increasingly problematic 
throughout the post-diagnostic trajectory. 
Undetected and untreated distress in individuals with cancer has been 
associated with poorer medical outcomes, decreased compliance and patient 
satisfaction, and increased healthcare costs (Carlson & Bultz, 2004; Zabora, 
Loscalzo, & Smith, 2000). Furthermore, unidentified distress may manifest 
physically as a variety of somatic complaints (e.g., pain, fatigue, etc.), which 
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physicians may respond to by ordering diagnostic tests and treatments that may 
be costly and unnecessary (Breslau, Curbow, Zabora, & Britzenhofeszoc, 2001; 
Zabora & MacMurray, 2012). This manifestation of physical symptoms in 
connection with one’s psychological state highlights an important observation 
pertaining to the relationship between physical and psychological domains. That 
is, while domains of functioning (e.g., physical, psychological, social, spiritual, 
role, etc.) may appear to be discrete entities, in fact they are intrinsically dynamic 
and deeply interrelated with one another. Furthermore, the biopsychosocial 
consequences of this connection between functional domains are evident in not 
only those with head and neck cancer, but also in their caregivers.  
Research has indicated that untreated caregiver distress not only 
compromises psychological well-being, but may also result in physical changes 
to the immune system that can limit glucose control, promote flare-ups in 
autoimmune diseases, and increase vulnerability to cardiovascular diseases 
(Rohleder, Marin, Ma, & Miller, 2009). Thus, a pervasive consequence evident in 
research related to unresolved distress, is that of elevated symptom burden both 
in those with cancer (Aaronson et al., 1993; Bjordal et al., 2001; Given et al., 
2004) and their caregivers (Stenberg, Ruland, & Miaskowski, 2010). Interestingly, 
quality of life data from the present study of individuals with head and neck 
cancer found that all but one domain (i.e., role functioning) of the observed 
clinically significant changes in quality of life scores to be symptom-related (e.g., 
pain, weight, appetite loss, eating, insomnia, trismus, xerostomia, sticky saliva, 
decreased senses). Furthermore, the Problem Checklist data from the present 
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study of caregivers found a high proportion of participants reporting personal 
physical concerns (e.g., problems with sleep, fatigue, eating, etc.) with equal or 
similar frequency to the psychological concerns (e.g., worry, fears, sadness, 
etc.). While these physical consequences were not directly assessed relative to 
their relationship with distress, findings from the present studies seem to suggest 
that elevated symptom burden represents a negative experience that can 
compromise one’s perceived quality of life, and possibly level of distress. Future 
research is required in order to verify these suggestions. Moreover, the ability to 
identify key symptom-related factors that contribute to elevated distress (e.g., 
fatigue, poorly managed pain, inadequate nutritional intake, etc.) may permit 
clinicians to offer simple, yet effective means of reducing distress-related 
symptoms, thereby also potentially reducing the experience of elevated distress. 
 In order to ensure that problems such as distress and the factors 
contributing to its development or exacerbation are identified in a timely manner, 
researchers and clinicians alike have recommended the use of systematic 
distress screening in order to identify those individuals who are experiencing 
elevated distress (NCCN, 2013). Researchers and psychologists have noted the 
importance of distress screening given that individuals who need psychosocial 
support often do not seek out resources for themselves (Waller, Williams, Groff, 
Bultz, & Carlson, 2011). Without screening and proper identification of distress 
many problems may remain unresolved even after the first year following 
diagnosis (Carlson, Waller, Groff, Giese-Davis, & Bultz, 2013). While the problem 
of distress in oncology was first described in the mid 1970’s by Weisman 
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(Weisman, 1976)13, the impetus for systematically identifying distress through 
screening programs in oncology has only gained global momentum over the past 
decade (Bultz & Johansen, 2011). In particular, relative to the acknowledgement 
of distress from a research perspective, there has been a significant increase in 
the number of research publications addressing the identification and 
management of distress in oncology since 2006, with a marked increase 
occurring in 2010 (Bultz & Johansen, 2011). However, despite this increased 
level of research and scholarship on this topic, questions remain regarding how 
to adequately address the problem of distress in oncology.  
Research has indicated that distress screening can be performed through 
a number of procedures including open interview, semi-structured interviews, or 
more frequently and pragmatically, through utilization of self-report 
questionnaires (Laraway & Rogers, 2012). Recently, standards for distress 
screening procedures have been developed by national psychosocial oncology 
organizations such as the Canadian Association for Psychosocial Oncology 
(CAPO) (CAPO, 2010) and the NCCN (NCCN, 2013). These recommendations 
have subsequently been endorsed by the American College of Surgeons (ACS) 
(ACS, 2012) and Canadian cancer accreditation agencies (Bultz et al., 2011). 
Further, several of these organizations (e.g., ACS, CAPO, NCCN) have 
recommended the routine use of self-report questionnaires that are specifically 
designed to screen for distress, such as the Distress Thermometer (NCCN, 
                                                 
13
 Karnofsky and Burchenal (1949) also noted the important role of “mood” in their early 
assessments of performance status in palliative care.  
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2013) and an accompanying Problem Checklist, in order to facilitate the 
identification of distress (ACS, 2012; CAPO, 2010; NCCN, 2013). 
Distress screening provides a simple and reliable method of identifying 
individuals who are experiencing problematic levels of distress. The use of self-
report surveys may be particularly useful for individuals who do not openly reveal 
their distress when speaking with physicians and healthcare professionals 
(Zabora et al., 2003; Zabora & MacMurray, 2012). That is, while some individuals 
may not be comfortable verbalizing their concerns, they may have a willingness 
to acknowledge a concern in this written, self-report format. By doing so, they 
may then provide an opportunity for the problem to be recognized by the 
healthcare team and, hopefully, provide the option to address the problem more 
directly. It may also promote the opportunity for the practitioner and the patient 
and/or caregiver to engage in a broader and more meaningful discussion relative 
to how the patient or caregiver is really doing. Moreover, the use of distress-
screening tools may communicate to individuals that the healthcare team is 
concerned about their quality of life and psychological well-being (Zabora & 
MacMurray, 2012). Based on its potential for quick scoring and interpretation, the 
Distress Thermometer and an accompanying Problem Checklist may be an 
appropriate distress-screening tool for clinical use. Additionally, the Distress 
Thermometer is quick to use, efficient to administer, and most importantly (from a 
research perspective) it is a statistically valid tool (Patrick-Miller, Broccoli, Much, 
& Levine, 2004; Ransom, Jacobsen, & Booth-Jones, 2006; Zwahlen, Hagenbuch, 
Carley, Recklitis, & Buchi, 2008). Ultimately the routine use of distress-screening 
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tools may provide a cost-effective means of identifying clinically significant levels 
of distress for individuals with head and neck cancer and their caregivers. 
However, it is also imperative to note that while distress screening may provide 
significant advantages towards the identification of problematic distress in those 
with head and neck cancer and their caregivers, screening alone is insufficient. 
Consequently, identification of distress is only the initial step in the clinical effort 
to alleviate the areas of concern that contribute to elevated distress in both those 
with head and neck cancer and their caregivers. 
Management of distress 
 In essence, the process of distress screening involves determining the 
level of risk presented by an individual’s psychosocial challenges and unmet 
needs and subsequently, ascertaining the degree to which assistance is desired 
or needed (Mitchell, 2011). Once the concerns have been identified and the 
desire for assistance has been expressed, the process of distress management 
may commence. Ideally, as soon as possible following the disclosure of clinically 
significant distress, a healthcare team member should meet with the individual to 
conduct a comprehensive assessment (Clark et al., 2012). This assessment 
should seek to gather, analyze, and synthesize information regarding the 
presence of psychosocial issues that may compromise the individual’s ability to 
make healthcare-related decisions, manage their illness (or their loved one’s 
illness), or maintain a desirable level of quality of life (Clark et al., 2012). 
Specifically, the assessment should include a discussion regarding psychological 
and behavioural symptoms (e.g., anxiety, worry, inability to experience pleasure 
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from usually enjoyable activities, etc.), physical symptoms (e.g., appetite, sleep, 
fatigue, etc.), the need for financial and/or spiritual support, concerns about body 
image, sexuality, and suicidal ideation, in addition to an assessment of existing 
coping mechanisms and social support networks (NCCN, 2013). Specific 
strategies for the management of distress will likely vary based on the 
information provided by the distressed individual. But it is clear that identification 
of concerns provides the pivotal starting point from which problems identified can 
be directly addressed as part of the cancer care process. Avoiding such 
identification, or acquisition of incomplete information is likely to contribute 
negatively to both short- and long-term cancer care outcomes. 
Multiple studies have demonstrated that certain forms of psychosocial 
intervention, including cognitive behavioural therapy and psycho-educational 
interventions, can be beneficial towards the goal of reducing distress in oncology 
(Chambers, Pinnock, Lepore, Hughes, & O’Connell, 2011; Fors et al., 2010; 
Hammerlid et al., 1999; Newell, Sanson-Fisher, & Savolainen, 2002). For 
instance, psychosocial interventions involving counseling (either structured or 
unstructured) and guided imagery improved quality of life and the general 
functioning of individuals with cancer (Newell et al., 2002), whereas psycho-
educational interventions (i.e., support group information sessions), skills 
training, and therapeutic counseling proved effective for caregivers (Northouse, 
Katapodi, Song, Zhang, & Mood, 2010). Additionally, online counseling and 
support groups have also been found to reduce distress in both caregivers and 
individuals with cancer when moderated by a registered mental health 
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professional (e.g., psychologist, social worker) (Ruland et al., 2013; Taylor & 
Luce, 2003). The proliferation of internet-based resources such as support 
groups that are conducted by registered health practitioners may provide another 
useful resource for caregivers and individuals with head and neck cancer, 
particularly if individuals live in a rural and remote setting or if they feel 
uncomfortable disclosing personal issues in a face-to-face forum. Irrespective of 
the specific type of intervention that is utilized, the key matter of importance is 
that distress is treatable (Carlson, Waller, Groff, Zhong, & Bultz, 2012) and its 
effective management has demonstrated worthwhile cost-benefit savings to the 
healthcare system (Bultz & Carlson, 2005). Moreover, this economic perspective 
provided by Bultz and Carlson (2005) suggests that if distress can be identified 
early and managed effectively, then we may be able to not only improve the 
overall functioning of those with cancer and their caregivers, but we may also 
potentially reduce the economic burden on the healthcare system that arises as a 
result of untreated or poorly managed distress. Therefore, a comprehensive 
discussion of the problem of distress in oncology would be remiss without 
acknowledgment of the economic implications of failing to address this problem. 
Economic Implications  
Despite acknowledgement by the medical community of the significant 
psychological burden and distress associated with a cancer diagnosis and the 
consequences of its treatment, there has been minimal effort to modify clinical 
practice, increase relevant hospital budgets, or implement third-party coverage 
for this key component of healthcare (Bultz & Carlson, 2005). Within Canada 
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where the provision of healthcare is both publicly funded and delivered, a survey 
of provincial cancer centers found that less than three percent of cancer agency 
operating dollars were directed towards psychosocial care (Bultz, 2002; as cited 
in, Bultz & Carlson, 2005). However, many forms of psychosocial intervention 
such as peer-counseling or support groups place little to no economic burden on 
the healthcare system and have been shown to be effective means of decreasing 
distress (Blake-Mortimer, Gore-Felton, Kimerling, Turner-Cobb, & Spiegel, 1999; 
Northouse et al., 2010; Ruland et al., 2013). The failure to identify and 
appropriately manage distress in oncology results in increased costs – both 
personal costs to the individual and financial costs to the healthcare system. 
In terms of the financial impact of psychosocial support on the healthcare 
system, a number of studies have noted benefits to individuals with either no 
added cost to the system or even reductions in overall costs. For instance, a 
meta-analysis of 90 studies established that psychosocial interventions were able 
to offset health expenditures by an average of 20% (Chiles, Lambert, & Hatch, 
1999), providing a considerable financial benefit to the system. Additionally, a 
recent systematic review on the economic value of psychosocial interventions 
determined that psychosocial interventions are inexpensive on a per patient 
basis and have the potential to improve quality adjusted life years with minimal 
financial input on the part of the healthcare system (Gordon, Beesley, & 
Scuffham, 2011). Thus, through reduction of the emotional and personal burden 
of cancer, it may also be possible to reduce its associated economic burden. Full 
acknowledgment of the “human side” of cancer care and a family-based 
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approach to the delivery of care are essential components of a compassionate 
and well-managed oncology program.  
Summary of contributions 
This program of inquiry into distress represents a salient and timely 
contribution to the literature. An important contribution of the first study (Chapter 
2) was the inclusion of participants often excluded from head and neck 
psychosocial oncology research; namely, those individuals who had received 
“bad news”, were not receiving treatment for a curative intent, had previously 
been diagnosed with depression, or those who had experienced a recurrence or 
metastases of their disease. While we acknowledge that there may be instances 
where inviting an individual to participate in a research protocol may be 
inappropriate and/or insensitive to the circumstances they are facing, distress-
related research that purposely excludes individuals who are experiencing a 
distressing life event, or those who may be prone to experiencing pathologic 
distress, arguably fails to provide a comprehensive perspective on the very 
factors which may both cause and exacerbate distress in these individuals. To 
willingly exclude this data from such individuals runs contrary to the intent of 
seeking to accurately understand the presence and impact that distress has 
across the disease trajectory. Consequently, we believe that the purposeful 
inclusion of individuals typically excluded from psychosocial oncology research in 
head and neck cancer represents an important first step in encouraging a more 
inclusive approach to psychosocial oncology research practices. As a result, we 
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believe this inclusionary approach may serve to identify a more accurate 
representation of distress that occurs in this unique clinical population. 
To the authors’ knowledge, the second study (Chapter 3) is the first to 
explore perceived distress and quality of life concerns in caregivers of individuals 
with head and neck cancer who have been either recently diagnosed (e.g., less 
than one week from diagnosis) or those who are long-term survivors (e.g. more 
than 20 years from diagnosis). Furthermore, this study also represents the first 
effort to utilize a single-item distress measure (e.g., Distress Thermometer) in 
caregivers of individuals with head and neck cancer. Ultrashort measures such 
as the Distress Thermometer have proven to be useful and effective for distress 
screening in busy, clinical environments (Vodermaier, Linden, & Siu, 2009). 
Consequently, use of the Distress Thermometer in head and neck cancer 
caregiver populations may afford the opportunity to promote the regular 
screening of distress, given its reliability and ease of use clinically (Vodermaier et 
al., 2009). Finally, this study is the first to report that the level of perceived 
distress in caregivers is related to the treatment status of the individuals with 
head and neck cancer (e.g., awaiting treatment, undergoing treatment, 
completed treatment) rather than the length of time since diagnosis, a suggestion 
that has been a prevailing hypothesis within psychosocial oncology literature 
(Hodges, Humphris, & Macfarlane, 2005). Further, we determined that this 
difference represented a large effect, which suggests that one’s treatment stage 
may have a sizeable and significant impact on perceptions of caregiver distress. 
While additional work is certainly required in order to verify this relationship, the  
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present findings suggest several specific recommendations for study.  
Directions for future research 
 First, since data from the caregiver study (Chapter 3) revealed that the 
treatment status of the individual with head and neck cancer (i.e., one’s position 
relative to the progression of treatment – awaiting, undergoing, completed) was 
significantly related to the distress level of the caregiver, additional research that 
investigates perceived distress relative to treatment status is recommended. In 
order to evaluate this potential relationship in a rigorous manner, the use of 
prospective, longitudinal designs are advised. Longitudinal analysis that employs 
regular follow-up with participants at each stage of treatment progression (e.g., 
awaiting, undergoing, completed) will likely elicit the most comprehensive data 
relative to potential facets of the relationship between caregiver distress and an 
individual’s treatment status.  
Furthermore, the assessment of trajectories of distress in both individuals 
with head and neck cancer and their caregivers is strongly recommended. To 
date, research conducted using mixed growth modeling techniques has revealed 
distinct patterns of distress that have challenged the accepted notion that 
distress declines over time (Choi et al., 2012; Fielding & Lam, 2013; Helgeson, 
Snyder, & Seltman, 2004; Lam, Ye, & Fielding, 2012; Lam et al., 2009; Lam et 
al., 2011; Lam, Shing, Bonanno, Mancini, & Fielding, 2012). Further, since 
research has suggested that between 5-20% of individuals with cancer 
experience chronically high levels of distress throughout the duration of the 
cancer trajectory (Lam et al., 2012; Lam et al., 2009; Lam et al., 2011; Lam et al., 
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2012), the ability to identify these chronically distressed individuals and 
subsequently provide psychosocial support should be a key goal of future clinical 
inquiry. Through this enhanced knowledge, we may be better able to understand 
the process of distress in oncology with the goal of working towards its reduction 
or alleviation.   
Additionally, given the highly individualized and heterogeneous nature of 
distress in both those with head and neck cancer and their caregivers, results of 
the present investigation would seem to support the acknowledgement of 
distress as the sixth vital sign, indicating that it should be monitored routinely. 
Thus, it may be valuable to investigate the feasibility and utility of implementing a 
standard distress screening program for both those with cancer and their 
caregivers. Owing to the brief nature of its administration and scoring 
procedures, an ultrashort instrument such as the Distress Thermometer has 
been recommended for use in busy clinical environments (Vodermaier et al., 
2009). However, given that caregivers of individuals with head and neck cancer 
may not be physically present at each clinical appointment, the ability to screen 
caregivers in-person during clinical visits may not always be feasible. Similarly, 
ongoing distress screening and management also may be challenging for 
individuals who live in rural or remote settings. Consequently, research that 
examines how health technology (e.g., Internet, Telehealth, smart phones, etc.) 
can be effectively used to identify and manage distress in individuals with head 
and neck cancer and their caregivers may be beneficial. The use of novel 
sources of health-related technology to engage in distress screening and 
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management may help to facilitate the routine and universal screening of distress 
in those with cancer and their caregivers. Ultimately, future research that builds 
on the insights gained within the present program of research could enhance the 
understanding of distress in oncology, as well as improve efforts to both identify 
and manage it in both individuals with head and neck cancer and their 
caregivers. By doing so, the comprehensiveness of care may be enhanced and 
long-term outcomes for both individuals with head and neck cancer and their 
caregivers may be optimized. 
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